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SUMMARY
Vascular hypertrophy has been identified as an important process in the 
development of essential hypertension. At present, the nature by which 
hemodynamic forces contribute to this process is poorly understood. To 
address the role of a hemodynamic component, the effect of a stretching force 
on vascular smooth muscle and endothelial cell function, was investigated.
This project involved the development of an in vitro cell stretching 
system which satisfied the essential criteria of a sterile, cell culture system. An 
initial proto-type was developed which vertically displaced cells grown on 
flexible membranes, by means of a vacuum. The surface area of the base of 
the dish was increased in response to suction and hence the cells attached to 
the base of the dish stretched. A non-uniform stretch of limited range was 
achieved using this system.
The second proto-type developed involved growing cells on silicone 
sheeting, mounted on a frame. Cells attached to the sheeting were stretched 
by increasing the length of the silicone. Due to the design of the system a fixed 
stretch within the range of 0-20% was achieved.
20% stretch stimulated c-fos mRNA expression and increased 
phosphoinositide turnover, in vsmc. However, 20% stretch did not induce c- 
jun or c-myc mRNA expression in vsmc. Mechanical stretch increased vsmc 
growth, although did not reach statistical significance. Endothelial cell studies 
showed that c-fos and c-jun mRNA expression was increased in response to 
20% stretch.
The results of these studies suggest that mechanical stretch may be an 
important stimulus, for the activation of signalling mechanisms, involved in 
vascular smooth muscle and endothelial cell growth. Therefore, such a force 
may play an important role in the development of vascular hypertrophy.
v
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CHAPTER ONE 
INTRODUCTION
1
1.1 Blood pressure and hypertension
1.1.1 Blood pressure
Blood circulates under pressure in a closed vascular system. This 
pressure is the resultant of cardiac output (CO) and the total peripheral 
resistance (TPR). CO is expressed as the volume of blood ejected from 
the left ventricle per minute. TPR takes into account the phasic changes 
in pressure during the cardiac cycle in relation to the elasticity and 
geometry of the large arteries, the inertial and viscous properties of the 
blood and the resistance to flow posed by small muscular arteries and 
arterioles.
The pressure within the vessels when the heart rythmically 
contracts is termed systolic blood pressure (SBP) and diastolic blood 
pressure (DBP) that which exists during the relaxation period. A normal 
range of values for systolic and diastolic pressures are 110-130/65-80 
mmHg (i.e systolic/diastolic).
Blood pressure is regulated by many factors of neural, endocrine 
and renal origin 1. Vasomotor nerves belonging to the autonomic 
nervous system and baroreceptors which are pressure-sensitive 
receptors located at strategic points in the arterial side of the circulation, 
can influence blood pressure. Deviations from a previously stable level 
of blood pressure affect these baroreceptors and elicit reflexes 
influencing the activity of the heart and blood vessels, so as to 
compensate for the deviation, such that blood pressure tends to return 
to its initial level. Humoral factors such as carbon dioxide concentration 
« C 0 2]). pH, adrenal medulla catecholamines, adrenal cortical 
hormones and vasopressin (AVP) also play a role in blood pressure 
regulation. A rise in [C 02] in the circulation dilates peripheral blood 
vessels and decreases blood pressure. A fall in pH also leads to a 
reduction in blood pressure by impairing the responsiveness of the 
blood vessel to noradrenaline and other vasoconstrictors. The 
catecholamine, adrenaline, increases SBP and decreases DBP. In 
conditions of adrenocortical insufficiency, the permeability of the 
capillaries is increased, an impaired responsiveness of blood vessels 
to noradrenaline exists and thus blood pressure is lowered. The 
posterior pituitary hormone AVP causes constriction of blood vessels 
and hence an increased pressure. Prostaglandins of the E series cause
2
a decrease in TPR and thus reduce blood pressure. The prostaglandin 
inhibitor indomethacin increases TPR in normotensive humans 2, which 
supports the role of prostaglandins in blood pressure control. Nitric 
oxide (NO) and endothelin, both derived from the endothelium of the 
vessel wall are known to have contrasting effects on blood pressure. 
NO relaxes blood vessels and decreases blood pressure, whereas 
endothelin raises blood pressure by potentiating constriction. 
Angiotensin II (ANG II), the function of which will be discussed in 
greater detail in section 1.3.1.3, exerts a direct vasoconstrictor action 
which leads to an elevation in blood pressure. In addition ANG II, 
releases aldosterone which results in salt and water retention with a 
rise in extracellular fluid volume and circulating blood volume. This 
results in an increased CO.
Under normal situations of stress or increased physical activity 
blood pressure rises. However, if the blood pressure remains 
persistently elevated above 140/90 mm Hg, the patient is classified as 
hypertensive.
1.1.2 Hypertension
Hypertension or high systemic arterial blood pressure may be divided 
into two groups: secondary hypertension in which the elevation of 
blood pressure is a consequence of another disorder or can be 
assigned to a clearly identifiable cause, and essential (primary) 
hypertension in which the underlying cause is not known.
1.1.2.1 Secondary hypertension
Many causes of secondary hypertension have been identified. Among 
these are renovascular disease where stenosis or arteriosclerosis 
restrict blood flow to one or both kidneys. Frequently, correction of the 
lesion results in amelioration of hypertension. Glomerulonephritis, an 
inflammatory disease of the glomerulus potentiates hypertension. A 
variety of hormone-secreting tumours also raise blood pressure. These 
include adrenal medullary chromaffin tumours s e c re tin g  
catecholamines, aldosterone- and cortisol-secreting tumours of the
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adrenal cortex and renln-secreting tumours of the kidney. 
Adrenocorticotrophic hormone- (ACTH) secreting tumours of the 
anterior pituitary excessively stimulate cortisol secretion containing 
hypertension. Finally, a series of inborn errors of corticosteroid 
biosynthesis and metabolism are associated with hypertension.
Hypertension can result as an effect of drugs including 
sympathomimetic amines, monoamine oxidase inhibitors, thyroid 
hormones, or oral contraceptives. The sympathomimetic amine 
ephidrine is given in the treatment of asthma. However, this drug acts 
on a-adrenoceptors in the blood vessel to produce a rise in blood 
pressure. The monoamine oxidase inhibitor pargyline is used as an 
antihypertensive agent because it inhibits the catabolism of 
catecholamines. However, the interaction of these agents with 
sympathomimetic amines can induce a severe hypertensive response. 
The thyroid hormone, thyroxine produces an increase in SBP and heart 
rate. There is a risk of development of hypertension or exacerbation of 
existing hypertension from oral contraceptives.
Unfortunately, these known causes of hypertension represent 
only a small proportion of cases.
1.1.2.2 Essential hypertension
Environmental and genetic factors play important roles in the 
development of essential hypertension.
Batumen 3 discovered that lead was the probable cause of 
essential hypertension in industrial workers. Increased salt intake, 
saturated fat and cholesterol, physical inactivity, increased intake of 
calories, obesity and stress have all been suggested to be factors 
which could potentiate coronary heart disease (Singh et aL4). Smoking 
is also known to be an important risk factor in the development of 
essential hypertension.
When these are accounted for it appears that a large proportion 
of the phenotypic variation observed in blood pressure is genetically 
determined 5. The variation in blood pressure appears to be accounted 
for by the sum of the variation in many genes, indicating that blood 
pressure is inherited as a polygenic trait. The nature of the genes 
responsible for the variability in blood pressure has not been 
elucidated although recombinant DNA technology is currently being
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applied to provide a better understanding of the role of genetic factors 
in hypertension .
Hypertensive patients are more likely to develop ischaemic heart 
disease and cerebrovascular disease (stroke). Because these risks are 
closely related to blood pressure and because blood pressure is 
abnormally increased in 15% of the adult population, hypertension is 
an important disorder.
1.1.2.3 Changes in vascular structure
In hypertension, changes in the vascular structure of the heart and 
vessels are evident. Left ventricular hypertrophy (LVH) occurs as a 
response of the heart to an increased workload. Meerson 6 
summarised the development of LVH as a progression through 3 
stages; hyperfunction, adaptive hypertrophy and ultimately failure. The 
actual shape of the adapting ventricular chamber depends on the 
nature of the hemodynamic overload. With pressure overload alone, 
blood is ejected against an increasing TPR (increased afterload) which 
causes the chamber to develop a concentric hypertrophy. Concentric 
hypertrophy is characterised by an increase in the thickness of the 
walls of the organ,with no enlargement and with diminished capacity 
(see Figure 1). With volume overload, an excessive venous return 
encourages the hypertrophy to adopt an eccentric morphology (see 
Figure 1), where hypertrophy of the organ occurs with a dilation of it's 
cavity 7 Two factors which can account for the variability of LVH other 
than overload are age and race 8. With advanced age, the hypertrophic 
response to either volume or pressure overload is attenuated. There is 
a greater prevalence of hypertension in blacks than whites.
The media of the rat aorta subjected to increased intraluminal 
pressure had a greater diameter, thickness and cross-sectional area 
than the media of normotensive animals 9*10. The increase in thickness 
was due to smooth muscle cell (smc) hypertrophy and/or hyperplasia. 
In the vascular beds of rats 11 and rabbits 12, hypertension increases 
the uptake of tritiated thymidine (a measurement of cell growth) in smc, 
strongly suggesting that vascular changes in the vessel wall occur in 
response to hypertension.
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Normal Eccentric
hypertrophy
Concentric
hypertrophy
Figure 1 Left ventricular hypertrophy.
If the thickness of the wall relative to the radius of the 
chamber does not increase proportionately, the volume of the 
chamber is increased and eccentric LVH occurs. However, if 
both relative wall thickness and left ventricular mass increase 
concentric LVH occurs.
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1.2 Vascular hypertrophy
The above evidence suggests that a relationship exists between 
pressure and hypertrophy. To study this relationship, it is necessary to 
begin by analysing the process of vascular hypertrophy.
Vascular hypertrophy can be defined as an increase in the size 
of the components of the blood vessel wall. Vascular hypertrophy is a 
common finding in resistance vessels in human and experimental 
hypertension. These changes could result from:
(1) An increase in individual smc size, known as hypertrophy 13>
14 .
(2) Depending on the site of the vessel, an increase in the cell 
number, defined as hyperplasia 13> 15. Yamori et a [.16 observed an 
increased growth rate of vsmc prepared from an experimental model of 
hypertension known as the spontaneously hypertensive rat (SHR), 
when compared to those of the control, normotensive Wistar-Kyoto 
(WKY) strain.
(3) Increases of collagen 17 and myosin 18. An increase in 
myosin content renders the vessel more responsive to vasoconstrictor 
agents. As a result of increased collagen content the vessel becomes 
stiff e r 19.
(4) Remodelling (See Figure 2). This involves a redistribution of 
vascular material to produce an increased media:lumen ratio, with no 
change in media mass, but a reduced lumen diameter (Figure 2c). In 
human essential hypertension, an increased media:lumen ratio has 
been observed in the vessels from hypertensive patients. However, the 
media volume per unit length was unchanged 20. This suggested that 
the number of cells was the same and that the increased media:lumen 
ratio was due to remodelling.
1.2.1 Folkow's amplifier
The positive feedback mechanism in Figure 3 illustrates the proposed 
relationship which exists betwen vascular hypertrophy and pressure.
It is known that blood vessels are hypertrophic in established 
hypertension, that increased pressure causes hypertrophy and that 
hypertrophy can increase resistance thereby raising blood pressure. 
These events have been linked by Folkow 21 (Figure 3). He proposed
7
(a)
Wall
thickness
I
Lumen
radius
(b)
(c)
Figure 2 Structural changes of arteries.
The media cross section of a control vessel is illustrated on 
the left. The various ways in which the media lumen ratio can 
be increased are shown on the right.
(a) When material is added to the outer surface of the vessel 
an increase in media thickness occurs.
(b) When material is added to the inner surface of the vessel 
the radius of the lumen decreases.
(c) Remodelling. When rearrangement of the existing material 
occurs.
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Overactive
pressor
mechanism
Elevated
blood ^ _______  Hypertrophy
pressure
positive feedback mechanism
Figure 3 The mechanisms by which a pressor agent and a 
growth factor can independently contribute to the 
development of vascular hypertrophy.
Growth
factor
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that minor overactivity of a pressor mechanism could raise blood 
pressure slightly. The result of this continued overactivity is to cause 
hypertrophy with further increases in blood pressure, through the 
positive feedback process. Thus a sustained rise of pressure could 
result from a very small pressor signal. This information has identified 
the importance of a hemodynamic component in producing elevated 
blood pressure. However, vascular hypertrophy sometimes precedes 
the rise of blood pressure observed in hypertension 22. 23. j o  explain 
this latter observation, a second component must play a role in 
elevating blood pressure independently of the pressure component. 
Furthermore pressure has been shown to be unchanged or slightly 
elevated in the venous system and in the right side of the heart in 
hypertension 24- 25, but hypertrophy develops in the veins of patients 
with hypertension and in the veins and pulmonary artery of 
hypertensive rats 26* 27. In the SHR, proof exists that hypertrophy either 
precedes the rise of blood pressure or occurs when blood pressure is 
only slightly raised 28« 29. To explain these observations, Lever 30 
postulated that the second mechanism is a trophic factor which could 
produce elevated blood pressure by hypertrophy, independently of 
pressure. Two possible trophic factors are noradrenaline and ANG II, 
both of which have been shown to stimulate the growth of vascular 
smooth muscle cells (vsmc) in vitro 31 • 32»33
1.3 Non-hemodynamic mechanisms
There are many theories on the pathogenesis of hypertension. The 
cause(s) of essential hypertension is not known and even where 
causes of secondary hypertension are known, there is disagreement on 
the mechanism by which arterial pressure is raised. However, it is clear 
from the literature that both hemodynamic and non-hemodynamic 
factors contribute to the development of vascular hypertrophy. The 
following section reviews the literature which discusses the importance 
of these 2 components.
In recent years, two factors have emerged as important 
nonhemodynamic agents in the development and reversal of 
ventricular hypertrophy, namely growth promoting substances and 
pharmacological agents. In the past, only the renin-angiotensin (RAS) 
and adrenergic nervous systems were believed to participate
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independently, or in association with hemodynamic changes in the 
hypertrophic process. It is now known that other naturally occurring 
humoral and vasoactive agents including growth factors participate in 
vascular and myocardial cell protein synthesis and growth.
1.3.1 Growth factors
Growth factors are agents which stimulate cell division. Examples are 
platelet-derived growth factor (PDGF), insulin-like growth factor (IGF), 
fibroblast growth factor (FGF), epidermal growth factor (EGF), 
transforming growth factor p (TGFp) and heparin-binding growth factor 
type one (HBGF-1). This will be discussed in greater detail in section 
1.3.1.4. The growth promoting agents considered in this section are 
proto-oncogenes.
1.3.1.1 Proto-oncogenes
Proto-oncogenes are the cellular homologues of oncogenes carried by 
retroviruses. Because oncogenes were shown to be involved in 
conditions of abnormal growth, this led to the idea that p ro to­
oncogenes may be involved in cell growth. Since then, it has become 
apparent that oncogenes are normal eukaryotic genes which have 
undergone a structural mutation, as a consequence of retroviral 
infection. A portion of the host's DNA has become incorporated with the 
viral genome and through a process of mutation, a new set of genes 
have been produced. Proto-oncogenes encode vital regulators of 
normal mitosis and cell growth. The involvement of proto-oncogenes in 
hypertension has been studied by looking at the effect of the pressor 
peptide, ANG II (see section 1.3.1.3) on proto-oncogene expression, in 
vsmc. Addition of ANG II to smc in culture, stimulated expression of the 
proto-oncogenes c-myc, c-fos and c-jun 34» 35> 36« 37. The proto­
oncogene c-myc has also been identified as playing a role in T cell 
and myeloid cell death 38»39. Thus the involvement of proto-oncogenes 
in cell growth is well established.
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Nomenclature
There is an accepted nomenclature which is used when discussing 
proto-oncogenes. The proto-oncogenes which are the normal cellular 
homologues of the gene are prefixed by c, e.g c-fos. The vira l 
oncogene is prefixed by v, e.g v-fos. Both the cellular and viral genes 
are written in italics. When discussing the protein products of proto­
oncogenes, e.g that of c-fos , the prefix and the italics are dropped and 
the protein is written as Fos.
Regulation of transcription
The protein products of the proto-oncogenes c-fos, c-myc, andc-yt/n 
exist within the nucleus, where their primary role is to regulate gene 
expression, by modulating the process of transcription.
The protein products of the proto-oncogenes c-fos (Fos) and c- 
jun (Jun) interact with each other to form a heterodimeric transcription 
factor, via the formation of a leucine zipper40, as shown in Figure 4. 
The leucine zipper domain is an a-helical structure composed of 
leucine residues spaced seven amino acids apart. This structure 
promotes dimerisation. The Fos/Jun heterodimer binds with high affinity 
and specificity to DNA elements of the 12-0-tetradecanoylphorbol-13- 
acetate response element (TRE) consensus sequence, a basic 
sequence derived from a large set of observed similar sequences. TRE 
was first identified as a phorbol ester-inducible promoter element, and 
the binding site for the transcription factor, AP-1 41 > 42> 43. Much 
evidence has indicated that the expression of c-fos and c-jun are 
rapidly induced by a number of external stimuli and that the Fos/Jun 
complex then turns on the expression of late response genes 
containing AP-1 sites 44.
c-myc has been implicated in controlling both proliferation and 
differentiation in various cell types 45. Increased expression of c-myc 
resulted in an increase in the rate of proliferation and prevented 
differentiation in mouse erythroleukemia cells 46. c-myc is abundantly 
expressed in the heart during the fetal period. However, its expression 
becomes undetectable soon after birth 47. This observation suggests a
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Figure 4 The formation of a leucine zipper.
The Fos and Jun proteins interact via their DNA binding 
domains. These sequences are located 7 amino acids apart. 
When multiple interactions of the Fos and Jun binding 
domains occur, this promotes the formation of an a-helix.
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relationship between c-myc expression and cardiocyte proliferation, 
which was supported by findings in transgenic mice 43
Thus, proto-oncogenes appear to have a key role in cell growth 
through their involvement in the process of transcription. Various proto­
oncogenes have been identified in vascular tissue and their function in 
vascular tissue may also be of a proliferative nature.
Other functions of proto-oncogenes
The protein products of proto-oncogenes are diverse as are their 
functions. However there appear to be three main categories under 
which these functions can be classified:
The c-mos proto-oncogene encodes for a protein kinase 
required for normal progesterone-induced maturation of frog oocytes 
and plays an important role in the activation of the cell cycle promoter, 
mitosis phase promoting factor (MPF)49. A serine/threonine protein 
kinase, which is strongly expressed in neonatal and adult rat tissue and 
cells is encoded byc-raf 50.
c-ras proteins were identified as guanine nucleotide-binding 
proteins (G proteins), in bovine brain, by Yamashita e\ aL 51. As G 
proteins are known to exert strict control of the activity of adenylate 
cyclase (AC), this suggests a role for Ras proteins as second 
messengers. There is a delayed increase in c-ras mRNA after aortic 
constriction in adult rat aorta 47. The fact that proto-oncogenes have 
second messenger effects and that they occur in vascular tissue where 
hypertrophy has been induced is strong evidence of a key role for 
proto-oncogenes in vascular growth.
Many proto-oncogene proteins have been shown to exhibit 
structural homology with growth factors or their receptors. This function 
is the most convincing evidence that proto-oncogenes are involved in 
cell growth. For example, the protein product of c-sis has been 
identified as one chain of the PDGF molecule 52. The product of c-erbB 
encodes part of the EGF receptor 53. C-mas encodes for a neuronal 
ANG II receptor53. Hunter 54identified the proto-oncogenes ros, met, 
and trk as being related to the insulin receptor.
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1.3.1.2 Mechanism of action of growth factors (Figure 5)
The plasma membrane contains many lipid precursors which when 
activated, for example by hormones, can serve as substrates for the 
generation of second messengers 55. A growth factor can interact with 
a receptor on the cell surface to cause activation of the enzyme 
phospholipase C (PLC) via the action of a G protein. G proteins are 
composed of three distinct subunits, a, p and y. The Py exist as a tightly 
associated complex that functions as a unit. The a-subunits have a 
single site for guanosine diphosphate (GDP) or GTP. The GDP-bound 
form of a binds tightly to py and is inactive, whereas the GTP-bound 
form of a dissocates and becomes active. The hydrolysis of 
phosphatidyl inositol 4, 5 bisphosphate (PIP2) is markedly stimulated 
by hydrolysis-resistant analogues of GTP, which will favour the active 
conformation of the G protein, and by aluminium fluoride (AIF4-), which 
can interact with a-bound GDP to mimic GTP and activate the a-subunit 
of the G-protein. The inhibition of this cascade by pertussis toxin, which 
is known to inhibit the Gj-protein, also points to the participation of a G 
protein in the signalling events associated with cell growth. The 
activation of PLC then catalyses the breakdown of PIP2, an inositol 
glycolipid located in the inner leaflet of the plasma membrane. Many 
inositol phosphates as well as diacylglycerol (DAG) are the products of 
this catalytic breakdown. Inositol phosphates can be converted to 
inositol by the sequential action of phosphatases.
It is now clear that phosphatidylcholine (PC) hydrolysis also 
contributes to the generation of DAG in the later phases of cellular 
responses and a possible role of phospholipase D (PLD) in the 
activation of protein kinase C (PKC) has been proposed 56>57
Inositol 1, 4, 5 trisphosphate (IP3) is a short lived messenger 
causing the rapid release of calcium ions (Ca2+)from intracellular 
stores. The elevated Ca2+ concentration ([Ca2+]) in the cytosol then 
triggers processes such as smooth muscle contraction, glycogen 
breakdown and exocytosis. DAG activates PKC which phosphorylates 
many target proteins at serine and threonine residues, leading to many 
physiological events. For example, the phosphorylation of glycogen 
synthase by PKC stops the synthesis of glycogen. PKC is enzymatically 
active only in the presence of Ca2+ and phosphatidylserine (PS). DAG
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Figure 5 The mechanism of action of growth factors.
The growth factor interacts with its receptor to stimulate PIP2 
hydrolysis via the activation of a G protein. The products of 
this hydrolysis are IP3 and DAG. IP3 facilitates the release of 
Ca2+ from intracellular stores and DAG activates PKC. PKC 
stimulates the expression of proto-oncogenes which function 
to regulate the transcription of other genes involved in cell 
growth.
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greatly increases the affinity of PKC for Ca2+ and therefore renders it 
active at physiological levels of this ion 53
Extracellular signals modulate the activity of many different types 
of transcription factors. PKC was shown to activate the AP-1 
transcription factor 59 (previously discussed in this section) and is 
responsible for transcriptional induction of many genes.
ANG II (see section 1.3.1.3) when binding to its receptor, 
activates receptor-operated Ca2+ channels and gives rise to Ca2+ 
influx. However, this is of minor importance for ANG ll-related trophic 
effects 60.
1.3.1.3 ANG II
Synthesis
The production of ANG II is summarised in Figure 6 . Renin is produced 
principally in the kidney. This proteolytic enzyme cleaves the amino 
terminal decapeptide from angiotensinogen, a glycoprotein which is 
synthesised in the liver, to produce the decapeptide angiotensin I (ANG 
I). This is further processed by angiotensin converting enzyme (ACE) 
which removes the two carboxy terminal amino acids to generate the 
active octapeptide ANG II. ANG II causes vasoconstriction and an 
increase in blood pressure. This factor also promotes aldosterone 
biosynthesis and secretion, noradrenaline release, renal sodium 
reabsorption, glycogenolysis and stimulation of thirst 61 > 62
Local RAS
The RAS is important in maintaining normal cardiovascular 
homeostasis and its participation in hypertension is well established. 
The existence of the components of the RAS has been reported in 
vascular and cardiac myocytes 63, where hypertrophy has been shown 
to occur. This suggests a possible role for ANG II as a growth factor in 
this tissue. A local RAS has also been identified in the adrenal cortex 
64> 65. Re et a[. 66 observed an ANG I generating activity in canine 
aortic smc which was inhibited by renin-specific antisera. An 
immunofluorescent study using renin-specific antiserum, demonstrated 
the presence of renin in canine aortic smc. Radiolabelling studies using
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Figure 6 The renin-angiotensin system.
The sequential cleavage of angiotensinogen by renin and ACE 
respectively, results in the synthesis of ANG II. ANG II functions 
as a growth factor, vasoconstrictor and stimulator of aldosterone 
production by the adrenal cortex.
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35S-methionine revealed the synthesis of a protein by these cells, with 
a molecular weight which corresponded to that of renin. When bovine 
aortic endothelial cells were incubated with angiotensinogen the 
production of ANG I was observed 67. The effect of pH on this activity 
was in agreement with that of bovine renal renin. The presence of renin 
in bovine aortic endothelial cells was further verified by 
immunofluorescence microscopy, using antirenin antisera.
ANG II as a growth factor
There are now several papers showing that ANG II has growth 
promoting effects on vsmc, both in vivo and in vitro.
Griffin et al. 68 administered sub-pressor concentrations of ANG 
II by minipump to rats for 10-12 days. Increased media width, increased 
media cross-sectional area and media/lumen ratio were observed. In 
the experimental animal model of hypertension, the SHR, ACE 
inhibitors were effective in preventing aortic hypertrophy 69. When the 
endothelium was removed from the carotid arteries of rats, the growth of 
vascular smooth muscle and extracellular matrix was inhibited by 
treatment with ACE inhibitors 70. The ACE inhibitor, perindopril, 
prevented the development of hypertension in the SHR, suggesting that 
the growth promoting effect of ANG II may be partly responsible for the 
elevation in blood pressure observed in this model of hypertension 
(Harrap etaL 7 i).
Hypertrophy and/or hyperplasia?
Whether ANG ll-stimulated growth is a result of hypertrophy and/ or 
hyperplasia is controversial. To answer this question, various 
techniques have been employed. Cell numbers have been evaluated 
to determine whether ANG II has produced a hypertrophic response. 
The rate of 3H thymidine uptake by vsmc has been measured to 
determine whether ANG II can stimulate DNA synthesis. The effect of 
ANG II on protein synthesis has been assessed by measuring the rate 
of 3H leucine uptake by cells.
Lyall et al. 33 observed an increase in the rate of growth when 
studying the effect of ANG II on rat mesenteric vsmc number. An 
increase in cell number was also observed when ANG II was added to
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human aortic smc 32 In contrast, Berk et aL 72 discovered that ANG II 
did not increase the number of aortic smc growing in culture but did 
increase protein synthesis. Geisterfer et al. 73 demonstrated that ANG II 
neither stimulated the proliferation of aortic smc made quiescent in a 
defined serum-free medium nor augmented the cell proliferation 
induced by serum or PDGF. ANG II increased smc protein content by 
20%, as determined by staining with fluorescein isothiocyanate. These 
findings suggest that ANG II can produce hypertrophy and hyperplasia 
in smc.
Possible mechanisms
Bobik et i l-  74 and Araki et a l 75 have shown that ANG II can stimulate 
PDGF synthesis in vsmc, which suggests that ANG II may potentiate 
growth by stimulating the synthesis of other growth factors. In cultured 
aortic smc, ANG II was shown to activate the phosphoinositide second 
messenger system (Figure 5) which is involved in cell growth 76. 
Naftilan et al- 341 35, 37 reported that ANG II induced expression of the 
proto-oncogenes c-myc, c-fos and c-jun in vsmc, which is also 
indicative of a growth factor role for ANG II in vsmc. Lyall Mai. 36 has 
shown that both increased phosphoinositide turnover and rapid 
accumulation of c-fos mRNA occurred as a result of the incubation of 
vsmc with ANG II and that these events occurred through the AT-| 
receptor. This evidence supports the role of ANG II as a growth factor in 
vsmc.
1.3.1.4 Other growth factors
The previous sections have described the growth promoting properties 
of proto-oncogenes and ANG II and demonstrated a role for these 
factors in the development of vascular hypertrophy, a feature of 
essential hypertension. A number of other growth factors may also play 
important roles in the process of vascular hypertrophy.
Endothelin , a potent vasoconstrictive peptide was isolated 
from cultured porcine endothelial cells 77 It has been shown to induce 
hypertrophy 7Q> 79> 8°. 81, stimulate phosphoinositide turnover and
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proto-oncogene expression 82«83, and elevate DNA synthesis ^  85«86 
in a number of cell types..
AVP, a potent vasoconstrictor and natriuretic factor, when 
added to cultured smc stimulated protein synthesis 87 and 
incorporation of [3H] thymidine into DNA 88 Campbell-Boswell et aL 32 
observed that AVP increased the number and size of arterial smc in 
culture.
PDGF. The 2 forms of PDGF, PDGF-AB and -BB in combination 
with TGF p (see later) have been shown to stimulate the proliferation of 
vsmc, isolated from the SHR 89. PDGF-BB has been shown to increase 
DNA synthesis and cell growth via Ca2+entry (Ko e taL90)- In rats with 
hypoxic pulmonary hypertension, an increased expression of PDGF A- 
and B-chain genes was observed in the lungs 91.
Insulin and particularly the closely related insulin-like peptides, 
are mitogenic to vsmc 92 IGF-1 receptors provide a common pathway 
for the stimulation of growth and related events (c-myc induction) by 
insulin and IGF-1 in cultured human vsmc 93. There is evidence to 
suggest that IGF-1 may play a role in the repair of the endothelium, by 
regulating smc proliferation 94. IGF-1 has been detected in conditioned 
medium from both porcine vsmc and endothelial cells 95. However, a 
report published by Murphy etaj . .96 localised IGF-1 mRNA to the 
smooth muscle layer of the adult rat aorta, but not to the endothelium.
Essential hypertension has been postulated as a disorder of 
growth, which originates in childhood 22> 97 The growth promoting 
properties of IGF-1 play an important role in this process.
FGF, a member of the heparin-binding growth-factor family, is 
present in rat aortic tissue 98 and is produced by vsmc in culture " » 10°. 
FGF is characterised by its avidity for heparin and ability to stimulate 
endothelial cell proliferation in vivo and in vitro 101. FGF may also play 
a role in the repair of the endothelium which may involve the 
stimulation of vsmc proliferation (Gajdusek et a[ . 102 ).
EGF. This factor was shown to activate S6 kinase in Swiss 
mouse 3T3 cells and vsmc 103> 104. Activation of this kinase by 
phosphorylation induces protein synthesis and initiates DNA synthesis 
104,105 eGF elicited a greater proliferative response of vsmc derived 
from SHR than those from WKY 104 Berk et al- 105 demonstrated that 
FGF caused contraction of rat aortic strips. FGF has a potential role in 
the development of vascular hypertrophy through its growth promoting
21
action. However, the ability of this factor to produce contraction may 
also be important as a mechanism through which growth factors can 
contribute to essential hypertension.
TGFp. The mRNA transcript levels of TGFp are significantly 
elevated in parallel with blood pressure 98. This finding together with 
the fact that platelets release as much TGFp upon aggregation as 
PDGF, suggests that this peptide also has a growth promoting role and 
may become actively involved in the development of atheroslerotic 
plaques 106. Treatment of cultured vsmc with TGFp lead to  
downregulation of PDGFAA receptor subunits and concomitant 
desensitisation to PDGFAA 107. This may culminate in cellular 
hypertrophy rather than hyperplasia 69
H B G F - 1 . HBGFs are a chemically defined family of 
polypeptides with mitogenic activity for a variety of cell types. 
Experimental findings suggest a relationship between HBGF-1 , LDL 
and PDGF in smc proliferation 108
1.3.1.5 Extracellular matrix (ECM)
Tissues are not composed solely of cells. A substantial part of their 
volume is extracellular space which is largely filled by an intricate 
network of macromolecules constituting the extracellular matrix. This 
matrix comprises a variety of versatile polysaccharides and proteins 
that are secreted locally and assemble into an organised mesh.
Changes in the component of the ECM, elastin, have been 
demonstrated which are relevant in the development of hypertension. 
Elevated elastin synthesis accompanies increased blood pressure, 
particularly in the large conduit vessels 109 and this trait is maintained 
in culture with vsmc from the SHR. As discussed earlier, hypertrophic 
vessels contain an increased amount of collagen 18. These 
observations suggest that alterations in the components of the ECM 
occur in the process of hypertrophy.
1.3.2 A tria l natriuretic peptide (ANP)
ANP is a hormone produced mainly in the atria of the heart. It exhibits 
diuretic, natriuretic 110 and vasorelaxant activities 111 and inhibits the
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secretion of renin, aldosterone and AVP. Atrial distention is the most 
powerful stimulus to ANP release but other stimuli appear to modulate 
its rate of synthesis and secretion. In contrast to adult heart ventricles, 
fetal and neonatal ventricles exhibit high levels of ANP gene 
expression and ANP synthesis 112* 113, suggesting that ANP may play 
a greater role in control of the cardiovascular system during early 
stages of life. A high rate of ANP gene expression is observed in the 
ventricles in a variety of pathological conditions including human 
congestive heart failure 114, in rats with myocardial infarction and 
cardiac failure 115 and in rats subjected to pressure overload 116« 117 
and in SHR 118. Montorsi et a l  119 observed that p la s m a  
concentrations of ANP were greater in hypertensive than normotensive 
patients. These experimental observations suggest that high ANP 
levels are associated with cardiovascular disease. However, this 
evidence was contradicted by Franco-Saenz et a l-12°- This group 
investigated the effects of a 4h infusion of 8-33-Met ANP in patients with 
hypertension. 8-33-Met ANP infusion caused a prolonged lowering of 
SBP with no change in DBP or CO. A possible explanation is that lower 
levels of ANP play a cardioprotective role but that higher levels may 
potentiate disease.
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1.4 Hemodynamic factors in hypertrophy
The role of non-hemodynamic agents, Including growth factors in the 
process of vascular hypertrophy and the development of essential 
hypertension has been discussed in detail. Hemodynamic factors are 
the parameters of interest in this project and the following section is a 
general review of in vivo and in vitro studies which have demonstrated 
an effect of hemodynamic load on cellular function. Subsections will 
deal with the individual forces to which cells within the vessel are 
exposed, namely shear stress and pressure and the effects that these 
parameters can induce, with relevance to hypertension.
The in vivo studies described are based on the use of the 
coarctation model of hypertension. This involves constricting the aorta 
to produce an area of high pressure proximal to the constriction and an 
area of low pressure distal to this point. Thus tissues can be exposed to 
a hemodynamic load by positioning the constriction appropriately.
Maclver et al- 121 examined the effects of pressure overload on 
proto-oncogene expression in cardiovascular tissues. The aorta 
proximal to the stenosis and mesenteric vessels were exposed to high 
blood pressure and thus increased load whereas the aorta below the 
coarctation was exposed to low blood pressure. To examine proto­
oncogene signals during the development of pressure-related vascular 
structural changes, levels of c-myc, c-fos, and c-H-ras mRNA were 
measured 72h and 9 days after the induction of coarctation. At 72h, 
there was a significant increase in c-myc, c-fos, and H-ras mRNA. A 
significant increase in proximal mass was observed at both of these 
time points but no changes in mesenteric artery morphology was 
observed in rats with coarctation. This vascular bed was positioned 
above the coarctation and was presumably exposed to a higher blood 
pressure and increased load. A structural change and induction of 
proto-oncogene expression had therefore been anticipated. Previous 
studies by this group have however shown that morphological changes 
in this tissue only reach statistical significance 28 days after surgery 
122. This may explain why no changes were observed.
Izumo et a l 117 also observed stimulation of the transcription of 
the proto-oncogenes c-fos and c-myc and the heat shock gene, hsp70 
in response to pressure overload in the ventricular myocardium, 1h 
after imposition of a load. Mulvagh et a l 123 observed induction of c-
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myc mRNA in the isolated rat heart in response to aortic constriction. 
Komuro et al. 47 studied the expression of several cellular oncogenes 
during the developmental stage and pressure-overloaded hypertrophy 
of rat hearts in vivo. Pressure overload resulted in increased levels of c- 
fos, c-myc and c-Ha-ras. An increase in c-fos and c-myc mRNA was 
detected at 30 min and 2h respectively, the levels were shown to peak 
at 8 h, and to return to baseline by 48h after the aortic constriction. The 
levels of c-Ha-ras showed a gradual increase. These observations 
were similar to the time course of expression achieved for these proto­
oncogenes through the developmental stages. This suggested that 
cellular hypertrophy induced by pressure overload may share a similar 
mechanistic pathway with cell proliferation.
In the same study, Maclver et al- 121 also examined the effect of 
increased load on phosphoinositide hydrolysis. The products of inositol 
lipid hydrolysis were measured 72h and 9 days after application of the 
coarctation. At 72h, coarctation had induced structural changes in the 
proximal aorta which were associated with increased inositol 
phosphate production. Increased inositol phosphate production was no 
longer observed 9 days after surgery, when most of the structural 
changes were completed. The results suggest that inositol lipid 
hydrolysis is an important process in the development of vascular 
hypertrophy in this model of hypertension. The overall conclusions of 
this study were that stimulation of proto-oncogene expression and 
phosphoinositide hydrolysis may mediate vascular remodelling and 
that alternative mechanisms may be involved in mesenteric vessel 
thickening where slower structural development is involved.
Pressure overload is associated with re-expression of the fetal 
contractile proteins 124, p-myosin heavy chain isoform 125 and a- 
skeletal actin 126. Imamura et al. 127 also demonstrated that myosin 
heavy chain gene expression was induced by increased pressure load. 
Many observations have been made describing changes which occur 
in the process of hypertrophy but the mechanism(s) by which these 
changes occur are poorly understood.
An advantage of studying the in vitro situation is that changes 
induced by hemodynamic load can be studied independently of 
humoral factors.
The results of a number of studies have suggested that in blood 
vessels, the mechanotransduction could be initiated at the level of the
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endothelial cells. Lansman et aL 128 proposed that stretch-activated ion 
channels in endothelial cells mediate the transduction of hemodynamic 
stresses. Olesen e ta !-129demonstrated that shear stress activated a 
potassium current in vascular endothelial cells. Signalling from the 
membrane to underlying vsmcs may take place via gap junctions or by 
the release of effector molecules (e.g growth factors). Taken together 
these findings are consistent with the concept that hemodynamic forces 
can directly initiate intracellular events controlling vascular tone and 
cell growth. Furthermore, Kent et al- 130 indicated that sodium influx in 
response to myocyte stretching may be one of the early signals 
mediating the hypertrophic response to mechanical stimulus in the 
adult mammalian myocardium. The exact involvement of the different 
ion channels in mechanical transduction and its relevance to 
cardiovascular remodelling remain to be determined.
The stimulation of induction of gene transcription in response to 
load has also been demonstrated from in vitro studies. Komuro et al- 
131 demonstrated that stretched neonatal rat cardiocytes express c-fos 
mRNA. The expression of c-fos mRNA in the myocardium has also 
been shown to increase by raising coronary blood flow, pressure or 
contractility in the isolated rat heart132
These observations agree with reports by Mann et a[ . 133 who 
showed that an increased mechanical load was enough to increase 
total RNA as well as protein synthesis in adult mammalian cardiocytes. 
As with in vivo observations, the signal transduction pathways 
mediating these responses are not well understood. However, von 
Harsdorf 134 demonstrated that phosphatidylinositol turnover was 
increased by myocardial stretch as indicated by the accumulation of 
inositol phosphates, suggesting that this intracellular pathway may 
mediate some of these processes.
26
1.5 Flow/stretch related forces
In vivo, cells are continuously being exposed to forces existing within 
the vessel. Such forces can be resolved into two components; pressure 
acting perpendicular to the surface and shear stress, a tangential 
dragging component resulting from friction with the endothelial surface 
135. The vsmc constituent of the vessel wall absorbs most of the 
pressure and the endothelium is subjected to all of the shear stress. To 
examine the effect of shear stress and pressure on metabolic, physical 
and morphological properties of various cell types, it is more practical to 
study the effects of these forces separately.
The parallel flow plate chamber and rotating cone apparatus, 
which will be described in greater detail in section 1.5.1, have been 
designed to study the component of shear stress. The pressure 
component, which is of most interest in this project, has been examined 
by looking at the effect of stretch on cellular properties. The most 
popular methods employed to apply stretch to cells will be described in 
section 1 .6 .
For practical purposes, many of the initial investigations have 
looked at the effect of a continuous force on cellular function. However, 
when the in vivo situation is considered it is obvious that the force 
exerted is not continuous. Blood flows through vessels in a pulsatile 
manner and therefore the component of shear stress which results from 
friction between the blood and the endothelial cells is also pulsatile in 
nature. As the rate of blood flow increases, the radius of the lumen 
increases to facilitate an efficient transfer of blood and hence the cells 
in the vessel wall are stretched and/or compressed.
The following section reviews the continuous and pulsatile 
experiments which have been performed to study the components of 
shear stress and pressure in various cell types.
1.5.1 Shear stress
Flow is known to influence the constriction and relaxation of small 
arteries and has been implicated in the appearance of localised 
atherosclerotic regions in large arteries. Thus, the role of the 
endothelium as a mechanotransducer of flow-related forces,
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particularly shear stress is of great interest. The majority of in vitro 
studies have examined the effect of shear stress on endothelial cell 
function by using parallel flow plate chambers (Figure 7), designed to 
provide steady laminar flow. A physiological range of 0-40 dynes/cm2 
was defined by Ohno et al- 136 to mimic the force of shear stress 
occurring in vivo.
The chamber is composed of two stainless steel plates 
separated by silicone sheeting which serves as a spacer and a gasket. 
The channel height is defined by this gasket thickness. A single 
coverslip with confluent endothelial cells is positioned in a circular 
recess in the bottom plate where a portion of the cell monolayer is 
exposed to flow. The chamber is maintained at 37°C by a copper 
heating plate mounted on top of the chamber. The heating plate is 
equipped with two electrical heat cartridges which receive electric 
current from a temperature controller. The shear stress is applied to the 
endothelial monolayer by perfusing medium through the channel using 
a syringe pump. Because the shear stress is a linear function of the flow 
rate through the channel, the amount of shear stress exerted can be 
directly calculated in dynes/cm2.
1.5.1.1 Biochemical events involved in growth
As discussed earlier, an increased rate of growth is an important event 
which has been identified in the development of hypertension. Thus, 
any factor which can stimulate cell growth is of great interest in the 
study of this disease state. This section reviews the studies which have 
looked at the effect of shear stress on biochemical events which can 
lead to cell growth.
ip3
As previously discussed, activation of the phosphoinositide pathway, is 
involved in the initiation of cell growth. The effect of shear stress has 
been tested on this pathway. A shear stress of 24 dynes/cm2 resulted in 
a marked increase in levels of IP3; removal of flow resulted in a gradual 
return of IP3 to basal levels137. The response of IP3levels was partially 
inhibited by ibuprofen and indomethacin, inhibitors of the enzyme 
cyclo-oxygenase which is involved in prostaglandin formation, 
indicating that the IP3 response was partly dependent on flow-induced
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Figure 7 Cross-section of parallel-plate flow chamber, 
from Ohno et al. (136).
Endothelial cells are placed on a coverslip and subjected to 
shear stresses as fluid flows across the coverslip.
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prostaglandin synthesis. From this evidence, it was suggested that 
shear stress may be an expernal signal which can be transduced into a 
biochemical response.
Ca2+
Ca2+ is an important second messenger which plays an essential role 
in processes such as muscle contraction. An elevated intracellular 
[Ca2+] ([Ca2+]j) can occur by entry through ion channels or as a result of 
increased release of Ca2+from intracellular stores. Mo et a l 138 and 
Ando et al- 139 examined the effect of adenosine triphosphate (ATP) on 
flow-induced changes in cell Ca2+ levels, in vascular endothelial cells. 
ATP is known to influence the tone of smooth muscle by activation of 
purinoceptors and subsequent activation of the phosphoinositide 
pathway. An increase in IP3 levels stimulates Ca2+ release which 
induces release of NO and smooth muscle relaxation. Both groups 
observed that under flow conditions, ATP increased the [Ca2+]j of the 
cells. Shen et al. 140 observed that application of a stepwise increase 
in shear stress from 0.08-8 dynes/cm2* to bovine aortic endothelial 
cells, increased [Ca2+] j , which attained a peak value in 15-40s, 
followed by a decline to baseline within 40-80s. In the presence of ATP 
or adenosine diphosphate (ADP), application of shear stress caused 
repetitive oscillations in [Ca2+]s in single cells, but an adenosine 
diphosphatase (ADPase) or adenosine triphosphatase (ATPase) did 
not inhibit the shear-induced calcium response. This suggests that ATP 
is not essential for the release of Ca2+. Bodin M a i- 141 showed that 
increased flow induced ATP release from vascular endothelial cells but 
not smc. Thus, flow alone can stimulate Ca2+ release. However, when 
extracellular ATP is added this causes an amplification of the flow- 
induced response.
This evidence suggests that shear stress can stimulate Ca2+ 
release from endothelial cells and that this effect can be explained by 
an increased production of ATP. The further addition of ATP will amplify 
the Ca2+ response leading to a greater production of NO and a greater 
degree of relaxation.
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1.5.1.2 Cell growth
It was of interest to examine whether shear stress could affect the rate 
of cell growth and therefore be an important contributor to vascular 
hypertrophy. The factors affecting this growth are discussed below.
Proliferation
A dose-related reduction in proliferation was observed when 
subconfluent bovine aortic endothelial cells were exposed to shear 
stress levels of >15 dynes/cm2 for 48h 142 which would deny a potential 
growth promoting role for shear stress. Proliferation was totally 
abolished at 90 dynes/cm2 for 48h. However, when this time point was 
exceeded proliferation resumed, which suggests that the length of 
duration of shear stress is an important factor in the stimulation of cell 
proliferation. Furthermore, aortic endothelial cells exposed to a shear 
stress of 30 dynes/cm2 caused inhibition of proliferation and the shear 
stress arrested the cells in the G0/G1 phase of the cell cycle 143. These 
observations are best explained by postulating that cells must adapt to 
the environment introduced by shear stresses by changes in their 
shape and cytoskeletal structure. In these circumstances, cell 
proliferation would be of low priority and mechanisms of cell mitosis 
would be inhibited at least during the period of adaptation.
Growth factors
The induction of growth factors by shear stress is an important area in 
the study of hypertension. Such factors might potentiate the growth of 
vsmc and contribute to vessel hypertrophy.
Hsieh et al- 144 investigated the effect of shear stress on PDGF-A 
and B chain mRNA levels in cultured human umbilical vein endothelial 
cells. The levels of both PDGF-A and B mRNA were increased by a 
physiological shear stress of 16 dynes/cm2, reaching a maximum 
approximately 1.5-2h after the application of shear stress and returning 
almost to control values at 4h. Bovine aortic endothelial cells were 
exposed to a steady laminar shear stress of 40 dynes/cm2 using the 
rotating cone apparatus (Figure 8 ). A motor induced rotation of a 
shallow cone which was fitted into a plexiglass holder. This movement 
caused the displacement of cell culture medium, which resulted in the
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Figure 8 Cross-section of rotating cone apparatus, 
from Franke et al. (148).
A transparent polycarbonate cone having an angle of 2.5° 
is fitted into a plexiglass holder and connected to a speed- 
controlled motor with variable rotational velocities. The 
cone is placed with its tip on the surface of the coverslip, 
containing the cells, under microscopic control.
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production of a shear stress on the endothelial cell monolayer. TGFp-j 
mRNA levels were increased several-fold compared to static controls 
within 2h of exposure, and remained elevated for 12h. The increase in 
mRNA levels was directly proportional to the intensity of the shear 
stress within the physiological range of 0-40 dynes/cm2. Shear stress 
also induced a markedly increased production of TGFp-j in cell 
membranes. Olesen et a L 129 showed that shear stress can activate a 
potassium ion ( K+ ) current in vascular endothelial cells. Addition of the 
K+ channel blocker tetraethylammonium, attenuated the shear stress- 
induced increase of TGFp1 mRNA and active TGFp-j136. This illustrated 
that TGFp-| formation in response to shear stress is partially mediated 
via K+ channel activation.
1.5.1.3 Cell morphology and structure
Can shear stress provoke a change in cell shape? There is good 
evidence that this is the case. Cells in a confluent monolayer change 
from a polygonal to an ellipsoidal shape and align uniformly with the 
direction of flow during exposure to a unidirectional fluid shear stress of 
>5 dynes/cm2 for 24 h 145. Endothelial cells obtained from the arterial 
circulation contain bundles of actin filaments known as stress fibres, but 
few if any are observed in endothelial cells of the venous circulation 
146,147  To determine whether shear stress is one of the factors which 
influences the distribution of actin filaments in endothelial cells, Franke 
et a L 148 exposed confluent monolayer cultures of human vascular 
endothelium to a fluid shear stress of 2 dynes/cm2 for 3h, approximately 
the stress occuring in human arteries in vivo. They reported that 
endothelial stress fibres could be induced in response to critical levels 
of fluid shear stress. This effect probably protects the endothelium from 
hemodynamic injury and detachment.
1.5.1.4 Other biochemical events
RAS
A local RAS exists in vascular and cardiac myocytes (1.3.1.3) 63 but its 
role has not been fully elucidated. The existence of these components 
has led to the suggestion that the growth factor, ANG II may be
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generated locally in these tissues. ANG II production can be studied by 
measuring ACE activity, the enzyme responsible for the conversion of 
ANG I to ANG II (see Figure 6 ). Fischel et al. 149 found that a shear 
stress of 30 dynes/cm2 for 24h produced a 70% reduction in cell growth 
of endothelial cells. This was accompanied by a 2.2  fold increase in 
ACE activity. The ability of ANG II to stimulate cell growth has been 
discussed in section (1.3.1.3). The effect of shear stress on ANG II 
production was examined in the expectation that shear stress would 
stimulate ANG II production, facilitate cell growth and thus play an 
important role in the development of vascular hypertrophy. However, 
shear stress inhibits ACE activity, results in a reduced ANG II 
production and therefore an inhibition of any growth signal which would 
be elicited by ANG II. This observation remains unexplained. Further 
studies verifying this inhibitory effect of shear stress on ACE activity are 
essential before a final conclusion can be drawn.
Prostaglandins
Prostaglandins are local hormones with short half-lives which exert 
paracrine and autocrine effects. Although some prostaglandins cause 
vasoconstriction, most seem to be vasodilator agents. Prostacyclin 
(PGI2)can induce relaxation of blood vessels. Since prostaglandins 
can affect peripheral resistance, they may influence the rate of 
hypertrophy and possibly even contribute directly to hypertrophy.
The effect of mechanical forces on bone cells such as 
osteoblasts is of great interest. Previous studies have examined the 
role of mechanical forces in bone fracture repair 15°. This work is of 
interest to this project in that their aims were concerned with the ability 
of mechanical forces to stimulate growth. Reich et al. 137 looked at how 
osteoblasts in culture respond to mechanical strain. An increase in the 
rate of prostaglandin E2 (PGE2) was observed when they were exposed 
to shear stresses of between 6 and 24 dynes/cm2. The effect of 
pulsatile flow on PGI2 production by human endothelial cells was 
investigated by Frangos et aL 151. The onset of flow led to a sudden 
increase in PGI2 production which decreased to steady state within 
several minutes. The PGI2 production rate of cells subjected to pulsatile 
shear stress was more than twice that of cells exposed to steady shear 
stress and 16 times greater than that of cells in stationary culture. This 
suggests that the pulsatile nature of blood flow in vivo may be an
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important physiological mechanism for controlling PGI2 production 
(FrangosetaL 152)-
Rubanyi et al. 153 measured the wall tension of intraluminally 
perfused canine femoral artery segments, and the content of the stable 
prostaglandin metabolite, 6 -keto PGF1a. The relaxing activity of the 
effluent was determined by exposure to coronary artery rings. At steady 
flow, the effluent contained 6 -keto PGF1ctand relaxed the bioassay 
rings. A sudden increase in steady flow from 2-4ml/min or the 
introduction of pulsatile flow, increased the release of 6 -keto PGF1a 
and induced further relaxations of the bioassay ring. No relaxations 
were observed with the effluent passing through a femoral artery 
segment without endothelium. Indomethacin depressed the release of 
6 -keto PGF1a during increases in flow but the cyclo-oxygenase 
inhibitor did not affect the relaxation of perfused femoral artery 
segments containing endothelium. These results suggest that in 
addition to PGI2, flow triggers the release of another relaxing substance 
from vascular endothelial cells. Grabowski M a i- 154 also observed that 
shear stress stimulates prostaglandin production in endothelial cells. 
Stepwise increases in shear stress from 0-14 dynes/cm2 caused rapid 
rises in PGI2 production to peak values within 2 min, followed by a 
decline over several minutes. Peak PGI2 production increased with 
severity of shear stress.
An increase in prostaglandin production in response to shear 
stress has been observed in a wide range of cell types. It is therefore 
likely that in such a situation, prostaglandins may assist in the control of 
TPR.
Endothelin
As has been previously discussed (section 1.3.1.4), endothelin exhibits 
growth promoting properties 81 • 82- 83 in vascular tissue. Thus, 
endothelin availability is a factor of great interest. Sharefkin et a l 155 
tested the effects of static culture versus high laminar shear stress (25 
dynes/cm2) on endothelin-1 precursor (preproendothelin) gene mRNA 
transcript levels and endothelin-1 peptide release in cultured human 
endothelial cells. Application of 25 dynes/cm2 of shear stress for 24h 
sharply reduced endothelial cell levels of preproendothelin mRNA and 
decreased endothelin-1 peptide release into the culture medium.
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Yoshizumi et al- 156 produced shear stresses using a rotating 
cone apparatus. Shear stresses of 8 dynes/cm2 stimulated the 
synthesis of endothelin mRNA in polygonal endothelial cells with a 
peak signal observed within 2 to 4h and also increased the release of 
im mu noreactive endothelin into the culture medium. The levels of 
endothelin mRNA in the ellipsoidal endothelial cells under high shear 
stress was not different from that of control level.
These observations suggest that low shear stress conditions 
favour an increased expression of endothelin gene and an increased 
release of endothelin into the medium. High shear stress conditions 
were shown to inhibit both expression and release. This provides 
evidence of endothelin's possible role in intimal hyperplasia. This 
condition occurs at sites of low shear stress where higher 
concentrations of endothelin-1 and increased synthesis of 
preproendothelin mRNA occurs.
NO
NO has a major role in maintainance of vascular tone.To evaluate the 
role of NO in flow-mediated control of vascular tone, the effect of shear 
stress on NO release was studied. The release of NO was greatly 
increased in porcine aortic endothelial cells on application of a shear 
stress of 6 dynes/cm2 157 Kelm et al- 158 also looked at the effect of 
shear stress on NO release. This system involved using microcarrier 
beads onto which endothelial cells had been grown. Increasing flow 
from 2  to 20  ml/min enhanced the basal NO release from endothelial 
cells fivefold. Buga et al. 159 using a similar in vitro bioassay system 
confirmed that increasing the perfusion pressure increased NO release.
Hutcheson e ta !-160perfused rat aortic segments with a buffer 
solution, using a peristaltic pump at a constant mean flow rate of 
9m I/m in. Any NO activity induced by shear stress was measured by its 
ability to relax preconstricted, endothelium-denuded, rat aortic rings. 
When examining the effect of frequency on shear stress-induced NO 
release, the amplitude was maintained at 2mmHg while the frequency 
was varied between 0.1-12Hz. The effect of a varied amplitude was 
studied by maintaining a frequency of 1Hz and varying amplitude within 
the range of 2-16Hz. The relaxation of the aortic segments was found to
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depend on the applied frequency of shear stress with maximum 
relaxation obtained between 4.2 and 6 Hz. In contrast, increasing the 
amplitude component facilitated a further constriction of the segments. 
Incubation of the donor vessel with a NO synthesis inhibitor or removal 
of the endothelium from the vessel by rubbing, abolished these 
frequency and amplitude effects.
Shear stress can stimulate NO release from cells. This action 
may possibly compensate for any change in vessel tone which has 
been induced by the shear stress. Both the frequency and amplitude 
components of shear stress control NO release but they produce 
contrasting effects.
Interleukins (IL)
IL are known to participate in the formation of atherosclerotic plaques. 
They thus have a role in the development of cardiovascular disease. 
Cultured bovine aortic endothelial cells secrete IL-1 and IL-6  in small 
quantities. Cucina et a l 161 subjected endothelial cells to a shear 
stress of 6 dynes/cm2 and found an increased production of both IL-1 
and IL-6 . Thus shear stress increases interleukin production but their 
precise purpose is not yet clear.
Lipoproteins
Lipoproteins are molecules composed of triglycerides, phospholipids, 
cholesterol and protein. Their principal function in the plasma is to 
transport lipids throughout the body. Lipoproteins can be classified by 
their composition of triglycerides, phospholipids, cholesterol and 
protein, into three main categories: very low density lipoproteins 
(VLDL), low density lipoproteins (LDL) or high density lipoproteins 
(HDL). LDL participates in the formation of atherosclerotic plaques 
which can lead to ischaemia and disease.
Bovine aortic endothelial cells were incubated with 125I-LDL 
labelled with a radioactive isotope of iodine, for 2 to 24h, in the 
presence of shear stress levels of 30 dynes/cm2 162 Increased LDL 
internalisation was observed after 24h but non-specific LDL 
endocytosis was not influenced by shear stress levels. This suggests 
that shear stress (flow) influences LDL internalisation and may provide 
a potential mechanism by which LDL participates in the formation of 
atherosclerotic plaques.
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1.5.2 Stretch
In vivo, cells are exposed to a pressure component as well as a 
component of shear stress. To mimic the pressure component in vitro, 
models have been designed which can expose cells to a controlled 
stretching force, resulting in an increase in the length of the cell. 
Several groups have examined the phenomenon of stretching on a 
variety of cell types and a diverse range of responses. The following 
section summarises the in vitro studies which have been performed in 
this field. The most popular techniques utilised are described in section 
1.6 .
1.5.2.1 Biochemical events involved in growth 
Ion channel activation
This is a possible mechanism by which a growth response can be 
evoked in a cell. The ability of shear stress to stimulate K+ channel 
activation has been mentioned previously (1.5.1.2). The effect of stretch 
on ion channel activation will now be reviewed in the following section.
The most common technique used in ion channel studies is that 
of patch clamping. This involves applying suction to the cell membrane 
using a micropipette. The application of suction causes the membrane 
to be stretched and can result in the opening of ion channels. Lansman 
M ai- 128 investigated the effect of stretching the cell membrane of aortic 
endothelial cells. A channel permeable to Ca2+ was activated and its 
opening frequency shown to increase with increasing stretch. Davis et 
al. 163 discovered that patch pipette suction activated a non-selective 
cation channel that was permeable to K+, sodium ions (Na+) and Ca2+, 
in vsmc. Taniguchi et §L 164 examined the effects of membrane stretch 
on Ca2+ -activated K+ channels in rabbit thick ascending limb cells, 
also by using a cell patch clamp technique. Pressure applied to the 
patch membrane increased fractional Open probability in the presence 
of Ca2+ in the pipette. The activity returned to control on releasing the 
negative pressure. Large conductance, Ca2+ -activated K+ channels in 
rabbit pulmonary artery smc were activated by membrane stretch 165. 
Activation by stretch appeared to occur by a direct effect of stretch on 
the channel itself or a closely associated component. In patches of cell
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membrane, stretch activation was seen under conditions which avoided 
involving cytosolic factors, release of Ca2+ from intracellular stores, 
stretch-induced transmembrane flux of Ca2+ or other ions potentially 
capable of activating the channel. Membrane stretch by patch clamping 
activated single-channel ionic currents in cultured mesangial cells 
which were permeable to Na+, K+ and chloride ions (Cl*)166. Channiel 
opening probabilities were directly related to the degree of suction, with 
threshold activation achieved for 5-10 mm Hg. These channels may 
represent a cellular mechano-reflex in mesangial cells. Ypey eta ! - 167 
discovered that stretching the membrane of chick osteoclast cells 
activates channels permeable to K+> Cl* and phosphate ions. Using 
patch-clamp electrophysiology, Bear 168 discovered a non-selective 
cation channel permeable to Na+, K+ and Ca2+ in rat liver cells.
The above studies show that ion channel activation is a stretch- 
mediated response induced in a range of cell types. The presence of 
mechanotransducing ion channels in such cells suggest that this is a 
common mechanism by which cells respond to an altered mechanical 
load.
Inositol phosphates
The effect of mechanical strain on phosphoinositide turnover has been 
studied as a potential second messenger involved in stretch-mediated 
effects. 20% stretch of pulmonary vsmc for 45s resulted in increased 
intracellular masses of IP3 and inositol tetraphosphate (IP4); 34±7 % 
and 58 ±12  % respectively 169. Repetitive stretch of these cells did not 
further alter the masses of either of the compounds. Stretching also 
increased inositol phosphate levels in cardiocytes 170. Rosales eta!. 
171 deformed endothelial cells using a cyclic, vacuum system (see 
section 1.6 ) and looked at the effect of strain on inositol phosphate 
production. Two procedures were adopted. The first set of experiments 
involved deforming endothelial cells at a frequency of 60 cycles/min for 
either 0, 1, 5, 10, 25, 50 or 100 cycles of stretch. The second involved 
deforming cells at a frequency of 60 cycles/min for 24h and then 
increasing the the frequency to 100 cycles/min for 0, 1,5, 10, 25, 50 or 
100 cycles. In each set of experiments lithium chloride was included, to 
minimise inositol phosphate degradation. The results demonstrated 
that either the initiation of pulsatile stretch or an acute change in the
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cyclic stretch frequency stimulated the generation of IP3| its metabolites 
inositol diphosphate (IP2) and inositol monophosphate (IP) and 
diacylglycerol. Brophy et al. 172 looked at the effect of decreasing cyclic 
strain on IP3 generation in endothelial cells. No differences were found 
in IP3 mass between endothelial cells that were stationary for 24h and 
cells exposed to cyclic strain for 24h. An immediate, significant increase 
in IP3was observed after a decrease in strain frequency. These results 
suggest that it is a change in the stretch frequency which elicits 
phosphoinositide hydrolysis in endothelial cells and that steady state 
cyclic strain conditions have no effect on hydrolysis.
The effect of stretch on phosphoinositide hydrolysis has also 
been examined in the intact rat heart. Increased release of inositol 
phosphates was detected when the right atria of rats were stretched 
173. The procedure involved inserting a balloon into the right atrium of 
the heart via the vena cava. Using a syringe the balloon was inflated 
and the atrium stretched. Stimulation was detectable after 1 min with 
significant increases observed after 10 or 20  min.
Isolated cells and intact tissues have shown a stimulated rate of 
phosphatidylinositol hydrolysis, in response to stretch. From the results 
it appears that a change in the strain experienced by the cells is the 
major factor which affects the rate of hydrolysis. An increased 
phosphatidylinositol hydrolysis is an event observed prior to cell 
growth. This therefore favours a role for stretch in the stimulation of 
growth.
PKC
The above results suggest that PIP2 hydrolysis occurs in response to 
stretch. Thus it is interesting to see whether stretch stimulates PKC 
activity. Rosales et al. 174 subjected endothelial cells to a 24% strain at 
60 cycles/min and observed a biphasic translocation of PKC from the 
cystolic to the membrane fraction. There was an early rise in PKC 
activity in the membrane at 10s which paralleled those of IP3 and DAG 
concentrations, and a second rise which occurred after 100s of cyclic 
strain and was sustained up to nearly 8 min. These results support the 
ability of stretch to stimulate PKC activity via an increased DAG 
production. Such events are important in the stimulation of cell growth.
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Ca2 +
The effect of stretch on [Ca?+]j has also been studied.
Katusic M a i- 175 suspended rings of canine basilar arteries in 
organ chambers and measured isometric tension using a force 
transducer. Stretch applied to the arteries caused the development of 
active tension in rings with endothelium but not in those in which the 
endothelium had been removed. Blockade of Ca2+ entry with diltiazem, 
or inhibition of cyclo-oxygenase with indomethacin, abolished the 
endothelium-dependent response to stretch. These results suggest that 
Ca2+ channel activation stimulates the release of a factor from the 
endothelium which may be identified as a prostaglandin.
Wirtz et al- 176 applied hydrostatic pressure to rat alveolar type II 
cells and measuredthe [Ca2+]j in single cells, before and after 
stretching. A single stretch of 16% caused a transient increase in 
cytostolic [Ca2+]. Both C a2+ mobilisation and exocytosis exhibited 
dose-dependence to the magnitude of the stretch stimulus.
The purpose of the study conducted by Armstrong Mai- 177 was 
to determine if passive stretch of rat soleus muscles would increase 
total muscle [Ca2+] and mitochondrial [Ca2+], Soleus muscles from 
female rats were isolated and incubated in vitro for 2h at resting length, 
or at the maximal in situ length. Total muscle [Ca2+] and mitochondrial 
[Ca2+] were elevated in both groups.
Each of these studies uses different techniques but all illustrate 
the fact that Ca2+ plays an essential role in stretch-mediated 
responses. The results support the assumption that stretch increases 
phosphoinositide hydrolysis, the formation of the products IP3and DAG 
and that IP3 formation facilitates Ca2+ release from intracellular bound 
stores.
Proto-oncogenes
In section (1.3.1.1) the importance of proto-oncogenes in the control of 
growth has been reviewed. Komuro M a i- 131 stretched rat neonatal 
cardiocytes by 9.3 ± 0.9 % and demonstrated that stretch stimulated c- 
fos expression in a stretch length-dependent manner. This was 
followed by an increase in amino acid incorporation into proteins. c-/bs 
mRNA rose within 15 min of cardiocyte stretching, peaked at 30 min 
and declined to undetectable levels by 240 min. In the presence of 
cycloheximide, a protein synthesis inhibitor, a greater increase in c-fos
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mRNA was observed on stretching, suggesting that this gene 
expression was not stimulated by newly synthesised proteins. A 
transfected chloramphenicol acetyltransferase (CAT) gene, used as a 
reporter gene, was linked to upstream sequences of the c-fos gene 
including its promoter and transfected into myocytes. On stretching 
these myocytes, the c-fos and CAT genes were expressed, suggesting 
that mechanical loading regulates c-fos mRNA transcription.
Sadoshima et a l.178 also examined the effect of stretch 
on c-fos induction in neonatal cardiocytes. However, this study also 
looked at the expression of c-myc,c-jun , the zinc finger class gene, Egr- 
1 and the cytokine-like gene, JE, in response to a 20% stretch. Peak 
expression was observed at 30 min for c-fos, c-jun , JE and Egr-1. 
Peak c-myc expression was attained at 1h. 12-48h of 20% stretch 
caused a progressive accumulation of ANP (1.3.2) and skeletal a-actin 
mRNAs (1.5.2.3). In this study, stretching for 48h induced the 
expression of p-myosin heavy chain mRNA. Shorter periods of stretch 
stimulated the expression of proto-oncogenes which as has been 
previously discussed are involved in the process of cell growth. Longer 
periods of stretch stimulated the expression of fetal genes; these genes 
have been shown to cause phenotypic changes that are characteristic 
in in vivo models of hypertrophy117 The fact that this in vitro study has 
initiated changes which occur in the in vivo situation is an encouraging 
indicator that stretching systems closely mimic the pressure force which 
is experienced in the vessel wall.
Stretching of cardiac myocytes also increased c-fos mRNA 
levels 179. The accumulation of c-fos mRNA by stretching was 
suppressed by PKC inhibitors but not by stretch channel blockers. 
Activation of PKC by phorbol esters stimulated the synthesis of c-fos 
mRNA. Another factor which stimulated c-fos expression was sodium 
influx. However, the addition of stretch channel blockers did not affect c- 
fos mRNA production. Why sodium influx stimulated c-fos mRNA 
expression remains unexplained.
Proto-oncogene and fetal gene expression have been induced 
in response to stretch. The above experimental findings suggest that 
PKC activation is the mechanism by which proto-oncogene expression 
is induced in myocytes and cardiocytes. It is reasonable to assume that 
PKC activation is also responsible for the expression of the fetal genes 
in response to cardiocyte stretching. This evidence further supports the
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the ability of stretch to stimulate second messenger systems which are 
involved in cell growth.
Protein synthesis
After gene expression has been induced the next step in the sequence 
of events is protein synthesis. Mann et a [.180 examined the growth- 
regulating effects of load changes in the isolated, quiescent, adult 
cardiocyte. An approximate increase in length of 10% resulted in mean 
increases of 186% in nuclear RNA synthesis and 89% in cytoplasmic 
protein synthesis.
Banes et al- 181 using a vacuum system (see section 1.6) 
exposed a fibroblast layer to a pressure of 0.13%, for periods of 25s 
stress and 5 min relaxation. This activity had no effect on a protein that 
co-migrates with actin, whereas a protein that co-migrates with tubulin 
decreased from 12.7 ± 0.451% in control cells to 8.53 ±0.182 % in 
stretched cells. Mechanical load has inhibited the synthesis of a protein 
in this case.
The effect of mechanical activity in the tibialis anterior muscles of 
rabbits, was studied by Goldspink et a l 182. Electrical stimulation in this 
muscle produced an increase in protein synthesis.
Both increased and decreased protein synthesis has been 
induced by exposing cells to a mechanical force. It is important to 
recognise that different techniques were used and that different cell 
types were studied. Thus further work is required to explain these 
contrasting observations.
1.5.2.2 Cell growth 
DNA synthesis
The effect of stretch on the rate of DNA synthesis in a cell, is a very 
attractive area of study because increased DNA synthesis is observed 
prior to cell division. Thus measuring DNA synthesis gives a good 
indication of tissue growth. Hasegawa et a l.183 stretched bone cells by 
4% and observed a 64% increase in the number of cells synthesising 
DNA. Brunette 184 discovered a similar increase in DNA synthesis on 
stretching epithelial cells by 4.2%. The ratio of cells with increased DNA 
synthesis in cultures stretched for 2h, to those in unstretched controls 
was 1.92±0.34.
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Sumpio et a l.185 exerted a 24% strain on porcine smc for 10s, 
followed by a 10s relaxation, for 7 days. This cyclic tension decreased 
cell number and DNA synthesis in comparison with control smc. This is 
in contrast to the results of previous studies for endothelial cells. 
Sumpio et aL 186 had previously showed increased proliferation in 
endothelial cells when exposed to cyclic stretch. The cells maintained a 
random orientation whereas smc exhibited a decreased proliferation 
and were shown to adopt a uniform pattern. Fetal rat lung cells were 
exposed to 48h of an intermittent stretch pattern of 5% elongation at 60 
stretches/min for 15 min, of each hour. Cell numbers were increased 
by 10%, cell doubling time was reduced from 71 to 55 hours, 3H 
thymidine incorporation into DNA increased by 61% and the thymidine 
labelling index increased 2.8 fold, compared to non-stretched controls 
187. This effect did not appear to be mediated by prostaglandins or 
leukotrienes because ibuprofen or BW 755C, prostaglandin synthase 
inhibitors, leukotriene biosynthesis inhibitors BW 755C or MK-866 and 
leukotriene D4 receptor antagonist MK-571 did not abolish stretch 
mediated effects. Nishioka et a l.188 applied cyclic stretch to osteoblast­
like (HT-3) cells and measured pH] thymidine incorporation. Within 5 
days of cyclic stretch, DNA synthesis was increased approximately 3- 
fold.
It is apparent that whether stretch induces an increase or 
decrease in DNA synthesis is dependent on which cell type is being 
studied. It is therefore necessary to be cautious when extrapolating 
results from one tissue to another.
Proliferation
The most accurate index of growth is to look at the rate of growth itself. 
Vandenburgh et a l 189 developed a computerised system which 
applied forces similar to those experienced by differentiating skeletal 
muscle myoblasts. This system generated three dimensional artificial 
muscles. These muscles contained parallel networks of long 
unbranched myofibres organised into fascicle-like structures. Tendon 
development was initiated and the muscles were capable of performing 
directed functional work.
The study of Antonio et aL190 investigated the effect of stretch on 
avian muscle fibres. A weight equal to 10% of the bird's mass was
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attached to the right wing while the left wing served as the intra-animal 
control. The weight was attached to the wing for 24h periods 
interspersed with 48 to 72h rest intervals. The actual stretch time was 5 
days while the length of treatment was 15 days. Muscle mass and 
length was shown to increase significantly 53.1+/- 9.0 and 26.1+/-7.3% 
in the stretched anterior latissimus dorsi. Fibre number remained 
unchanged. Mean fibre area increased significantly by 27.8+/-6.0% in 
the stretched latissimus dorsi. These results indicate that stretching 
muscle fibres can stimulate their growth. In this study, intermittent 
stretch produced muscle fibre hypertrophy without fibre hyperplasia.
Until now, the effect of a physical force on processes which are 
involved in cell growth have been examined but now these studies 
have gone one step further to look at the growth process itself. The 
above experimental evidence confirms that a stretching force can 
stimulate cell growth via the second messenger events which have 
been previously discussed.
1.5.2.3 Cell morphology and structure
Shear stress can alter cell shape (1.5.1.3). Does stretch have an effect 
on this parameter? The majority of smc of muscular and elastic arteries 
are orientated at an angle of 20-40° to the longitudinal axis of the 
artery. Betz et a l-191 reported that repeated local transmural electrical 
stimulation of the carotid artery wall of rabbits caused a proliferation of 
smc into the subendothelial space. The smc of the proliferate lie with 
their longitudinal axis parallel to the direction of flow, i.e. at right angles 
to the resultant vector of the distending forces. Within 6 months after a 4 
week stimulation period, the subendothelial cells of the proliferate 
change their orientation and are finally arranged as in the normal 
media, whereas the cells at the base of the proliferate remain in an 
orientation parallel to the longitudinal axis of the artery.
Dartsch et a l-192 found that mechanical stimulation of aortic smc 
to produce an increase in cell length within the range of 2-20%, altered 
the orientation of the vsmc. The cells which were stretched with an 
amplitude of 2% remained in random orientation after 14 days of 
continuously performed cyclic stretching. The cells which were 
stretched 5% for 12 days orientated at an angle of 61 ± 9 degrees to the 
direction of stretching, while the cells which were stretched with an
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amplitude of 10% for 6 days orientated at an angle of 76±5 degrees. 
The cells on stationary and unstretched membranes remained in 
random orientation.
Terracio et a l.193 subjected cardiac myocytes, endothelial cells 
and fibroblasts to a 10% cyclical distention 10 times/min for 72h. Within 
24h of being exposed to the mechanical stretch, the cells became 
elongated and orientated perpendicular to the direction of the stretch. 
This indicates that cyclical mechanical stimulation directly influences 
the cellular organisation of the heart cells in vivo. Samuel 194 stretched 
adult rat cardiac myocytes in a unidirectional manner, using a 
computerised mechanical cell stimulator. A continuous unidirectional 
stretch of the substratum during the cell attachment period induced a 3- 
fold increase in the number of rod-shaped myocytes orientated parallel 
to the direction of movement.
Stretch can therefore affect the orientation of cells. To determine 
whether physical forces can alter cell shape by reorganising the 
cytoskeleton, the effect of stretch on actin gene expression was 
determined 195. Fibroblasts were stretched within the range of 0-9.2%. 
9.2% stretch produced the greatest increase in F-actin gene expression 
and 3.3% the least. These observations provide evidence that the 
microfilament system of fibroblasts exhibits rapid dynamic responses to 
mechanical deformation which may result in an altered cell shape. 
Mesangial cells were exposed to continuous stretch-relaxation for 72 to 
96h at a rate of 100 cycles/min at an applied pressure of 7 to 8kPa 196. 
Fluorescein-isothiocyanate-labelled phalloidin staining indicated an 
increase in the density of actin filaments in these cells.
The fact that stretch can alter cell orientation may be of 
importance in the process of remodelling which is observed in 
hypertension. The fact that actin gene expression is affected by stretch 
may explain why this change in cell behaviour has occurred. Any 
effects load may have on actin could result in vasoconstriction, 
increased resistance and elevated blood pressure.
1.5.2.4 Other biochemical events
Adenosine 3' 5'-cyclic monophosphate (cAMP)
The enzyme AC is present in the plasma membrane of most cells. In the 
presence of magnesium ions, this enzyme catalyses the conversion of
46
ATP to cAMP. cAMP functions to promote protein kinase activation, a 
second messenger effect which may be important in cell growth. It is 
broken down by phosphodiesterases. Does stretch affect this system?
Mills et a [.197 examined the effect of a strain of 24% on AC 
activity (ACA), in porcine, coronary artery smc. ACA decreased 
significantly after 5 min. However, the extent of reduction did not 
become more significant after 30 min of strain. Adopting a similar 
procedure, this group have also shown that basal and forskolin 
stimulated ACA were stimulated by acute cyclic strain, in bovine aortic 
endothelial cells 198. ACA increased progressively from 1 to 5 min and 
returned to basal by 7 min. Because ACA is increased in response to 
strain in endothelial cells the effect of strain on cAMP levels was 
determined. Iba et a l-199 were unable to detect an increase in cAMP 
levels in human saphenous vein endothelial cells. These experiments 
were performed in the presence of the the phosphodiesterase inhibitor, 
3-isobutyl-1-methylxanthine (IBMX), to prevent the degradation of 
cAM P.
At present, it is unclear why contrasting results were obtained for 
ACA activity, in smc and endothelial cells. Why an increased ACA 
activity did not elicit an increase in cAMP levels in the presence of IBMX 
is also unclear and requires further validation.
Prostaglandins
As previously mentioned, prostaglandins such as PGI2 which exerts a 
vasodilator action, are involved in the control of vessel calibre. 
Therefore, any effect mechanical load may have on the 
production/release of this factor is of vital importance. Differences in 
secretion of PGI2 by venous and arterial endothelial cells, grown in a 
static or mechanically active environment, was investigated by 
Upchurch et al. 2oo. Endothelial cells from bovine aortas and venae 
cavae were subjected to cyclic deformation, up to 17% elongation and 
60 cycles/min. After 3 to 5 days the supernatant fluids were assayed for 
PGI2 activity. Under static o r  control conditions, venous endothelial 
cells secreted significantly more PGI2 than did arterial cells from the 
same animal. Sumpio etaL 201 subjected aortic endothelial cells to 10s 
cycles of 24% elongation and 10s of relaxation for 1, 3 or 5 days. The 
medium was collected to assess for PGI2 activity. Cyclic stretching
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increased PGI2 activity in a time-dependent manner. Carosi et al. 202 
cyclically strained bovine aortic endothelial cells by 5% or 10%, for 24h 
at 1Hz. At a physiological level of 10% cyclic strain, PGI2 secretion rates 
were increased by 2.5- fold above stationary controls. Because no 
effect was observed at 5%, it is evident that a threshold level of 
activation was required before an increase in PGI2 secretion could 
occur. A stretch frame was utilised by Vandenburgh et al- 203 to stretch 
skeletal muscle by 20%. This resulted in increased prostaglandin 
synthesis.
Each of these studies agrees that stretching can induce PGI2 
production. This may be a general effect for different cell types as 
enhanced PGI2 production was observed in both endothelial cells and 
skeletal muscle. Under conditions of stress, PGI2 production may be 
stimulated by cells to compensate for any changes in vessel calibre 
which this state may have induced.
Endothelin
The activity of the potent vasoconstrictor endothelin in a cell is one of 
the factors which determines vessel diameter and hence resistance. 
The way in which the cell responds to mechanical stretch with respect 
to endothelin, has not been fully elucidated.
Bovine aortic endothelial cells increase production of endothelin into 
culture medium up to 6-fold in response to cyclic stretch 202» 204.
Harder et a[. 205 looked at the effect of increased pressure on 
cerebral artery function. When the cerebral arteries were pressurised to * 
between 40 and 160 mmHg, there was a 13.2% reduction in diameter. 
The reduction in diameter was lost and vessels dilated to pressure 
when the endothelium was removed. When the denuded vessel was 
exposed to an intact donor vessel, the denuded vessel recovered its 
ability to contract, suggesting that increased pressure may cause the 
release of a contractile substance from the vascular endothelium. 
Oxyhemaglobin, a NO antagonist, did not alter the response to 
pressure in these isolated cerebral arteries further suggesting that the 
reduction in diameter results from the release of a contractile substance 
from the vascular endothelium, and not inhibition of NO.
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NO
If stretch altered release of NO, this may have an adverse effect on 
vessel diameter. The enhanced release of NO resulting from increasing 
the tension of aortic rings of rabbit aorta was described by Ohno et al- 
206. The levels of the second messenger guanosine 3 \ 5'-cyclic 
monophosphate (cGMP), which is stimulated by NO, was monitored on 
stretching the aortic rings. Tissue cGMP levels significantly increased 
with the increase in resting tension in endothelium-intact rings, but not 
in denuded rings. These stretch-induced endothelium-dependent 
tissue cGMP increases were unaffected by the calcium channel 
blockers, nicardipine and diltiazem.
Hishikawa e ta i. 207 exposed human endothelial cells to 
increased pressure by pumping compressed helium into the flask in 
which they had been grown. Increasing the transmural pressure was 
shown to decrease NO release from endothelial cells .
In aortic rings, pressure was shown to increase NO release, but 
in endothelial cells a decrease was observed. In these studies, different 
cell types and different animal models were used. This is the best 
explanation for these contrasting results. Further work is required to 
verify the effect of pressure on NO production.
Tissue plasminogen activator (t-PA)
The fibrin component of clots are broken down by the serum protease, 
plasmin. Plasmin is formed by the activation of plasminogen, an 
inactive precursor. This conversion is carried out by t-PA. The activity of 
t-PA can be controlled by the action of plasminogen activator inhibitor 
(PAI-1).
Due to vessel wall damage, vascular cells may be exposed to a 
high pressure environment. After completion of the clotting process, the 
magnitude of forces may decrease and conditions return to normal. It is 
obvious that such cells experience a range of different pressures 
throughout this process. Do changes in pressure influence the 
production of factors involved in vessel repair?
Increased levels of t-PA were found in the culture medium of 
endothelial cells subjected to cyclic stretch 208.
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ECM
The ECM represents a major component of the cell which actively 
participates in signal transduction (see section 1.3.1.5). It is therefore 
important to determine whether mechanical stress causes a 
modification of cell structure and/or matrix elaboration which may then 
affect the function of specific second messenger systems. Sumpio MuL 
209 subjected smc to a regimen of 10s elongation (25%), followed by 
10s relaxation, continuously for 5 days. This three-cycle-per-min 
stretching stimulated smc production of collagen. Bovine aortic 
endothelial cells were subjected to 24% cyclic deformation, 3 
cycles/min, 10s of elongation alternating with 10s of relaxation, for 5 
days 21 °. Endothelial cell production of collagen was inhibited with 
repetitive deformation. The reasons why smc increased collagen 
production but endothelial cells reduced production in response to 
stretch, using a similar procedure, are presently unclear.
Harris et aL 196 examined the effect of continuous stretch- 
relaxation upon mesangial cell growth and function. Mesangial cells 
were exposed to a continuous stretch-relaxation regimen for 72 to 96h 
at a rate of 100 cycles/min at an applied pressure of 7 to 8kPa. The 
peak and minimal deformation values were chosen to represent 
glomerular capillary pressures in vivo. The mesangial cells adopted a 
stellate or straplike morphology. The mechanical stretch/relaxation 
treatment increased the % of protein representing collagenous proteins 
in these cells with an increase in the relative amounts of types I and III 
collagens. There was a selective increase in the relative amount of type 
I homotrimer, a molecular form of type I collagen. Furthermore, Riser et 
aL 211 found that exposing mesangial cells to repeated mechanical 
strain increased collagen type IV and collagen type I production. This 
evidence suggests that high pressures like those which exist in the 
condition of nephrosclerosis, induce the production of proteins in 
mesangial cells which may have a potential role in the development of 
this state.
Leung et aL 212 used a motor system to stretch arterial smc 
cyclically and found that this treatment resulted in up to fourfold 
increase in the rates of type I and III collagen, hyaluronate and 
chrondroitin 6-sulphate synthesis. Synthesis of types I and III collagen 
was increased to the same degree. Nishioka et a[. 188 applied cyclic 
stretch on HT-3 cells using a computerised, pressure-operated
instrument that physically deformed cells. The synthesis of collagenous 
protein in the cell extracts, after cyclic stretching, was examined on day 
7 and findings compared with those of static controls. HT-3 cells 
cultured under conditions of cyclic stretch produced significant amounts 
of collagenous protein. Stretching appears to be a powerful stimulus for 
collagen production in different cell types.
Sottiurai eta[. 213 showed that subjecting arterial smc to 110% 
stretching of their original length, 52 times/min for 8, 48 and 56h caused 
myofilaments to be largely replaced by rough endoplasmic reticulum. 
Cyclically stretched cells were also shown to form numerous 
intercellular contacts and showed little evidence of cytoplasmic 
degradation while stationary cells showed few contacts and contained 
numerous cytosomes and lamellar bodies. Stretch had induced 
significant changes in the components of the ECM which may have 
pronounced effects on the signalling mechanisms of these cells.
Studies on endothelial cells suggest that one class of cell 
adhesion molecules, integrins, act as mechanoreceptors and transmit 
mechanical signals to the cytoskeleton 214.
Two components of the ECM, namely collagen and integrins are 
affected by cell stretching. These results suggest that stretching may 
have pronounced effects on the transduction of signals throughout the 
matrix.
ANP
ANP is released by atrial distension in vivo. Application of tension to 
atrial cardiocytes in vitro causes a dose-dependent increase in 
immunoreactive ANP release into the culture medium 2i 5.24h after the 
stretch stimulus, an increase in ANP mRNA levels could be detected. 
The calcium channel blocker, verapamil, had no effect on stretch- 
dependent immunoreactive ANP release, whereas the calmodulin 
inhibitor, calmidzolium, suppressed basal as well as stretch dependent 
secretion. This implies that an important relationship exists between 
intracellular calcium metabolism and immunoreactive ANP release.
ANP secretion was measured in non-contracting preparations of 
combined right and left rat atria by Page Mai- 216 who found that by 
increasing distending pressure, ANP secretion was increased. 
Schiebinger Mai- 217 stimulated ANP production in isolated rat left atria 
using norepinephrine and endothelin. By altering the tension of the
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atria in the range of 0, 0.5, 1.5 g, an increased ANP production in 
response to these stimuli was attained. The maximum ANP 
concentration was achieved at a tension of 1.5 g. The possible role of 
pressure as a stimulus for increased ANP production in ventricular 
hypertrophy was investigated by Kinnunen e ta L  218. ANP gene 
expression was increased in the hypertrophic ventricular cells of SHR. 
Stretching of the ventricles produced a rapid but transient increase in 
ANP secretion and ANP release with rising pressure. Newman et al. 
219 quantified the secretion of ANP-containing granules in myocytes in 
response to different degrees of atrial distension. Stretch was produced 
by altering the perfusion pressure and hence altering the degree of 
distension of rat atria. By increasing the degree of distension of the right 
atrium a proportional rise in the release of secretory granules from 
individual myocytes was produced. This supports the ability of stretch to 
stimulate ANP secretion from secretory granules.
Enzyme activity
To study the effect of stretch from a more general viewpoint, it is ideal to 
study the activity of enzymes which are always present in the cell. 
Creatine kinase which is associated with energy production in heart 
and skeletal muscle and alkaline phosphatase which is involved in 
bone growth, are examples of such enzymes. Vandenburgh et a t 220 
used a mechanical cell stimulator to stretch and relax muscle cells. In 
this study, the skeletal muscle was exposed to a stretching force which 
ranged from 3.5-46%. Initiation of mechanical stimulation increased the 
efflux of creatine kinase during the first 8-1 Oh of activity but the efflux 
rates returned to control levels after this time period. Decreased total 
cell protein content accompanied the elevation of creatine kinase efflux. 
Creatine kinase release from a cell is normally indicative of cell death. 
Thus, it is not surprising that a decrease in protein content was also 
observed which suggested cell damage/death had been induced by 
the stretch regimen. These observations can be explained by the fact 
that large values of stretch were used which obviously damaged the 
cells and resulted in release of creatine kinase and possibly other 
proteins from the cells.
Nishioka et aL 188 applied cyclical stretch to osteoblast-like cells 
using a computerised, pressure-operated instrument. Cyclical stretch 
enhanced alkaline phosphatase activity. The effect was considered to
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be regulated through PGE2 production because stretch reduced levels 
of PGE2 in the medium. When PGE2was added there was a significant 
decrease in alkaline phosphatase activity. The reason why stretch 
stimulates alkaline phosphatase activity and the mechanism by which 
PGE2 affects this activity are not clear and require further study.
Metabolic rate
Metabolic rate can be studied by measuring glucose uptake by the cell 
since glucose is the energy source required for glycolysis. It is also 
reasonable to measure lactate release because this is a byproduct of 
glycolysis during increased skeletal muscle function. Hatfauldy et al. 
221 mechanically stimulated avian pectoralis muscle cells by repetitive 
stretch-relaxations of the cells substratum and studied the effect on the 
rates of deoxy-D-glucose uptake and lactate efflux. During the first 4-6h 
of mechanical stretching, the deoxy-D-glucose uptake and lactate efflux 
increased 34 and 26% respectively. At 8 and 24h of activity, neither 
parameter was elevated relative to control values. Rates significantly 
elevated with continued activity beyond 24h and reached maximum 
levels by 48h.
No significant increase in the rates of deoxy-D-glucose uptake 
and lactate efflux at 8 and 24h activity can be explained by the fact that 
the increased glycolysis observed during the first 4-6h produced a 
dramatic increase in lactate levels which led to inhibition of glycolysis. 
An increased lactate concentration decreases the [pH ]j and inhibits 
glycolytic enzymes present in the cell. In muscle and blood, lactate 
levels are quickly removed and metabolised, a circulatory system does 
not exist in tissue culture and lactate levels can therefore accumulate to 
inhibit glycolysis. In the experiment the tissue-cultured muscle cells 
were fed fresh medium at 24h, this would result in a change in the 
intracellular pH of the cells. This is why glycolysis was seen to resume 
after 24h.
Parathyroid hormone-related protein (PTHrP)
PTHrP exhibits similar biological effects to parathyroid hormone. The 
expression of the parathyroid hormone gene is confined to the 
parathyroid gland but PTHrP expression is found in mammalian and
53
avain tissues. The function of PTHrP in these tissues is unknown but 
such a widespread distribution suggests a paracrine or autocrine role.
PTHrP in the pregnant rat uterus is dependent on the occupancy 
of the uterus by the fetus. PTHrP gene expression is dependent on the 
degree of stretch of the uterus. To determine whether stretch of smooth 
muscle is a stimulus for PTHrP gene expression, its activity was 
measured in uterine tissue and in-the rat bladder. An intrauterine 
balloon system was developed that allowed experimental reproduction 
of the mechanical effects of the fetal pup in utero 222 Increased PTHrP 
mRNA in the unoccupied horn of unilaterally pregnant or virgin rats 
could be elicited as early as 1h after balloon inflation and was 
maintained for up to 72h. This suggests that mechanotransduction is 
responsible for a preterm peak in PTHrP mRNA expression. The effect 
of stretch on PTHrP in the rat urinary bladder was measured by 
Yamomoto et al. 223 It was observed that under normal conditions, the 
PTHrP mRNA levels in the bladder correlated with the urine volume, i.e. 
the extent of bladder distension. When bladders were distended by the 
accumulation of urine, levels of PTHrP mRNA increased dramatically 
with time. On limiting the distension to one half of the bladder, the 
increase in mRNA was observed only in the distended portion.
These observations verify a physiological role for PTHrP in 
uterine and bladder smooth muscle function.
Arrythmias
Previous observations have shown that stretch can cause the release 
of a factor(s) which can have a slowly developing effect on the 
cardiovascular system. Studies on isolated hearts have shown that 
stretch can also have an instant action on the heart by triggering 
arrythmias 224» 225. This can lead to ventricular fibrillation which is 
frequently fatal. It is therefore necessary to study this action of stretch in 
greater detail.
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1.6 Methods used to exert pressure on cells
When designing a system to exert physical forces on cells, many factors 
have to be considered. The first is whether a compressive force which 
will produce a decrease in cell length or a stretching force which will 
increase cell length is required. The range over which the force will 
function is a very important initial factor because if this has to be altered 
expensive changes in the design of the system may be required. The 
ability of the system to provide a reproducible force is also necessary. 
The size of the system has to be considered and will depend upon 
which factor is being measured e.g a large number of cells are required 
for RNA extraction when measuring changes in mRNA levels induced 
by a particular stimulus. Thus, the system has to be large enough to 
facilitate a reasonable cell growth. The system must be sterile so as to 
minimise any contamination problems.
The following section describes the more popular used 
techniques which have been developed to look at the effect of pressure 
on cellular function.
1.6.1 Petriperm dishes
Petriperm dishes are cell culture dishes which are manufactured by 
Bachofer Ltd, Germany. These dishes have flexible membrane bases 
which can be deformed. Important features are that they facilitate the 
growth of a number of different cell types and their tightly fitting lids 
minimise contamination.
Using the principle of Petriperm dishes, Hasegawa et a l 183 
devised a simple method for applying mechanical stretching to bone 
cells, as shown in Figure 9. Bone cells were cultured in the flexible 
membrane of Petriperm dishes. The dishes were placed over a 
template with a convex surface and then a lead weight was placed on 
top of the dish. This caused the membrane to adopt the shape of the 
template and thus stretched the membrane and the tightly attached 
cells. A template producing a 4% increase in surface area was used. 
The deformation of the dish was reversible, making it possible to 
alternate periods of mechanical stretching with periods when no stress 
was applied; i.e a cyclic regimen. As already mentioned, the degree of 
stretch was dependent on the curvature of the template and could be
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(a)
Figure 9 A schematic representation of the apparatus 
used to stretch cells, from Hasegawa at al. (183).
(a) The system is composed of a petriperm dish and a covex 
template.
(b) The petriperm dish is placed on top of the convex 
template.
(c) A weight is then placed on top of the dish, causing the 
flexible base of the dish to be upwardly displaced, to adopt the 
shape of the convex template. Cells grown in the dishes are 
therefore stretched.
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varied by either changing the curvature of the template or by altering 
the weight applied.
More recently, Gardner et al. 215 also used Petriperm dishes to 
stretch atrial cardiocytes. The cells were grown in the dishes and 
placed over a reservoir containing saline solution. By infusing a known 
volume of saline into the resevoir, the flexible membrane of the 
petriperm dish was upwardly displaced and thus the attached cells 
stretched.
There are several problems with these methods. It is 
inconvenient to be continually applying and removing a weight or 
infusing and removing saline when conducting experiments. It would 
also be difficult to modify the systems to study a cyclic force instead of a 
continuous one. This method does not produce a uniform displacement 
of the base of the dish. The central area is displaced to a greater extent 
than the periphery of the base. This means that the cells grown in the 
dishes will be stretched by different amounts. An additional drawback of 
the method used by Hasegawa et a l-183 is that only a 4% increase in 
surface area was achieved, which is small.
The previous two methods have involved upward displacement 
of the petriperm bases. It is also possible to achieve a downward 
displacement. A new vaccum-operated instrument was constructed by 
Banes et a l 181- This was able to apply static or variable duration, 
cyclic tension to cells in vitro. The unit used a vaccum to deform a 
petriperm dish which could yield a 0.13% compression to cells situated 
on the inner surface, measured by strain gauge recordings. The stress 
unit consisted of a plexiglass manifold bearing six gasketed vaccum 
ports (Figure 10). Rubber gaskets were recessed 1.5mm in the 
plexiglass and the gasket remained 1.5mm above the plane of the 
vacuum port. The gaskets received a coat of vacuum grease and the 
plates were centred over the ports. One side of the unit contained a 
metered fitting to which a vacuum could be applied and measured, 
while the other side had a bleed valve used to adjust the vacuum level. 
The stress unit fitted onto a tray inside a C02 incubator. Vacuum and 
bleed hoses were led through a vent at the top of the incubator to avoid 
disturbing the internal atmosphere. On application of the vacuum, the 
culture plates were drawn flush with the vaccum port opening, 
achieving a maximum deflection of 1.5mm at the plate centre. When the
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Figure 10 Schematic of vacuum-operated system, 
from Banes et al. (181).
(a) The three components that constitute the tension unit 
are a solenoid valve, timer and a vacuum unit.
(b) The flexible base of a petriperm dish is vertically 
displaced by a vacuum and cells grown in the dish are 
stretched.
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vacuum was released, the plates returned to their original conformation 
for a chosen period of relaxation.
The vacuum system has proved to be a popular technique but its 
main disadvantages are that the stretch produced is uneven and only a 
small stretching force can be generated using this system. Again, the 
central area of the base of the dish is displaced greater than the 
periphery. Therefore, the cells grown in the dish are stretched by varied 
amounts. A greater range of stretch is required to conduct a thorough 
study of the effect of stretch on various aspects of cell function.
A different method which also used Petriperm dishes was 
designed by Brunette 184 to stretch epithelial cells. The apparatus was 
composed of an orthodontic screw embedded in an acrylic resin to fit a 
petriperm culture dish. The petriperm dish was utilised because the 
flexible plastic membrane of the dish could be stretched by turning the 
screw. The amount of stretching was not uniform throughout the dish. In 
the central area where the observations were made there was a 4.2% 
increase in length in the axis along which the force was applied.
1.6.2 Stretch frame
The system devised by Vandenburgh et al. 203 involved the use of 
stretch frame, which were horizontally adjustable by means of a thumb 
screw. Figure 11 illustrates the system used to stretch skeletal muscle 
myotubes. Clear silicone membranes, on which the cells were grown, 
were attached to the base of the apparatus. By turning the screw, an 
increase in the length of the silicone was achieved and hence the 
attached cells stretched. This system could achieve a stretch of 10.8% 
in magnitude.
The major disadvantage of the stretch frame system was that it 
appeared that the amount of stretching would be non-uniform  
throughout the silicone sheet and therefore the cell layer, and would be 
most pronounced in the central area. Vandenburgh etal. 203 had not 
shown any silicone measurements at different positions on the silicone 
to prove otherwise. A uniform distribution of stretch is an important 
requirement for the study of this factor on cellular function.
59
Stretch frame
Thumb screws
(a) Before stretching
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Clear silicone 
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(b) After stretching
0=i Area of silicone membrane has 
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Figure 11 Schematic of a stretch frame, from 
Vandenburgh et al. (203)
(a) Cells are grown on a silicone membrane which is 
attached to the frame.
(b) By turning the thumb screws the area of the silicone 
membrane is increased and the attached cells stretched.
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1.6.3 Compressive forces
Richardson 150 developed a system which could apply compressive 
forces to bone cells in culture in the study of bone fracture repair. An 
electric motor and gearing system were used to provide a controlled 
source of cyclic loading (Figure 12). A cam translated the circular 
motion produced by a motor, into an axial motion of a pumping rod. 
Bone cells were grown on silicone discs containing a notch which 
exactly fitted the end of the pumping rod. As the rod came into contact 
with the disc, the silicone and the attached cells were compressed.
A major problem encountered by Richardson 150 was that the 
bone cells adhered poorly to the silicone. To improve this, the effect the 
following cell adhesion-promoting agents was analysed; 10 and 
lOOjygml"1 I poly-lysine, 25/ygml-1 fibronectin, 2 and 20% gelatin. 
However, neither of these agents were suitable. Another approach 
used stainless steel pins to anchor chick tibial explants against the 
silicone. A further method used to hold explants in position involved 
raising small flaps of the silicone surface to act as sprung clips. This 
was successful but the resulting silicone surface was uneven so this 
prevented microscopic examination of the growing cells. The final 
method used involved holding bone fragments in place using 
cyanoacrylatate ("superglue"). This was effective and did not prevent 
cell growth but disrupted the migration of cells onto the silicone surface. 
At the end of this project no suitable adhesive had been found. An 
additional disadvantage of this system is that it was difficult to maintain 
sterilility. Because of all these problems the proposed experiments 
were not completed.
1.6.4 Conclusions
The latter system which subjected cells to a compressive force was the 
only system which experienced contamination problems. Sterility is one 
of the most important features of a cell culture system. To use this 
system, the design would have to be altered to overcome this problem. 
Poor cell adhesion was also experienced which, as mentioned earlier, 
is also an important feature required of such a system. If cells are not 
suitably attached to their substrate, they will detach when a force is
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Figure 12 Schematic of system used to compress cells, 
from Richardson (150)
Cells grown on silicone blocks are subjected to a compressive 
force when rotation of a tufnol cam displaces a piston and 
causes the piston to make contact with the blocks.
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applied. For these reasons, this method is not convenient to use in the 
study of pressure on cells.
Each of the techniques which used Petriperm dishes were 
successful because cells grow well in these dishes and were free from 
any sterility problems. Their only drawback is that due to the size of the 
dishes, the extent to which the membrane can be displaced is very 
small. The maximum stretching force that was generated using 
Petriperm dishes was 4.2%. To mimic the forces to which cells are 
subjected in vivo, a greater range of stretch is required. Another 
drawback of using Petriperm dishes is that when the flexible base is 
stretched the central area is stretched to a greater extent than the 
periphery. Each cell requires to be stretched by the same amount.
It was speculated that the stretch frame would also produce a 
non-uniform force. This appears to be an important problem which is 
associated with the design of each of these systems. In other aspects, 
the use of a frame appeared to be a suitable method which could be 
employed in such investigations.
The primary objective of my project was to develop a system 
capable of mechanically stretching vsmc and endothelial cells, in 
culture. The system had to feature each of the essential characteristics 
previously discussed and also solve the problems of non-uniform 
stretch and restricted range of stretch which had been experienced 
using other systems. On achieving a suitable system preliminary 
experiments were proposed, to study the role of mechanical forces in 
the development of vascular hypertrophy.
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CHAPTER TWO 
MATERIALS AND METHODS
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2.1 Materials
2.1.1 Biochemicals
Agarose, ANG II, antibodies, bovine serum albumin, bromphenol blue, 
cesium chloride, coomassie brilliant blue G, dextran sulphate, Dowex 
mixed resin, Dowex-1 chloride, emetine, ethidium bromide, formamide, 
2-[N-Morpholino] ethanesulfonic acid (MOPS), phosphate buffered saline 
(PBS) tablets, polyvinylpyrrolidine, rabbit anti-human von Williebrand 
factor, sephadex, and sodium acetate were purchased from Sigma 
(Dorset, England).
Agar, bacto agar, casamino acids and yeast extract were purchased 
from Difco (Surrey, England).
Buffer tablets (pH7), sodium dodecyl sulphate, trichloroacetic acid and 
hydrochloric acid were bought from BDH (Poole, England). 
Diaminoethanetetra-acetic acid (EDTA), formaldehyde (38% w/v) 
glycerol, sodium hydroxide, sodium chloride, sodium citrate, sodium 
dodecyl sulphate and formaldehyde were bought from FSA laboratories 
(Loughborough, England).
HB101 and DH5a competent cells were purchased from Gibco BRL 
(Paisley, Scotland).
Ficoll 400 was bought from Pharmacia LKB (Buckinghamshire, England). 
RNAzol B was purchased from Biogenesis Ltd. (Bournemouth, England). 
Analar ethanol was purchased from Hayman Ltd. (Essex, England). 
Isopropanol and chloroform were purchased from Rhone Poulenc 
Chemicals Ltd. (Manchester, England).
Decon 75 solution was purchased from Scotlab (Coatbridge, U.K). 
Fluorescein was purchased from Amersham International PLC 
(Buckinghamshire, England).
Vectashield mounting medium was purchased from Vector laboratories 
(Burlingame, California).
2.1.2 Radiochemicals
18.5 j;Ci of deoxy (5-3H) cytidine 5'-triphosphate ammonium salt (CTP), 
(3000 Ci/ml) and 1 mCi of myo-[2-3H] inositol (10-20 Ci/mmol) were 
purchased from Amersham International PLC (Buckinghamshire, 
England).
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2.1.3 General solutions/buffers
Concentrated (20x) sodium saline citrate (SSC)
175.3g of sodium chloride and 88.2g of sodium citrate were dissolved in 
800ml of glass distilled water (dH20). The solution was brought to pH 
7.0 using 5M hydrochloric acid, the final volume adjusted to 1 litre with 
dH20, and the pH rechecked. The solution was autoclaved and stored at 
4°C. The final concentrations of sodium chloride and sodium citrate were 
3 M and 0.3M respectively.
1xSSC, 0.5xSSC and O.IxSSC were obtained by dilution of 
20xSSC in dH20.
Deionised distilled water (ddH20).
Approximately 50g of Dowex mixed resin was added to 3 litres of dH20  
and stirred for 2h using a magnetic stirrer. The water was then filtered, 
autoclaved, cooled and stored at 4°C.
L-broth/agar plates
5g of p-lab yeast extract, 5g of sodium chloride, 10g of casamino acids 
and 2ml of 1M sodium hydroxide solution were dissolved in 1 litre of 
dH20  and autoclaved. The solution was cooled and stored at 4°C.
0.5M EDTA , pH 8
18.6g of EDTA were dissolved in 80ml of dH20. The solution was 
brought to pH 8 with 5M sodium hydroxide solution and the volume 
made up to 100ml with dH20.
Tris EDTA (TE) electrophoresis buffer
0.2ml of 0.5M EDTA (pH 8) and 0.121g of Tris chloride [final 
concentration 100mM] was dissolved in 80ml of dH20  and the volume 
made up to 100ml using dH20. The resulting solution had a pH of 8.0.
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Concentrated (50x) Denhardt's reagent
1g of polyvinylpyrrolidine, 1g ficoll and 1g bovine serum albumin were 
dissolved in 80ml of dH20. The volume was made up to 100ml with 
dH20. The solution was aliquoted and stored at -20°C.
Concentrated (10x) MOPS
41.2g MOPS was dissolved in 1600ml of 0.1 M sodium acetate and the 
pH of the solution adjusted to 7.0 with 10M sodium hydroxide solution. 
20ml of 0.5M EDTA was then added, the pH adjusted to 8.0 and the 
volume made up to 2 litres with dH20. This solution was stored at 4°C. 
IxMOPS was obtained by dilution of 10xMOPS in dH20.
RNA loading dye solution
500g\ of bromphenol blue (0.1 mg/ml), 500//I of glycerol and 500g\ of 
deionised formamide were combined and mixed thoroughly. One part 
ethidium bromide 1 mg/ml was then added to 2 parts of this solution. The 
dye solution was stored at -20° C.
DNA loading dye solution
500g\ of bromphenol blue (0.1 mg/ml) was combined with 500/yl of 
glycerol. The solution was mixed thoroughly and stored at -20°C.
Dowex-1-formate
Dowex-1 chloride (100g) was washed with 1 litre of dH20  to remove 
broken beads, transferred to a scintered glass funnel and washed with 2 
litres of 2M sodium hydroxide. It was then further washed with 1 litre of 
dH20, 500ml of 1M formic acid, 5 litres of dH20  and finally with dH20  
until a constant pH of 5.5 was achieved. The Dowex was then poured 
from the funnel and stored in dH20.
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Versene solution
Versene was purchased from the University of Glasgow, Department of 
Virology. The recipe for the versene was: 80g of sodium chloride, 2g of 
potassium chloride, 11.5g of sodium hydrogen phosphate, 3.3g 
potassium hydrogen phosphate, 2g of EDTA and 15ml of phenol red 
(1%) were dissolved in 10 litres of dH20. The pH of the solution was 
7.12 -7.3. The solution was autoclaved and stored at 4°C.
Trypsin solution
Trypsin solution was also purchased from the University of Glasgow, 
Department of Virology. The recipe for the solution was : 8g of sodium 
chloride, 2ml of potassium chloride (19%), 0.1g of sodium hydrogen 
phosphate, 1g of dextrose and 3g of tris amino methane, were dissolved 
in 700ml of dH20. 1.5ml of phenol red (1%), penicillin (100.000U) and 
0.1g of streptomycin were added to this solution. The volume was made 
up to 1 litre with dH20  and 2.5g of trypsin added. The solution was then 
autoclaved and stored at -20° C.
Trypsin/versene
This solution contained 20ml of versene and 5ml of trypsin.
2.1.4 Cell culture reagents and disposable apparatus
Collagen (type I), collagenase (type II), elastase (type IV), fibronectin, 
gelatin, Hanks' balanced salt solution (HBSS), poly-l-lysine and soya 
bean trypsin inhibitor were purchased from Sigma (Dorset, England). 
Penicillin (100U/ml), streptomycin (100mg/ml) and fungizone (250/;g/ml) 
were purchased from Gibco BRL (Paisley, Scotland).
Dulbecco's modified Eagle medium (DMEM) containing 4.5g/litre 
dextrose, DMEM without glutamine or inositol, heat inactivated foetal calf 
serum (FCS), L-glutamine, heat inactivated horse serum (HS) and tissue 
culture flasks were bought from ICN Flow (Irvine, Scotland).
Cell scrapers were purchased from Northumbria Biologicals Ltd. 
(Northumberland, England).
Silicone sheeting was bought from Altec (Hampshire, England). Sterile, 
disposable 10ml pipettes and sterile bijoux containers were purchased
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from Sterilin Ltd. (Hounslow, England).
Sterile 0.22/ym filter units were bought from Millipore S.A. (Molsheim, 
France).
Glisseal sealant was purchased from BDH (Poole, England). Plastic, 
sterile forceps were purchased from Steriseal (Worcestershire, England).
2.1.5 Molecular biology reagents and disposable apparatus
Geneclean II kits were obtained from Stratech Scientific (Luton, 
England). Qiagen plasmid kits were purchased from Hybaid (Middlesex, 
England). Oligolabelling kits were purchased from Pharmacia 
(Buckinghamshire, England). Blot transfer systems 11.14, restriction 
enzymes and reaction buffers were obtained from Gibco BRL (Paisley, 
Scotland). Micro-centrifuge tubes were purchased from Scotlab 
(Coatbridge, Scotland). Sterile pastettes, universal containers and 
pipette tips were bought from Alpha Laboratories (Hampshire, England). 
Hybond-N transfer membranes were purchased from Amersham 
(Buckinghamshire, England). RNA zol™ was bought from Biogenesis 
Ltd. (Bournemouth, U.K).
2.2 General methods
2.2.1 Glassware
All items of glassware were washed in solutions of the detergent Decon 
75, rinsed with dH20  and dried in an oven at 60°C.
2.2.2 Micropipetting
Solution volumes in the range of 1-25/il were transferred accurately 
using digital pipettes obtained from Scotlab (Coatbridge, Glasgow). 10- 
10OOpI were transferred reproducibly using Finn-pipettes purchased from 
Lab systems (Hampshire, England).
2.2.3 pH measurement
Measurements of pH were carried out using a digital, pH/temperature 
meter obtained from FSA (Loughborough, England). This apparatus was 
regularly standardised using a solution of pH7, prepared using buffer
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tablets.
2.3. Cell culture 
2.3.1 General equipment
The following is a list of the general items of equipment used in cell 
culture;
Heraeus laminar flow hood : FSA laboratories (Loughborough, England). 
Heraeus C 02 incubator: MDH (Hampshire, England).
Diavert inverted microscope : Leica UK Ltd. (Milton Keynes, England). 
Electronic Coulter counter (ZM) : Coulter Electronics Ltd. (Luton, 
England).
Fume hood : Fumair Ltd. (Hertford, England).
2.3.2 Vsmc preparation
Vsmc were grown from mesenteric arteries of male (150-200g) Sprague- 
Dawley rats (Plate 1). Mesenteric arteries (6 arteries per preparation) 
were removed under sterile conditions, cleaned of residual fat by blunt 
dissection and incubated for 5 min in DMEM containing 1.25mg/ml type 
II collagenase, 0.25mg/ml type IV elastase and 0.05mg/ml soya bean 
trypsin inhibitor. The adventitia was then removed by dissection. The 
cleaned arteries were then cut into small pieces and incubated in fresh 
enzyme solution, with periodic trituration, until a single cell suspension 
was obtained. Cells were then collected by centrifugation (200g/5min), 
resuspended in 5ml growth medium ; DMEM containing 10% FCS, 10% 
HS, 100U/ml penicillin, 100mg/ml streptomycin and 2mmol/l L-glutamine, 
and grown in 25cm2 tissue culture flasks. This growth medium was used 
for all cell culture work, unless otherwise stated. Cells were maintained 
at 37°C in a 5% carbon dioxide (C02)/95% air humidified atmosphere. 
Plate 2 shows vsmc 2 days in culture and Plate 3 confluent vsmc. For 
the first few days in culture the cells were spindle shaped, contained 
substantial bundles of myofilaments (assessed by electron microscopy) 
and contracted in response to addition of ANG II. Figures 13a and 13b 
show the contraction of vsmc on addition of ANG II, as assessed by 
time-lapse video recordings. The smooth muscle nature of the cells was 
also consistent with the lack of staining for von Williebrand factor (see 
section 2.3.2.1). At confluence the cells displayed the hill and valley
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Plate 2. Vsmc prepared as described in section 2.3.2 and grown in 
culture for 2 days.
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Plate 3. Vsmc grown in culture for 5 days. By this time they have 
reached confluence.
73
Figure 13.
Vascular smooth muscle cells before (A) and after (B) 
addition of ANG II, 10'5M. (B) shows the contractile 
response of the cells to ANG II.
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characteristics of smooth muscle cell cultures when examined with 
phase-contrast microscopy and would grow to form multi-layers.
2.3.2.1 Staining cells with von Williebrand factor
Cells were plated down in plastic tissue culture flasks and fixed in ice 
cold 50% acetone/methanol (1:1), at 4°C. The cells were washed with 
PBS (x1) for 5 min and then incubated with rabbit, anti-human, von 
Williebrand factor (Diluted 1 in 200 in 1xPBS) for 30 min, at 37°C. The 
cells were then washed with 1xPBS for 3, 15 min incubations. The cells 
were next incubated with donkey, anti-rabbit Ig, fluorescein, for 30 min, 
at 37°C. This was followed by 2, 15 min washes in x1 PBS. The cells 
were finally mounted in Vectashield mounting medium. Control cells 
were incubated as described above but the first antibody was omitted.
2.3.3 Passaging vsmc
At confluence, the medium was decanted and an appropriate volume of 
versene added, to cover the bottom of the flask, for 10s. The versene 
was decanted and an appropriate volume of a versene/trypsin (4:1) 
solution was added to the flask for 10s. The versene/trypsin solution was 
also decanted and the flask of cells incubated at 37 °C until all of the 
cells detached. The cells were triturated using a fine tipped pipette and 
transferred into new flasks at a 1 : 3 split ratio. Vsmc were used between 
the second and seventh passage for experiments.
2.3.4 Endothelial cell preparation
Bovine aortae were obtained from the local abbatoir and flushed through 
with a saline solution composed of 0.9% sodium chloride, 250/;g/ml 
fungazone, 100U/ml penicillin and 100/vg/ml streptomycin, to remove 
excess blood. The ends of the aortae were tied off with string and 
brought back to the laboratory (Figure 14). The fat was removed from the 
outer vessel wall using scissors and forceps and the intercostal arteries 
tied off with thread. Approximately 20ml of a collagenase mixture 
containing 1.25mg/ml collagenase, 250/7g/ml fungazone, 100U/ml 
penicillin and 100/yg/ml streptomycin was introduced to the vessel via a 
syringe and incubated at 37°C for 15 min. The vessels were massaged
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aorta intercostal arteries
tied off with 
string
tied off with thread
supply collagenase 
mixture via syringe
Figure 14 Preparation of endothelial cells from bovine aortae.
Aortae were flushed through with saline and brought back to the 
laboratory. The ends were tied off with string and the intercostal arteries 
tied off with thread. Endothelial cells were displaced from the inner wall 
of the vessel by enzymatic digestion followed by gentle rubbing of the 
vessel.
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to displace the endothelial cells from the inner wall and the solution 
containing the cells collected in a syringe. The solution was centrifuged 
at 200g, 5°C for 6 min, the supernatant removed and the pellet 
resuspended in 20ml of growth medium (same recipe for growth medium 
as outlined in section 2.3.2, with an additional 250jyg/ml fungizone). The 
cells, one aorta per flask, were grown in 75 cm2 flasks at 37°C, in a 
humidified 5% C02 to 95% air atmosphere. Cells typically reached 
confluence after 3-4 days. Plate 4 shows a photograph of confluent 
bovine aortic endothelial cells, which exhibit the cobblestone appearance 
characteristic of these cells. The endothelial cells stained positively with 
von Williebrand factor, as shown in Plate 5. von Williebrand factor was 
located in the cytoplasm of the endothelial cells.
2.3.5 Passaging endothelial cells
The same procedure outlined in section 2.3.3 was used.
2.4 Pre-treatment of silicone sheeting
Silicone sheets were cut into rectangles 8x5cm in area, cleaned by 
washing in 0.1% Decon 75 solution and then rinsed thoroughly in dH20. 
The silicone was transferred to aluminium foil, autoclaved at 121°C and 
dried at 60°C overnight.
2.5 Growth of vsmc on Petriperm dishes and silicone sheets
2.5.1 Treatment of Petriperm dishes with cell adhesion-promoting 
agents
Petriperm dishes were coated with either collagen, fibronectin, gelatin or 
poly-l-lysine, as described below.
Collagen: A 0.01% collagen solution in 0.1 M acetic acid was filter 
sterilised and 10ml of the solution applied to the silicone. The silicone 
was incubated at 37°C for 3h, rinsed with serum-free medium and 
allowed to dry at 37°C for 3h.
Fibronectin: 10ml of a 25/vg/ml fibronectin solution dissolved in serum- 
free medium was applied to the silicone, incubated at room temperature 
for 20 min, rinsed with serum-free medium and allowed to dry at room
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Plate 4. Endothelial cells prepared as described in section 2.3.4 and 
grown in a tissue culture flask, for 4 days. The confluent endothelial cells 
adopt a cobblestone appearance.
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Plate 5. Photograph of endothelial cells which have been stained with 
von Williebrand factor, as described in section 2.3.2.1.
temperature in a laminar flow hood.
Gelatin: 10ml of a 2% gelatin solution was applied to the silicone 
and incubated at 37°C for 2h. The silicone was rinsed with serum-free 
medium and allowed to dry at 37°C for 3h.
Poly-l-lysine: 10/yg/ml of poly-l-lysine dissolved in serum-free 
medium was added to the silicone and incubated at 37°C for 3h. The 
silicone was rinsed with serum-free medium and allowed to dry at room 
temperature in a laminar flow hood.
In all experiments, cells were plated at a cell density of 0.05 x 106 
cells per Petriperm dish. After 3 days in culture the cells were detached 
from the dishes using the standard methods outlined in section 2.3.3, 
and cell numbers determined using an electronic Coulter counter.
2.5.2 Treatment of silicone sheets with cell adhesion-promoting 
agents
The protocol used was the same as that described for Petriperm dishes 
in 2.5.1. However, 0.8 x 106 cells in 10ml of growth medium, were plated 
onto the stretching apparatus.
2.5.3 Plating vsmc on the stretching apparatus
The perspex components of the apparatus were sterilised overnight in 
70% ethanol and air dried in a flow hood. Autoclaved silicone sheets 
were mounted onto the vertically aligned screws at a resting tension and 
each piece of apparatus fully constructed. 0.8 x 106 cells in 10ml of 
growth medium were placed onto the fibronectin-treated silicone sheets.
2.5.4 Distribution of vsmc on silicone sheet
To demonstrate that vsmc were growing uniformly across the silicone 
membrane, the following experiment was performed. Cells were grown 
to confluence on fibronectin-coated sificone and stained for protein as 
follows. The growth medium was removed from the wells and 10ml of 
formaldehyde (2%) placed onto the silicone for 10 min. The solution was 
then removed and replaced with 10ml of 1% coomassie brilliant blue G 
stain for 20 min. The silicone was rinsed thoroughly with 1xPBS to 
remove any excess stain and each piece of silicone photographed. As a 
control, silicone sheets which did not have vsmc attached were also
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stained in a similar manner.
2.6 Endothelial cells
2.6.1 Endothelial cell adhesive experiment
The same procedure as that outlined for vsmc (section 2.5.1).
2.7 Stretching and ANG II experiments 
2.7.1. Varied time intervals
2.7.1.1 Stretching vsmc and endothelial cells by 20% over various 
time intervals
When confluent, vsmc or endothelial cells on fibronectin-coated silicone 
were deprived of serum for 24h. After this period the medium was 
removed and replaced with 12ml of serum-free medium. The length of 
silicone was increased from a resting tension of 80mm to 96mm, by 
turning the handle, to produce a 20% stretch. Cells were exposed to 
20% stretch for the following time points; 0, 15, 30, 60, 180 or 360 min.
2.7.1.2 Treating vsmc with ANG II over various time intervals
When confluent, vsmc in 180 cm2 tissue culture flasks were deprived of 
serum for 24h. After this period, the medium was removed and replaced 
with 50ml of serum-free medium containing 1jaM ANG II. Vsmc were 
treated with ANG II for 0, 15, 30, 60,180 or 360 min.
2.7.3 Effect of increasing stretch length
When confluent, vsmc on fibronectin-coated silicone, were deprived of 
serum for 24h. After this period the medium was removed and replaced 
with 12ml of serum-free medium. In this experiment, the vsmc were 
exposed to a varied stretch of either 0, 5, 10, 15 or 20%, over a fixed 
time interval of 15 min. These degrees of stretch were achieved by 
increasing the length of the silicone to 84, 88, 92 or 96mm respectively.
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2.7.4 Effect of 20% stretch on vsmc numbers
Vsmc were plated at a cell density of 0.4x106 cells/per piece of 
apparatus in standard growth medium. This was designated as day 0 of 
the study. On day 1, the number of cells present on 3 pieces of 
apparatus was evaluated using a Coulter counter, the medium removed 
from each of the remaining pieces of apparatus and replaced with 
DMEM containing 10% FCS, 100U/ml penicillin, 100mg/ml streptomycin 
and 2mmol/l L-glutamine. 10 pieces of apparatus were stretched by 20% 
and the remaining 10 unstretched pieces were used as controls. On day 
2, the medium was removed from 3 stretched and 3 control pieces of 
apparatus and the number of vsmc present in the medium determined. 
The number of cells growing on the silicone for the 3 stretched and 3 
control pieces of apparatus was then determined. This procedure was 
also repeated on days 3 and 4.
2.7.5 Effect of 20% stretch on phosphoinositide metabolism
Phosphoinositide metabolism was measured by a modification of the 
procedure of Berridge et aL 226. Vsmc were plated at a density of 0.8 
x106 cells onto fibronectin-coated silicone sheets. Cells were grown until 
they reached confluence. They were then washed twice with serum-free 
medium and incubated for a further 48h in 10ml of inositol free DMEM 
containing 4 x 10"6 Ci/ml myo-[2-3H] inositol. At the end of the 
incubation, the medium was removed and the cells washed with 10ml of 
HBSS followed by a 5 min wash with HBSS containing 10mmol/l glucose 
and 1% bovine serum albumin (HBG). The cells were then incubated for 
10 min with 10ml HBG containing 10mmol/l lithium chloride to inhibit 
inositol-1 phosphatase. The vsmc were then stretched by 20% at 37°C 
for 20 min. Incubation of unstretched vsmc with either 10% FCS or 10_ 
7M ANG II for 20 min were used as positive controls. Incubations were 
terminated by removal of the medium followed by addition of 6.2ml of ice 
cold methanol. The cells were then scraped from the silicone and 
transferred into polypropylene tubes. After addition of chloroform (3.1ml) 
and ddH20  (3.1ml), the contents were mixed, allowed to stand for 30 
min and centrifuged at 250g for 15 min. An aliquot of the upper phase 
(400/vl) was transferred to a glass tube containing 2.2ml H20 and 250//I 
of a 50% slurry of Dowex-1-formate. After addition of the aqueous
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solution to the Dowex, the tubes were mixed and left until the Dowex had 
settled. The aqueous solution was then removed by aspiration. The resin 
was washed twice with 4ml ddH20, twice with 4ml 60 mmol/l ammonium 
formate, followed by 5 mmol/l sodium tetraborate and then twice again 
with ddH20. The inositol phosphates were eluted from the resin with 3 
washes of 0.6ml 1 mol/l ammonium formate, followed by 3 washes of 0.1 
mol/l formic acid. The eluates from the ammonium formate and formic 
acid washes were combined to give a final volume of 3.6ml and added to 
10ml Ecoscint A. The samples were counted for 10 min in a scintillation 
counter.
2.8 Molecular biology
2.8.1 General equipment
Whirlimixer, magnetic stirrer and silica cuvettes : FSA laboratories 
(Loughborough, England).
Power supply, spectrophotometer, gel electrophoresis apparatus (G-100 
tank): Pharmacia LKB (Buckinghamsire, England).
Grant water bath, microcentrifuge, autoclave, electronic balance, 
magnetic stirrer, pH meter: Scotlab (Bellshill, Scotland).
Techne hybridiser and transilluminator: GRI (Essex, England).
UV stratalinker: Stratagene (Cambridge, England).
Microwave : Comet (Glasgow, Scotland).
Series 900 mini monitor: Mini instruments (Essex, England). 
Hypercassettes and Fuji x-ray film : Amersham (Buckinghamshire, UK).
2.8.2 Transforming bacterial cells
HB101 and DH5a-competent cells, which had been stored at -70°C, 
were thawed on ice. A 1^ 1 aliquot of the appropriate plasmid, at a 
concentration of 500 /;g/ml, was added to a 100^1 aliquot of HB101 or 
DH5a cells and left on ice for 30 min. The cells were heat shocked by 
incubation at 42°C for 90s and then placed on ice for 2 min. 0.5ml of L- 
broth was then added and the cells incubated at 37°C in an orbital 
incubator for 60 min. 100ml of agar was autoclaved, allowed to cool and 
separated into 2, 50ml portions. To one portion the appropriate antibiotic 
was added e.g. tetracycline at a final concentration of 30/;g/ml, or 
ampicillin at a concentration of 50/;g/ml. Four plates, each containing
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25ml agar were poured and allowed to set. After the 60 min incubation 
the transformed cells were spread onto one agar plate containing the 
antibiotic and one agar plate without antibiotic. Untransformed cells were 
used as a control and spread onto the remaining two plates, with and 
without antibiotic. The plates were then incubated at 37°C overnight.
The results obtained for a successful transformation were as 
follows;
untransformed / without antibiotic growth
untransformed / antibiotic no growth
transformed / without antibiotic growth
transformed / antibiotic growth
2.8.3 Plasmids
The details of the plasmids used in this study are described below:
The 1.3Kb v-fos complementary deoxyribonucleic acid (DNA) 
[cDNA] in the plasmid pAT153 was a gift from Dr. Ann Wyke, Beatson 
Institute for Cancer Research, Glasgow. The plasmid was initially 
obtained from Curran et ah227 The plasmid was amplified in DH5a cells 
and then excised using the restriction enzymes Bgl 11 and PVU II and 
reaction buffers, according to the manufacturer's instructions.
The plasmid pSP65 containing a 0.8kb insert of c-myc was also a 
gift from Dr. Ann Wyke, Beatson Institute for Cancer Research, Glasgow. 
The plasmid was initially obtained from Hayashi et al.228 The plasmid 
was amplified in DH5a cells and excised using the restriction enzymes 
ECoRI and Hind III.
The pBS5K plasmid containing nucleotides 53-1444 of c-jun was 
a gift from Dr. R. Breathnach, Universite de Nantes, Nantes, Cedex, 
France. The plasmid was initially obtained from Angel et ah 229 The 
plasmid was amplified in DH5a cells and excised using ECoRI.
2.8.4 Small scale preparation of plasmid DNA
10ml of L-broth containing the appropriate antibiotic, was added to 4 
universal containers. Three single colonies were taken from the plate 
containing transformed cells with antibiotic (section 2.8.2) and one 
colony transferred into each of three universal containers. One colony 
from the untransformed cells without antibiotic plate was transferred into
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the fourth universal to act as a control. The cells were incubated 
overnight at 37°C in an orbital incubator. The following day, three 
universals contained turbid solutions i.e those which contained 
transformed cells. The remaining universal contained a solution of 
untransformed cells. (The following protocol was performed in 
accordance with the manufacturers instructions and utilised solutions 
provided in a midi Qiagen kit). The most turbid solution (1ml) was placed 
into an Eppendorf tube, spun for 15s at 15,000g in a microcentrifuge and 
the supernatant removed. Another 1ml of the solution was added to the 
Eppendorf tube, spun for 15s at 15,000g, the supernatant poured off and 
drained. A further 1ml of the solution was added, spun for 15s, the 
supernatant removed and drained. The pellet was resuspended in 4ml of 
buffer P1 consisting of 100/yg/ml RNase, 50mM Tris/hydrochloric acid, 
10mM EDTA, pH8. 4ml of buffer P2 containing 200mM sodium hydroxide 
and 1% sodium dodecyl sulphate was then added and the tubes mixed 
and left at room temperature for 5 min. 4ml of buffer P3 consisting of 3M 
potassium acetate at pH 5 was then added and mixed. The solution was 
spun at 4°C, 15,000g, for 30 min. The supernatant was removed using a 
fine tipped pipette and further spun at 4°C, 15,000g, for 10 min, to obtain 
a particle-free lysate. A Qiagen tip 100 was equilibrated with 3ml of 
buffer QBT containing 750mM sodium chloride, 50mM MOPS, 15% 
ethanol at pH 7, 0.15% Triton-X-100 and emptied by gravity flow. The 
supernatant was applied to the tip and washed with 10ml of buffer QC 
consisting of 1M sodium chloride, 50mM MOPS and 15% ethanol at pH 
7. The DNA was eluted with 5ml of buffer QF. Buffer QF is composed of 
1.25M sodium chloride, 50mM Tris/hydrochloric acid and 15% ethanol, at 
pH 8.5. The DNA was precipitated with 0.7 x the volume of isopropanol 
and spun at 4°C, 15,000g, for 30 min. The DNA was washed with 10ml 
of 70% ethanol, spun for 15 min at 15,000g, 4°C, drained and 200//I of 
TE buffer added. The DNA sample was stored at -70°C.
2.8.5 Large scale preparation of plasmid DNA
(The following protocol was performed according to the manufacturers 
instructions. Solutions were provided in the Qiagen kit. All buffers used 
are the same as in 2.8.4).
A 2ml aliquot of the solution of overnight culture, produced in the 
small scale preparation was removed, added to 500ml of broth 
containing the appropriate antibiotic (tetracycline at a concentration of
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30/yg/ml, or ampicillin at a concentration of 50/yg/ml), the contents 
poured into a large glass dimple flask and placed in the orbital incubator 
at 50g, 37°C, overnight. The following day 8.5ml of the culture was 
removed, added to 1.5ml of autoclaved glycerol, mixed and aliquoted 
into 1ml batches. The samples were frozen in an ethanol/dry ice bath 
and stored at -70°C. Of the remaining solution approximately 250ml was 
placed into plastic centifuge tubes, balanced and spun at 15,000g, 4°C 
for 5 min. The supernatant was removed, tubes drained and the pellets 
resuspended in 10ml of buffer P1. 10ml of buffer P2, prewarmed at 
room temperature, was then added, mixed gently and incubated at room 
temperature for 5 min. Next 10ml of buffer P3 was added and 
immediately mixed gently. The solution was spun at 15,000g, 4°C for 30 
min and the supernatant removed using a fine tipped pipette. The 
supernatant was further spun at 4°C, 15,000g for 10 min, to obtain a 
particle-free lysate. A Qiagen tip 500 was equilibrated with 10ml of buffer 
QBT and emptied by gravity flow. The supernatant was applied to the tip, 
washed with 30ml of buffer QC and the DNA eluted with 15ml of buffer 
QF. The DNA was precipitated with 0.7 x volume of isopropanol and 
spun at 4°C, 15,000g for 30 min. The DNA was washed with 20ml of 
70% ethanol, spun for 15 min at 15,000g, 4°C, drained and 500/yl of TE 
buffer added. The DNA sample was stored at -70°C.
2.8.6 Quantification of DNA and ribonucleic acid (RNA)
5/yl of the DNA/RNA sample was added to 995pl of ddH20  in an 
Eppendorf tube. The solution was mixed and transferred into a silica 
cuvette. The absorbance of the solution at 260nm and 280nm was 
measured using a spectrophotometer. The absorbance of the solution at 
260nm and 280nm is directly proportional to the concentrations of RNA 
or DNA respectively present in the sample. The ratio of the absorbance 
values obtained at 260nm and 280nm (i.e A260/A280) is an index of the 
purity of the RNA sample. This ratio varied from 1.8-2.0, where 2.0 
represented a pure RNA sample with minimal protein contamination. The 
amount of DNA present in 1 ml of a sample was calculated by multiplying 
the A280 value x50 because an optical density of 1 represents 50j/g of 
DNA. The amount of RNA present in 1 ml of a sample was calculated by 
multiplying the A260 value x40 because an optical density of 1 represents 
40//g of RNA. The total amount of DNA/RNA present in the sample was 
then calculated by multiplying the above value by the dilution factor. For
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example 5/yl of sample was diluted in a total volume of 1ml. Thus the 
sample was diluted 1 : 200. To obtain a value for the total amount of 
DNA/RNA in the sample the calculated value had to be multiplied by 
200.
2.8.7 Digestion of plasmid with restriction enzymes
cDNA Reaction buffers
v-fos React II and sodium chloride
c-myc React III & React II
c-jun React III
5/yl v-fos, 2\}\ React II (x10), 2//I PVU II and 11/yl ddH20  were 
placed in an Eppendorf tube and incubated at 37°C for 3h. To this 
reaction mixture 2\i\ Bgl II, 3/yl sodium chloride (1M) and 8//I ddH20  were 
then added and incubated at 37°C for a further 3h.
5fj\ c-myc, 1/yl EcoRI, 1/yl React III and 3/yl ddH20  were placed in 
an Eppendorf tube and incubated at 37°C for 3h. To this reaction mixture 
'\fj\ Hind III, 1/yl React II and 8//I ddH20  were then added and incubated 
at 37°C for a further 3h.
5fj\ c-jun, 2\i\ EcoRI, 1/vl React III and 2/yl ddH20  were placed 
in an Eppendorf tube and incubated at 37°C overnight.
For each cDNA, after the appropriate incubation period, a 15/yl 
sample of the cut plasmid was run on a DNA gel, to ensure that the 
reaction was complete.
2.8.8 DNA gels
The gel was prepared by dissolving 0.8g agarose in 100ml of TE buffer 
and the solution microwaved to melt the agarose. 1/yl of ethidium 
bromide (10mg/ml) was added to the solution and allowed to cool to 
room temperature. The solution was then poured into a perspex plate 
(78mm x 105mm) containing a plastic comb. The plate was placed into a 
G-100 tank and submerged in TE buffer. 2ml of DNA loading dye was 
added to the samples which were loaded into the wells of the gel. The 
samples were run at 60V for 3h.
The insert was cut from the DNA gel using a scalpel blade and
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separated from agarose using the components supplied in a gene 
cleaning kit.
2.8.9 Gene cleaning
The components required for this procedure were supplied in a 
Geneclean II kit.
The gel slice was weighed into an Eppendorf tube and a volume 
of saturated 6M sodium iodide added, corresponding to 2.5x weight of 
the gel slice. The tube was placed in a water bath at 50°C. If after 5 min 
at 50°C the slice had not dissolved, it was returned to the water bath for 
a further 1 min. Next "glass milk" (silica matrix) was resuspended by 
thoroughly mixing and the appropriate volume added to the sample (5fj\ 
of glass milk for each 5/yg of DNA present, then another 5j;l for each 
1pg). The sample was spun at 15,000rpm in a microcentrifuge for 10s 
and the supernatant removed. To the pellet 200/yl of NEW solution 
(containing NaCI, Tris, EDTA, H20  and ethanol), which was supplied in 
the kit, was added and the pellet resuspended using a fine tip. The 
samples were then spun for 10s at 15,000rpm, the supernatant removed 
and the process repeated twice more. Any remaining solution was 
removed using a fine tip and 50//I of TE buffer added. The pellet was 
resuspended in TE buffer and incubated at 50°C for 3 min, then spun at 
15,000rpm for 30s. The supernatant which contained the eluted DNA 
was removed. A further 50//I of TE buffer added to the original tube and 
the pellet resuspended. The solution was spun at 15,000rpm for 30s and 
the DNA removed. This latter step was repeated a third time. The 3x50|/l 
DNA samples were then combined together in an Eppendorf tube. 5/il of 
the gene cleaned DNA and 5p\ of a DNA ladder were run on a DNA gel, 
to ensure that the isolation of the insert had been successful. The DNA 
was then aliquoted into 50ng batches. Scans of DNA gels containing 
samples of (1)v-fos, (2)c-myc and (3)c-jun after gene cleaning, are 
shown in Figure 15. The length of these fragments was checked by 
comparing the positions of the inserts to that of the DNA ladder.
2.8.10. Northern analysis
When preparing RNA from vsmc and endothelial cells grown on silicone, 
the cells were removed from the silicone in 10ml of serum-free medium,
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1) v-fos
No. of base pairs
2036
1635
1018
516
No. of base pairs
^_r4072
-*—3054
^-2036
-*-1635
-*-1018
-*-516
No. of base pairs
r  3054 
2036 
-*-1635 
-*-1018 
-*-516
Figure 15.
DNA gels containing gene cleaned samples of 1) v-fos,
2) c-myc and 3) c-jun. The samples were run against a 
DNA ladder and their length calculated by comparing 
their positions on the gel to the bands of the DNA ladder.
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using a ceil scraper, transferred into a universal container and the 
silicone rinsed with a further 5ml of medium. When preparing RNA 
fromcells grown in tissue culture flasks, the cells were removed from the 
flasks in 15ml of serum-free medium, using a cell scraper, transferred 
into a universal container and the flask rinsed with a further 8ml of 
medium. The sample was spun at 200g, 5°C for 5 min and the 
supernatant removed. 1ml of RNAzol B was added to the sample and 
vortexed. The contents were then transferred into an Eppendorf tube 
containing 100/vl chloroform, vortexed and placed on ice for 5 min. The 
Eppendorf tube was spun at 15,000rpm in a microcentrifuge for 15 min. 
The upper layer was transferred into a clean Eppendorf tube and an 
equal volume of isopropanol (approximately 600/71) added. The sample 
was placed on ice for 45 min, spun at 15,000rpm for 15 min, the 
supernatant removed and the pellet drained. 500/71 of 70% ethanol was 
added to the pellet and the RNA stored at -70°C. When required, the 
RNA samples were spun at 15,000rpm for 15 min and drained until 
almost dry. 100/71 of ddH20  was then added to each sample, vortexed to 
dissolve the RNA and placed at 65°C for 10 min. The amount and purity 
of RNA was determined as described in section 2.8.6. 10/yg aliquots of 
RNA were transferred to Eppendorf tubes containing 250/71 of ddH20, 
500/yl of ethanol (AR grade) and 25/71 of 3M sodium acetate, pH 5.2 and 
stored at -70°C.
In preparation for electrophoresis RNA (10/7g) was dissolved in 
10/71 of ddH20  and 5/71 of the following solution was then added: 
deionized formamide, 1250 /7l; 37% formaldehyde, 400/71; 10x MOPS 
(0.2mol/l), 0.05mol/l sodium acetate pH7.0; 0.01 mol/l Na2EDTA, 250/71, 
and heated at 65°C, for 10 min. Samples were chilled on ice, 2/7l of RNA 
loading dye added and run on agarose gels.
2.8.10.1 RNA gels
1.2g of agarose was dissolved in a solution containing 10ml of x1 MOPS 
(20mmol/l) and 73ml of ddH20, by heating in a microwave until 
dissolved. 17ml of formaldehyde (6%) was then added to this solution 
and left to cool to room temperature. The solution was then poured into a 
perspex plate (78mm x 105m) containing a plastic comb. The plate was 
then placed into a G-100 tank and submerged in TE buffer. The samples 
were run at 60V for 3h.
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2.8.10.2 RNA transfer
RNA was transferred from the gels to nylon membranes In 20xSSC by a 
blotting process. After blotting overnight the RNA was crosslinked onto 
the nylon membrane using ultra violet radiation and rinsed with 5xSSC 
solution. The membrane was placed in plastic sheeting and stored at 
-20°C.
2.8.10.3 Prehybridisation
250/vl of salmon testes DNA (100/yg/ml) was boiled for 5 min and then 
placed on ice for 5 min. The DNA was added to a prehybridisation 
solution containing 500/;l of 10% sodium dodecyl sulphate (0.1%), 5ml of 
50x Denhardt’s solution (5x), 12.5ml of 20xSSC solution (5x), 27ml of 
ddH20  and 5g of dextran sulphate (1%). 15ml of the solution was poured 
into a hybridisation tube. The membrane containing RNA was placed 
inside the tube with the RNA side facing uppermost and any air bubbles 
removed by pressing on the membrane with a plastic pipette. The tube 
was placed inside the hybridisation incubator at 65°C and the filters 
prehybridised for at least 4h.
2.8.10.4 Random priming cDNA probes
Reagent mix and Klenow fragment used in this procedure were supplied 
in an oligolabelling kit (Pharmacia, Buckinghamshire, England).
The reagent mix was composed of a buffered aqueous solution 
containing deoxy adenosine triphosphate (dATP), deoxy guanosine 
triphosphate (dGTP), deoxy thymidine triphosphate (dTTP) and random 
hexadeoxtyribonucleotides.
24/yl of ddH20  was added to 1’0/7l of a cDNA probe (50ng) and 
boiled for 5 min. 10/7l of reagent mix and 5/yl of CTP were added and all 
the components gently mixed together. 1//I of klenow fragment was then 
added to the tube and placed in a water bath at 37°C for a 1 h incubation. 
The radiolabelled probe was separated from unincorporated 32P CTP on 
a sephadex G-50 column.
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2.8.10.5 Hybridisation
The radioactive cDNA was boiled for 5 min, placed on ice for 5 min and 
injected into the hybridisation tube containing the filter. The tube was 
then replaced into the hybridisation incubator and left for approximately 
18h, at 65°C.
2.8.10.6 Washing filters
Filters were washed with 10ml of 1xSSC containing sodium dodecyl 
sulphate at a final concentration of 0.5%, at 65°C, for 20 min. The filter 
was monitored using a mini monitor and if the counts were >10 
counts/min a further wash was performed with 0.5xSSC (0.5% sodium 
dodecyl sulphate) solution at 65°C, for 20 min. The radioactivity of the 
filter was again determined and if the reading was still >10 counts/min a 
third wash was performed at O.IxSSC (0.5% sodium dodecyl sulphate) 
solution. Autoradiography was performed with Kodak X-omat film at 
-70°C for 1-2 days.
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CHAPTER THREE 
RESULTS (A)
DEVELOPMENT OF CELL STRETCHING SYSTEM
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3.1 Background
The initial aim of the project was to design a system capable of 
mimicking the forces to which vascular cells are subjected in vivo. In the 
vessel wall, the principal flow-related forces to which cells are exposed 
are shear stress and pressure (see section 1.5). This project focussed 
on the effect of pressure. In vivo, with increased and decreased blood 
flow, changes in blood vessel calibre occur. Consequently, the cells of 
the vessel wall are compressed and stretched. To simplify this situation 
of interest, this project examined the effect of a stretching force on 
cellular function in an environment free of humoral influences.
When choosing which method to stretch cells, it was important to 
examine the techniques which had already been used to apply 
mechanical forces to cells in culture. As discussed in section 1.6, two 
principal techniques have been used to produce a stretching force. The 
first system involves displacing the flexible bases of Petriperm dishes 
and the second the use of stretch frames. Both systems are suitable for 
stretching cells and exhibit the essential features required of a cell 
culture system. An important feature is that sterility can be maintained 
throughout the studies. The major disadvantages associated with these 
methods is that stretch is non-uniform and the range to which cells can 
be stretched is restricted. The greatest degree of stretch was achieved 
in the centre of Petriperm dishes and in the case of the stretch frames 
one would expect to achieve the greatest stretch in the centre of the 
silicone sheet. This means that cells grown on the dishes and the 
silicone are stretched by different amounts, relative to their position on 
the substrate. It is easier to interpret results obtained from cells which 
have been stretched by a fixed length, regardless of their position on 
the apparatus.
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3.2 First prototype
On reviewing the literature and assessing the requirements of the 
stretching apparatus, it seemed most practical to include Petriperm 
dishes in the design of the system. Advantages of using Petriperm 
dishes in addition to their suitability as a substrate for cell growth, was 
that they were suitable for the sectioning of cells and for processing 
procedures required for histological analysis. Another advantage was 
that the Petriperm dishes were not bulky and could be easily housed in 
an incubator. Furthermore, the dishes were available commercially. It 
was proposed that cells would be grown on the dishes and when 
confluent they would be vertically displaced by means of a vacuum. 
Displacement of the bases using suction was chosen because the 
introduction of a vacuum pump inlet into the incubator was feasible by 
boring a hole at the rear of the incubator.
3.2.1 Growth of vsmc and endothelial cells in Petriperm 
dishes
In previous published experiments (section 1.6), several cell types grew 
well on the Petriperm dishes. Therefore the ability of Petriperm dishes 
to facilitate the growth of vsmc and endothelial cells was tested.
Figure 16 shows the effect of various cell adhesion-promoting 
agents on vsmc growth in Petriperm dishes. Petriperm dishes were 
coated with either 0.01% collagen (type I), 25 j/g/ml fibronectin, 2% 
gelatin solution, or 10 /yg/ml poly-l-lysine, as described in section 2.5.1. 
Control dishes remained untreated. Vsmc were seeded in the dishes at 
a density of 0.05x106 cells per dish, allowed to grow for 3 days and cell 
numbers determined. There was no significant difference in the number 
of cells present in the dishes which had been coated with either 
collagen or poly-lysine, compared to control values. Coating the dishes 
with gelatin and fibronectin resulted in a 2- and 2.4-fold increase 
respectively. Thus fibronectin was chosen as the most suitable cell 
adhesion-promoting agent. To ensure that endothelial cells also grew
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Cell adhesion- promoting agents
Figure 16. Effect of coating Petriperm dishes with collagen (0.01%), 
fibronectin (25ng/ml), gelatin (2%), or poly-lysine (10^g/ml) on vsmc
growth. Vsmc were plated at a density of 0.05x106 cells and grown 
in Petriperm dishes, as described in the methods (section 2.5.1). 
After 4 days in culture, cell numbers were determined using an 
electronic Coulter counter. Values are expressed as mean ± S.E.M.
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well in fibronectin-coated Petriperm dishes, a similar experiment was 
performed. Petriperm dishes were coated with 25 /yg/ml fibronectin and 
vsmc seeded at a density of 0.1x10s cells per dish. Control dishes did 
not receive fibronectin treatment. The cells were left to grow for 4 days 
and cell numbers determined. A 1.5-fold increase in the number of cells 
in dishes which had been coated with fibronectin was observed, 
compared to the number of cells grown in untreated dishes (Figure 17). 
Thus coating of Petriperm dishes with fibronectin was a suitable 
treatment to potentiate vsmc and endothelial cell growth.
3.2.2 Design
Figure 18 illustrates the first prototype apparatus developed. It 
consisted of a perspex block onto which an “o" ring was raised 1.3mm 
above the base. A Petriperm dish was placed on top of the “o” ring after 
greasing and on application of a vaccum the membrane was vertically 
displaced. This apparatus could be placed inside an incubator, 
maintained at a humidified 37°C atmosphere, with 95% air / 5% C 02.
3.2.3 The effect of stretch on c-fos messenger RNA (mRNA) 
expression
The aim of the first experiment was to determine whether a "stretching" 
force could induce proto-oncogene expression. Proto-oncogenes are 
known to be expressed prior to cell proliferation.
Vsmc were seeded at a density of 0.2x10s cells per dish and left 
to grow for 3 days, until confluent. The cells were made quiescent by 
serum deprivation for 24h and then stretched for either 0, 15, 30, 60, 
180, or 360 min. Control vsmc remained unstretched. RNA was 
prepared from the vsmc and the effect of stretch on the expression of 
the proto-oncogene c-fos mRNA determined. The results obtained are 
illustrated in Plate 6. A maximum c-fos mRNA expression was 
achieved after 30 min of stretching and was abolished by 180 min. The 
time course of induction for c-fos mRNA on stretching was similar to 
that previously described by Lyall et al. 36 for ANG II in vsmc. This was
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Figure 17. Effect of coating Petriperm dishes with fibronectin (25MQ/ml), 
on endothelial cell growth. Endothelial cells were plated at a density of 
0.05x106 cells and grown in the Petriperm dishes, as described in the 
methods (section 2.5.1). After 4 days in culture, cell numbers were 
determined using an electronic Coulter counter. Values are expressed 
asmean±S.E.M; n=5.
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(a)
leading to vacuum supply
"o" ring raised 1.3mm 
above base. A Petriperm dish 
sits on top of this "o" ring.
perspex block
Petriperm dish with a 
"stretchable",membrane base 
on which cells are grown.
application 
of suction
The base of the Petriperm dish 
is vertically displaced.
Figure 18. First prototype of stretching system.
(a) This is a schematic representation of the prototype. The system is 
composed of a perspex base of which a circular area has been cut out 
to allow the introduction of a vacuum and a rubber "o" ring. A Petriperm 
dish is positioned over the "o" ring.
(b) A cross sectionional area of a Petriperm dish is shown in Figure 18b. 
Application of a vacuum results in the vertical displacement of the base 
of the dish.
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Plate 6. A representative autoradiograph showing the effects of stretch 
on c-fos mRNA induction, in vsmc. Vsmc were plated at a density of 
0.2x106 in Petriperm dishes and grown to confluence. Cells were 
deprived of serum for 24 hours and then stretched for 0, 15, 30, 60, 180 
or 360 min. RNA was extracted from the cells, run on agarose gels and 
blotted onto nylon membranes, as described in the methods (section 
2.8.10). The membranes were hybridised with a v-fos cDNA probe and 
exposed to x-ray film for 48h, at -70°C.
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very exciting because it showed that stretch produced similar effects to 
a growth factor (ANG II), and that the experimental system was 
functional.
3.2.4 Displacement of Petriperm dish base
It was possible to observe the vertical displacement of the membrane 
by the naked eye. This was further verified by applying suction to a 
Petriperm dish and then pouring in 5ml of a plaster of Paris/water 
mixture (50:50). After 15 min the plaster had set and the vacuum was 
switched off. When the mould was removed from the dish it was evident 
that under suction the flexible membrane had adopted a dome shape, 
as shown in Figure 18b. These findings illustrated that the membrane 
was stretched. Clearly from the shape that the base of the Petriperm 
dish adopted, the stretch was not uniform over the base of the dish.
When the base of the dish is relaxed it is flat and when displaced 
it adopts a convex shape. To calculate the area of of the convex surface 
the formula used is: Area=3.14(r2 + h2), where r= the radius of the 
Petriperm dish, which was measured as 2.5cm, and h=the vertical 
displacement of the membrane, which for this system is 1.3mm (see 
Figure 19). From these figures the area of the convex surface was 
calculated to be 19.69cm2. It was necessary to calculate the area of the 
membrane in the unstretched state. This was calculated using the 
equation for the area of a circle; Area=3.14(r2), where r=2.5cm. Thus 
the area of the flat surface was 19.63cm2. Application of the vacuum 
thus produced a 0.06cm2 increase in area, which was an overall 
increase of 0.3%.
3.2.5 Problems with first prototype
From these observations two major problems became apparent. The 
first was that base of the dish was stretched in a non-uniform manner 
and thus the cells grown in the Petriperm dishes were stretched by 
different amounts. The second problem was that a maximum stretch of 
0.3% was too small to reproduce physiological conditions. in vivo
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Figure 19. A cross-sectional area of a Petriperm dish under suction. 
Measurements of the radius of the base and the maximum height 
by which the base could be displaced are shown in this figure.
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studies suggest that vessels experience greater forces than could be 
achieved using this initial prototype. For example, Hebert et al. 227 
measured changes in rat resistance vessels, in response to 
baroreceptor stimulation, and found a 12.03 ± 2.7% increase in 
diameter length. Although the degree of stretch could be increased by 
increasing the height of the "o" ring, the consequence of this would be 
for the base to adopt a more elongated shape giving a stretch of even 
more non-uniform nature. An additional disadvantage of this system 
was that a Petriperm dish has a relatively small base area. A confluent 
cell layer yielded approximately 20//g of total RNA, which was only 
enough RNA to perform Northern analysis a restricted number of times. 
Larger dishes were not commercially available. Although the vacuum 
system was not suitable for further investigations, it had illustrated that 
fairly minimal stretch could induce expression of c-fos mRNA by vsmc.
3.3 Second prototype
An apparatus capable of achieving a stretch from 0-20%, to cover the 
range used by other groups and to enable work to be performed 
outwith these values was planned. This could be achieved most 
practically by a stretch frame system. The problem of non-uniform 
stretch which had been previously experienced using this method was 
to be resolved in the design of the new system. The advice and skills of 
engineers from Glasgow University, Department of Physics and 
Astronomy were employed. Careful design and precision engineering 
were adopted in the development of the system.
3.3.1 Design (Plate 7)
The apparatus was made of a perspex base onto which 4 screws were 
vertically aligned. The base had a rectangular area in the centre cut out 
for examination of the cells by inverted microscopy. Rectangular pieces 
of silicone sheeting containing holes at each corner were mounted onto 
the base by placing them over the 4 screws. The sheet was secured by
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silicone sheet well in
which cells are grown
handle
perspex base
Plate 7. Initial design of cell stretching apparatus.
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two pieces of perspex which were placed on top of the silicone in a 
parallel configuration. When secured, the silicone sheet adopted a 
rectangular well shape in which cells could be grown. A perspex lid 
was placed on top of the silicone to minimise contamination. To 
increase the length of silicone sheet, the handle at the side was turned 
in a clockwise direction. In the unstretched position the distance 
between perspex blocks was 80mm. To stretch the silicone and hence 
the tightly attached cells by 5%, the distance between the perspex 
blocks was increased to 84mm. 10%, 15% and 20% were achieved by 
increasing the distance between the blocks to 88, 92 and 96mm, 
respectively.
To check that the apparatus did not leak, 10ml of serum-free 
medium was poured into the silicone well of one piece of apparatus 
and placed overnight in an incubator. No leaking occurred. This proto­
type could produce a stretch of up to 15%. Subsequent systems which 
could produce a maximum stretch of 20% were achieved by increasing 
the length of the perspex base. In the initial design, the screws of the 
apparatus were made of brass. In subsequent systems, these were 
changed to plastic to minimise corrosion. Plate 8 illustrates the modified 
version of the stretching apparatus. The plans of the apparatus are 
shown in Figure 20. 24 identical pieces of apparatus were constructed 
and checked for leaking as before.
3.3.2 Properties of the silicone sheet in response to stretch
The uniformity of stretching throughout the whole area of the sheet was 
tested. This had been a limitation in other stretching systems. A grid of 
40, 1cm2 squares was drawn on a piece of silicone sheeting 8x5cm in 
area and the change in length of the squares as the silicone was 
stretched by 0, 5, 10, 15 and 20% was measured. The measurements 
were performed at 37°C, the temperature maintained in an incubator, to 
ensure that the elasticity properties of the silicone were not affected by 
temperature. Five pieces of silicone sheeting, each from a different 
batch, were examined.
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silicone sheet well in
which cells are grown
perspex base
Plate 8. Modified design of cell stretching apparatus.
handle
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top clamps (D)
top clamp of 
mechanism 
holder (E)
guide for metal screw (F)
perspex base (A)
moving clamp (C)
fixed clamp (B)
metal screw to which handle
is attached (G)
Figure 20. Three dimensional drawing of the stretching apparatus showing 
the positions of the various components. Figures 20 A, B, C, D, E, F, G show the 
plans for each of the components of the apparatus labelled A-G, in the above 
diagram.
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The mean stretch achieved by the whole sheet was studied and the 
results shown in Figure 21. This figure shows that there were no 
significant differences in the length of individual squares at different 
positions on the sheet, as reflected by the small values obtained for 
standard errors. These results suggest uniformity of stretching of the 
silicone sheet both within and between batches of material.
3.3.3 Vsmc growth on silicone sheet
To determine whether vsmc grew well on the silicone sheet, an 
analysis of growth was performed. On day zero, 0.5 x 106 vsmc were 
plated down onto the untreated silicone sheeting of twenty pieces of 
cell stretching apparatus. The same number were placed into twenty 
untreated 75cm2 tissue culture flasks. The number of cells present on 4 
pieces of apparatus and in 4 flasks were evaluated daily for 5 days, at 
which time the vsmc in the tissue culture flasks reached confluence. 
Even though more cells had been placed down onto the untreated 
silicone per cm2 , vsmc grew at a slower rate on untreated silicone than 
on untreated tissue culture flasks (Figure 22). On day 5, the flasks 
contained approximately 7 times the number of vsmc present on the 
silicone. Untreated silicone sheeting was therefore not a suitable 
substrate for vsmc growth. The efficacy of various cell adhesion- 
promoting agents to potentiate vsmc adhesion and growth on the 
silicone sheet was tested as follows. Silicone sheets were coated with 
either 0.01% collagen (type I), 25 j;g/ml fibronectin, 2% gelatin solution, 
or 10 /yg/ml poly-l-lysine, as described in section 2.5.2. Untreated 
silicone sheets were used as controls. After the appropriate treatment, 
vsmc were seeded at a density of 0.8 x 106 cells per piece of silicone 
sheeting, grown for 4 days and cell numbers determined. Figure 23 
shows the number of cells on the silicone after 4 days in culture. 
Silicone coated with either collagen or gelatin contained approximately 
0.6x106 cells, which was not significantly different from control values. 
Poly-lysine coated silicone contained approximately 1.2x106 cells, a 
small but significant increase over control. However, an approximate 5- 
fold increase in cell number was observed for vsmc grown on 
fibronectin-treated silicone. Fibronectin-coated silicone sheets provided
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(a) 80mm (0%).
(b) 84mm (5%).
(c) 88mm (15%.)
Silicone sheet
1 2 3 4 5
(d) 92mm (15%).
Silicone sheet
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10-
(e) 96mm (20%).
Silicone sheet
Figure 21. Properties of 
silicone sheet in 
response to stretch.
A grid consisting of 40 
squares was drawn onto 
5 pieces of silicone, 
each from different 
batches, numbered 1, 2,
3,4 and 5. The change 
in length of each 
individual square was 
measured as the length 
of the silicone sheet was 
increased from 80mm, to 
84mm, 88mm, 92mm 
and 96mm. Results are 
expressed as mean 
length ± S.E.M.
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Figure 22. Growth of vsmc on untreated silicone sheet compared 
to untreated cell culture flasks. 0.5x106 vsmc were plated down 
onto the silicone sheeting of 20 pieces of apparatus and the same 
density placed into 20,75cm2 tissue culture flasks. This was 
regarded as day zero of the study. The number of cells present on 
4 pieces of apparatus were evaluated daily, for 5 days, until the 
vsmc in the flasks had reached confluence.
Results are expressed as mean ± S.E.M; n=4.
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control collagen fibronectin gelatin poly-lysine 
Cell adhesion promoting agents
Figure 23. Effect of coating silicone sheet with cell adhesion-promoting agents, 
on vsmc growth. Silicone sheets were treated with collagen (0.01%), 
fibronectin (25ng/ml), gelatin (2%) or poly-lysine (10ng/ml). Vsmc were
plated at a density of 0.8x106 cells and grown on the silicone sheet as 
described in the methods (section 2.5.2). After 4 days in culture, cell numbers 
were determined using an Electronic Coulter counter. Values are expressed 
mean ± S.E.M; n=5.
the best substrate of those tested for vsmc growth. Plate 9 shows vsmc 
which grew to confluence on fibronectin-treated silicone. The growth of 
vsmc on fibronectin-treated silicone can be compared to that of vsmc 
growth on a tissue culture flask, by comparing Plate 9 with Plates 2&3 
(Methods, section 2.3.2). These observations support the fact that 
fibronectin is a suitable substrate for vsmc growth.
To confirm that the vsmc had grown evenly over the fibronectin- 
treated silicone membranes, cells were grown to confluence on the 
silicone and then stained for protein using the protein stain coomassie 
blue, as described in section 2.5.4. Fibronectin-treated silicone without 
cells attached was also stained and used as a control. As shown in 
Plate 10b, an even blue staining was produced over the surface of the 
rectangular piece of silicone signifying that vsmc growth was evenly 
distributed across the silicone sheet. Silicone sheeting without vsmc 
attached did not stain with coomassie blue (Plate 10a).
3.3.4 Endothelial cell growth on silicone sheet
Studies on endothelial cell growth and the effects of stretching were 
also planned. Thus it was important to test silicone sheeting as a 
substrate for endothelial cell growth.
Bovine aortic endothelial cells at a density of 0.5 x 106 cells were 
plated down onto the untreated silicone sheeting of twenty pieces of 
cell stretching apparatus and the same number placed into twenty 
untreated 75cm2 tissue culture flasks at day zero of the study. The 
number of cells present on 4 pieces of apparatus and in 4 flasks was 
determined daily for 5 days at which time the endothelial cells present 
in the tissue culture flasks had reached confluence.
Figure 24 demonstrates that endothelial cells grew at a slower 
rate on silicone sheeting than in tissue culture flasks. On day 5, the 
flasks contained approximately 6 times the number of endothelial cells 
that were present on the silicone sheet. This was in agreement with the 
observations made for vsmc. The effects of the various cell adhesion 
promoting agents used in 3.3.3, were tested on endothelial cell growth . 
Figure 25 demonstrates that collagen, gelatin and poly-lysine-treated 
silicone, contained approximately 1.4x10s cells, which was only slightly
119
Plate 9. Photograph of confluent vsmc grown on fibronectin-treated 
silicone sheets.
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(a) (b)
Plate 10. Coomassie blue stained silicone with and without vsmc 
attached. Vsmc were plated at a density of 0.8 x 106 cells on fibronectin 
treated silicone sheets, grown to confluence and stained with coomassie 
blue as described in section 2.5.4 (10a). As controls, fibronectin treated 
silicone sheets without attached vsmc were also treated with coomassie 
blue (10b).
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Figure 24. Growth of endothelial cells on silicone sheet compared to tissue culture 
flasks. Endothelial cells at a density of 0.5x106 cells were plated down onto the 
silicone sheeting of 20 pieces of apparatus and the same density placed into 20, 
75cm2 tissue culture flasks. This was regarded as day zero of the study. The 
number of cells present on 4 pieces of apparatus and in 4 flasks were evaluated 
daily for 5 days, until the endotheial cells in the flasks had reached confluence. 
Results are expressed as mean ± S.E.M; n=4.
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Figure 25. Effect of coating silicone sheet with cell adhesion-promoting agents 
on endothelial cell growth. Silicone sheets were treated with collagen (0.01%), 
fibronectin (25^g/ml), gelatin (2%) or poly-lysine (10yg/ml). Endothelial cells
were plated at a density of 0.8x106 cells and grown on the silicone as 
described in the methods (section 2.5.2). After 4 days in culture, cell numbers 
were determined using an electronic Coulter counter. Values are expressed as 
mean ± S.E.M; n=5.
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greater than the control value of 1.2x106 cells. The rate of endothelial 
cell growth on fibronectin-treated silicone was 3-fold greater than that of 
untreated silicone sheeting. These results revealed that fibronectin- 
treated silicone is also a good substrate for endothelial cell growth. 
Plate 11 shows endothelial cells which grew to confluence on 
fibronectin-treated silicone. When Plate 11 is compared to Plate 4 
(section 2.3.4 of the methods), it can be seen that endothelial cells grow 
as well on fibronectin-treated silicone as they do in untreated tissue 
culture flasks.
3.3.5 Change in length of vsmc produced by a 20% stretch
The results obtained from analysing the change in length of squares 
drawn on silicone sheets suggested that the silicone sheet was 
stretched in a uniform manner throughout. However, it was important to 
show that vsmc did not become detached during stretching and that 
they remained tightly adhered and were stretched by the same amount 
as the silicone sheet.
Vsmc were plated sparsely onto the fibronectin-treated silicone 
(10 x 103 cells per piece of silicone sheet). This cell concentration 
allowed observation of a single cell. A single unstretched cell was 
photographed and then the silicone sheet was stretched by 20%. After 
stretching, the cell was photographed again. This was very difficult 
because each time the handle was turned, the cell moved out of the 
field of vision. Thus, the cell stretching apparatus had to be carefully 
moved to bring the cell back into focus.
A representative experiment is shown in Plates 12a&b. The 
length of the cell increased from 17.5/ym (Plate 12a) to 21j;m (Plate 
12b) after stretching the silicone sheet by 20%. The mean change in 
length of a single vsmc was 22.7+/-1.63%. This was not significantly 
different from the stretch imparted to the silicone sheet.
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Plate 11. Photograph of confluent bovine aortic endothelial cells grown 
on fibronectin-treated silicone sheets.
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(a)
Distance= 17.5jim
(b)
Distance=2Vm
Plate 12. Photographs of a single vsmc unstretched (a) and after a 20% 
fixed stretch (b).
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3.4 Final modifications
The system was further modified to allow microscopic examination of 
the original apparatus (Plate 7). The conventional inverted microscope 
has too short a focal length to view the cells on the silicone sheet. This 
problem was solved by reducing the thickness of the perspex base. The 
modified perspex base is shown in Plate 8.
3.5 Conclusions
A cell stretching apparatus was designed which resolved the major 
problems associated with previous systems, namely non-uniform 
stretch and limited range of stretch. The problem of restricted range of 
stretch was overcome by designing apparatus to achieve a stretch of 0- 
20%. The study conducted by Hebert et al. 230 suggests that this is a 
suitable range to examine. Thorough investigation showed that the 
silicone sheet was evenly stretched throughout the rectangular area.
Measuring a single cell in the unstretched position and after 20% 
stretch confirmed firm cell adhesion and a close correlation between 
silicone and cell stretch. Other groups studying the effects of stretch on 
cellular function did not confirm that the cells that were being stretched 
experienced a similar force to their subtrate. This is an important point 
which had to be confirmed.
Vsmc and endothelial cells grew well on silicone sheeting which 
had been treated with the cell adhesion-promoting agent, fibronectin. 
Staining had also shown that vsmc grew uniformly throughout the 
whole area of the rectangular piece of silicone.
Having checked all of the necessary requirements of the 
cell stretching apparatus and having verified that these had all been 
met in this system, it was now possible to examine the effect of stretch
127
on second messenger function. The results of which are discussed in 
the folowing chapter.
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CHAPTER FOUR
RESULTS(B)
PROTO-ONCOGENE, PHOSPHOINOSITIDE 
AND VSMC GROWTH STUDIES
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4.1 Proto-oncogene measurements
4.1.1 Vsmc
The aim was to use the system designed for stretching vsmc and 
endothelial cells in culture to study whether the forces existing in blood 
vessels play a role in the development of vascular hypertrophy. To 
examine whether stretch stimulates vsmc growth, proto-oncogene 
expression was measured. Proto-oncogenes are known to be expressed 
prior to cell proliferation and are therefore useful indicators of cell growth.
Vsmc which had been deprived of serum for 24h, were stretched 
by 20% for 0, 15, 30, 60, 180 or 360 min at 37°C. RNA was prepared 
from the cells, as described in section 2.8.10. RNA samples were 
processed for Northern analysis and the results obtained by 
autoradiography.
4.1.1.1 Expression of c-fos mRNA
Plate 13 is a photograph of a representative autoradiograph showing the 
effects of 20% stretch on c-fos mRNA expression, c-fos mRNA was 
undetectable in unstimulated cells. However, in response to a 20% 
stretch there was a rapid accumulation of c-fos mRNA, which was 
maximal at 15 min, still detectable at 30 min and then declined to basal 
levels. In parallel to these experiments, the effect of the growth factor, 
ANG II, on c-fos mRNA expression in vsmc was measured. Quiescent 
vsmc were treated with 1 jiM ANG II for 0,15, 30 60, 180 or 360 min and 
c-fos mRNA expression measured. Plate 14 shows that 1 ANG II 
produced maximum expression between 15 and 30 min and that 
expression returned to basal levels by 180 min. Therefore 20% stretch 
produced a similar time course of c-fos mRNA expression to that of a 
growth factor. From these results, we can conclude that stretch and 
growth factors such as ANG II can both stimulate c-fos mRNA 
expression over a similar time course. The work with ANG II was 
performed as part of a study (see publication list) to identify the ANG II 
receptor subtype which was responsible for the stimulation of proto­
oncogene expression and phosphoinositide metabolism 36.
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Plate 13. A representative autoradiograph showing the effects of a fixed 
stretch of 20% on c-fos mRNA induction, in vsmc. Vsmc were plated at a 
density of 0.8 x 106 cells and grown to confluence. Cells were serum 
deprived for 24h and then stretched by 20% for 0, 15, 30, 60, 180 or 360 
min. RNA was extracted from the cells, run on agarose gels and blotted 
onto nylon membranes. The membranes were then hybridised with a v- 
fos cDNA probe, as described in section 2.8.10. The autoradiograph was 
exposed to x-ray film for 72h, at -70°C.
For each of the proto-oncogene studies discussed ,6 separate experiments 
were performed. For each experiment one representative data set are shown. 
In each experiment a control group in which no intervention was performed 
was studied. Flowever, because no proto-oncogene expression was observed 
for the control group these photographs are not included in the results.
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Plate 14. A representative autoradiograph showing the effects of 1^m 
ANG II on c-fos mRNA induction, in vsmc. Vsmc were plated at a density 
of 0.8 x 106 cells and grown to confluence. Cells were serum deprived for 
24h and then stretched by 20% for 0, 15, 30, 60, 180 or 360 min. RNA 
was extracted from the cells, run on agarose gels and blotted onto nylon 
membranes. The membranes were then hybridised with a v-fos cDNA 
probe, as described in section 2.8.10. The autoradiograph was exposed 
to x-ray film overnight, at -70°C.
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Having studied the time course of c-fos mRNA expression in response to 
stretch and having established that a maximum c-fos expression was 
achieved usually by 15 min, the next step was to determine whether the 
concentration of the c-fos mRNA signal was dependent on the degree of 
stretch. Cells which had been deprived of serum for 24h were stretched 
by 0, 5, 10,15 or 20%, for 15 min, at 37°C. Plate 15 is a photograph of a 
representative autoradiograph showing the results obtained in this study. 
The levels of c-fos mRNA were increased with increasing length of 
stretch and maximal levels were achieved by 15%. Thus the intensity of 
the c-fos mRNA signal was dependent on the degree of stretch.
4.1.1.2 Expression of c-jun mRNA
The protein product of the proto-oncogene c-jun plays an important role 
in the regulation of transcription, via the formation of the AP-1 complex 
(section 1.3.1.1). Therefore, the effect of 20% stretch on c-jun mRNA 
expression was studied. Quiescent vsmc were stretched by 20% for 0, 
15, 30, 60, 180 or 360 min and c-jun mRNA expression measured 
(section 2.8.10). On several occasions,c-jun mRNA expression was 
observed in unstimulated cells, but c-jun mRNA expression was not 
induced in response to 20% stretch, c-jun mRNA expression in 
unstimulated vsmc has also been observed by other groups 231 • 232»233.
To determine whether ANG II could stimulate c-jun mRNA 
expression in vsmc, quiescent vsmc were treated with 1^M ANG II for 0, 
15, 30 60, 180 or 360 min and c-jun mRNA expression measured. The 
results obtained from this group of experiments are shown in Plate 16. 
The mRNA for c-jun was undetectable in unstimulated vsmc. Maximum 
expression was seen between 30 and 120 min stimulation and at 180 min 
this declined to almost basal levels. The growth factor ANG II induced c- 
jun mRNA expression in vsmc but 20% stretch did not.
4.1.1.3 Expression of c-myc mRNA
The processes of proliferation and differentiation are known to be 
controlled by the proto-oncogene c-myc 46. Thus, the effect of 20% 
stretch on these events was studied by examining c-m yc  mRNA 
expression, in quiescent vsmc. Vsmc were deprived of serum for 24h and 
then stretched by 20% for 0, 15, 30 or 60 min and c-m yc mRNA
133
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Plate 15. A representative autoradiograph showing the effects of a varied 
stretch on c-fos mRNA induction, in vsmc. Vsmc were plated at a density 
of 0.8 x 106 cells and grown to confluence. Cells were serum deprived for 
24h and then exposed to a varied stretch of either 0, 5, 10, 15 or 20%, for 
15 min. RNA was extracted from the cells, run on agarose gels and 
blotted onto nylon membranes. The membranes were then hybridised 
with a v-fos cDNA probe, as described in section 2.8.10. The 
autoradiograph was exposed to x-ray film for 48h, at -70°C.
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Plate 16. A representative autoradiograph showing the effects of 1 (liM 
ANG II on c-jun mRNA induction, in vsmc. Vsmc were plated at a density 
of 0.8 x 106 cells and grown to confluence. Cells were serum deprived for 
24h and then treated with 1 ANG II for 0, 15, 30, 60, 180 or 360 min. 
RNA was extracted from the cells, run on agarose gels and blotted onto 
nylon membranes. The membranes were then hybridised with a c-jun 
cDNA probe, as described in section 2.8.10. The autoradiograph was 
exposed to x-ray film overnight, at -70°C.
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expression measured (section 2 .8 .10). 60 min was chosen as the end 
time point of the experiments because Naftilan et a[. 34 had shown that c- 
myc mRNA expression in vsmc occurred rapidly in response to ANG II 
with maximum expression after 30 min. By studying fewer time points, 
more pieces of apparatus could be used for each time point which would 
increase the amount of RNA available for each of the time points studied. 
A basal c-myc mRNA expression was observed in unstimulated cells. 
However, in response to 20% stretch, this expression persisted over the 
15, 30 and 60 min time points but did not increase above control levels 
(Plate 17).
To compare the effect of 20% stretch with that of a growth factor, 
the effect of 1nM ANG II on c-myc mRNA expression was investigated. 
Vsmc were deprived of serum for 24h and then treated with 1 jiM ANG II 
for 0,15, 30 or 60 min and c-myc mRNA expression measured. Plate 18 
shows that c-myc mRNA expression was detectable in unstimulated 
cells, which increased after 15 min stimulation and reached maximum 
levels between 30 and 60 min.
In conclusion, mechanical stretch increased c-fos mRNA with 
maximal expression occuring between 15 and 30 min. There was no 
evidence that stretch increased mRNA for either c-jun or c-myc. 
However, ANG II stimulated both c-jun and c-myc mRNA in vsmc.
4.1.2 Endothelial cells
Endothelial cells experience shear stresses but are also exposed to 
mechanical forces. The effect of stretch on proto-oncogene expression in 
bovine aortic endothelial cells was studied. The endothelial cell studies 
concentrated on the effects of 20% stretch on the expression of the proto- 
oncogenes c-fos and c-jun because of their importance in the regulation 
of transcription.
4.1.2.1 Expression of c-fos mRNA
Endothelial cells which had been deprived of serum for 24h, were 
stretched by 20% for 0, 15, 30, 60, 180, or 360 min, at 37°C. RNA was 
prepared from the cells, as described in section 2 .8.10  and the samples 
processed for Northern analysis. Plate 19 is a photograph of a
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Plate 17. A representative autoradiograph showing the effects of a fixed 
stretch of 20% on c-myc mRNA induction, in vsmc. Vsmc were plated at 
a density of 0.8 x 106 cells and grown to confluence. Cells were serum 
deprived for 24h and then stretched by 20% for 0, 15, 30, 60, 
min. RNA was extracted from the cells, run on agarose gels and blotted 
onto nylon membranes. The membranes were then hybridised with a o  
myc cDNA probe, as described in section 2.8.10. The autoradiograph 
was exposed to x-ray film for 72h, at -70°C.
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Plate 18. A representative autoradiograph showing the effects of 1[iM 
ANG II on c-myc mRNA induction, in vsmc. Vsmc were plated at a 
density of 0.8 x 106 cells and grown to confluence. Cells were serum 
deprived for 24h and then treated with 1 ANG II for 0, 15, 30, 
or 60 min. RNA was extracted from the cells, run on agarose gels and 
blotted onto nylon membranes. The membranes were then hybridised 
with a c-myc cDNA probe, as described in section 2.8.10. The 
autoradiograph was exposed to x-ray film overnight, at -70°C.
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Plate 19. A representative autoradiograph showing the effects of a fixed 
stretch of 20% on c-fos mRNA induction, in endothelial cells. Endothelial 
cells were plated at a density of 0.8 x 106 cells and grown to confluence. 
Cells were serum deprived for 24h and then stretched by 20% for 0, 15, 
30, 60, 180 or 360 min. RNA was extracted from the cells, run on agarose 
gels and blotted onto nylon membranes. The membranes were then 
hybridised with a v-fos cDNA probe as described in section 2.8.10. The 
autoradiograph was exposed to x-ray film overnight, at -70°C.
representative autoradiograph showing the effects of a 20% stretch on c- 
fos mRNA expression, in cultured endothelial cells. Low levels of c-fos 
mRNA signal was detected in unstimulated cells. However, 20% stretch 
for 15 min resulted in a rapid accumulation of c-fos mRNA, which 
declined to basal levels by 30 min and was undetectable by 60 min. This 
is a similar time course of c-fos mRNA expression as was observed 
when the effect of 20% stretch and V M  ANG II, on c-fos mRNA 
expression in vsmc was investigated.
4.1.2.2 Expression c-jun mRNA
Endothelial cells which had been deprived of serum for 24h, were 
stretched by 20% for 0, 15, 30, 60, 180, or 360 min at 37°C. RNA was 
prepared and c-jun mRNA expression measured as described in section 
2.8.10. Plate 20 is a photograph of a representative autoradiograph 
showing the effects of a 20% stretch on c-jun mRNA expression in 
cultured endothelial cells. Minimal levels of c-jun mRNA were detected in 
unstimulated cells, levels achieved maximum from 15 to 60 min and c-jun 
mRNA levels persisted to 360 min. 20% stretch did not induce c-jun 
mRNA expression in vsmc but the time course of c-jun mRNA 
expression produced by 1 nM ANG II was very similar to that induced by 
20% stretch in endothelial cells.
These studies have shown that mechanical stretch can stimulate 
c-fos and c-jun mRNA expression in endothelial cells.
4.2 Phosphoinositide metabolism
The effect of stretch on phosphoinositide turnover was studied.
Confluent vsmc were pre-labelled with 3H-myo-inositol for 48h, 
subjected to 20% stretch for 20 min and total inositol phosphate 
production measured, according to the procedure of Berridge 226, as 
described in section 2.7.4. 20 min was chosen for the incubation time 
because vsmc treated with ANG II for 20 min showed a 1.8 fold increase 
in total inositol phosphate production 36. Vsmc were treated with either 
10% FCS, which was included as a positive control, 10_7M ANG II, to 
compare the effects of stretch with that of a growth factor, or 20% stretch,
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Plate 20. A representative autoradiograph showing the effects of a fixed 
stretch of 20% on c-jun mRNA induction, in endothelial cells. Endothelial 
cells were plated at a density of 0.8 x 106 cells and grown to confluence. 
Cells were serum deprived for 24h and then stretched by 20% for 0, 15, 
30, 60, 180 or 360 min. RNA was extracted from the cells, run on agarose 
gels and blotted onto nylon membranes. The membranes were then 
hybridised with a c-jun cDNA probe as descbibed in section 2.8.10. The 
autoradiograph was exposed to x-ray film overnight, at -70°C.
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for 20 min. The cells were then lysed and total inositol phosphate 
production was measured.
Figure 26 shows the results expressed as a % of control ± S.E.M. 
where control =100%. Incubation with 10% FCS resulted in a 7.7 fold 
increase in inositol phosphate levels released. This result had been 
anticipated because FCS contains many growth promoting substances 
and is therefore a good positive control. Incubation with 10_7M ANG II 
resulted in a 2.3 fold increase in inositol phosphates released. After 
stretching cells by 20% for 20 min, a 3.2 fold increase in inositol 
phosphate levels was measured. Thus both 20% stretch and 10_7M ANG 
II mediated inositol phosphate release in vsmc.
4.3 Growth response of vsmc to mechanical stretch
The experiments described above for rat mesenteric vsmc showed that 
stretch induced c-fos mRNA expression and increased inositol phosphate 
production but had no effect on c-jun or c-myc mRNA expression. The 
next group of experiments performed was to determine whether a fixed 
stretch could stimulate vsmc growth. This was achieved by examining the 
effect of stretch on vsmc number.
Vsmc were plated at a cell density of 0.4x106 cells/per piece of 
apparatus on day 0 of the study. The cells were fed with growth medium 
containing 20% serum. The following day (day 1) the number of cells 
present on 3 pieces of apparatus was counted, the medium removed 
from each of the remaining pieces of apparatus and replaced with growth 
medium containing 10% serum. 10 pieces of apparatus were stretched by 
20% and the remaining 10 unstretched for control purposes. On day 2, 
the medium was removed and counted to determine whether any vsmc 
had become detached as a consequence of cell stretching. The number 
of vsmc present on the fibronectin-treated silicone was then determined 
for 3 stretched and 3 controls. This procedure was also repeated on day 
3. On day 4 the number of cells present in the medium and on the 
fibronectin-treated silicone were determined for the remaining 4 stretched 
and 4 controls. Figures 27 & 28 show the results obtained for the 
fibronectin-treated silicone and medium, respectively.
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Figure 26. Effect of 20% stretch, 10% FCS and 10_7M ANG II on phosphoinositide 
turnover, in vsmc. The cells were plated at a density of 0.8 x 106 cells, grown on 
fibronectin-coated silicone membranes and labelled with [3H]-inositol.The cells were 
either stretched by 20%, or stimulated with 10% FCS, or 10"7M ANG II. Total [3H]- 
inositol phosphates released were measured. Results are expressed as a % of 
control ± S.E.M., where control =100%; n=6 .
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Figure 27. Effect of 20% stretch on vsmc growth. On day 0, cells were 
plated at a density of 0.4 x 106 cells / per piece of apparatus, in growth 
medium containing 20% serum. The following day the number of cells 
present on 3 pieces of apparatus was determined. 10 pieces of apparatus 
were then stretched by 20% and the remaining 10 left unstretched. The 
growth medium was replaced by medium containing 10% serum. Cell 
numbers were evaluated on days 2 ,3  and 4. Results are expressed as 
mean-fold increase in cell number ± S.E.M; n=3.
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Figure 28. Effect of stretch on vsmc detachment. On day 0, vsmc were plated at a 
density of 0.4 x 106 cells / per piece of apparatus. On day 1,10 pieces of apparatus 
were stretched by 20% and the remaining 10 used as controls. Over the following 3 
days the growth medium was removed and the number of vsmc present in the medium 
of stretched and control vsmc was determined. n=3.
145
In Figure 27, results are expressed as a mean-fold increase in the 
number of cells present on the apparatus compared with day 1, ±  S.E.M. 
Figure 27 shows that although the number of cells in the control group 
were higher than the stretch group on days 2, 3 and 4 , this did not reach 
statistical significance. Therefore no significant difference was observed 
in the rate of growth of stretched compared to control vsmc.
In Figure 28 results are expressed as mean cell number ± S.E.M. 
Very low cell counts were measured in the medium of control and 
stretched vsmc, suggesting that the vsmc had not become detached. No 
significant difference was observed for the number of vsmc present in the 
medium of stretched vsmc compared to control vsmc. Thus stretch did 
not cause cell detachment.
Although 20% stretch had produced an increase in c-fos mRNA 
expression and inositol phosphate production, 20% stretch alone did not 
produce a statistically significant increase in vsmc growth rate.
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CHAPTER FIVE 
DISCUSSION
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5.1 The relevance of the present study to understanding the 
aetiology of hypertension
As discussed in the introduction, vascular hypertrophy (section 1.2) 
contributes to the development of essential hypertension. Vascular 
hypertrophy is characterised by an increase in the media:lumen ratio of 
the small resistance vessels (section 1.1.2.3), which produces an 
increased pressure in the systemic arterial circulation. Much research 
has been focussed on elucidating the aetiology of essential hypertension 
because it is also associated with increased risk of ischaemic heart 
disease and stroke.
At present, essential hypertension cannot be explained by 
impairment of a single parameter. It is accepted that a combination of 
factors are responsible for its development. Folkow 21 postulated that a 
hemodynamic component was involved in the development of vascular 
hypertrophy. This theory was extended to include the role of a non- 
hemodynamic growth-promoting component (Lever et a[. 22). Possible 
non-hemodynamic components include both vasoconstrictor peptides 
and peptide growth factors. The role of the non-hemodynamic factors 
(e.g ANG II) has been extensively studied. However, the hemodynamic 
component has been less well studied, especially in vitro and it was on 
this component that my project focussed.
The hemodynamic component consists principally of the forces 
of shear stress and pressure which are exerted on the vessel wall 
(Davies 135). Endothelial cells and vsmc are subjected to the pressure 
component whereas only the endothelial cells experience the shear 
forces within the vessel. The radius of resistance vessels change with 
increased and decreased blood flow. When an increase in flow is 
required to facilitate maximum blood flow, the radius of the lumen will 
also be at its maximum diameter. This will be accompanied by a 
reduction in the radius of the media. As a result of this, the cells of the 
vessel wall will be mechanically deformdd. When the vessel relaxes the 
cells will retain their original size and conformation. Thus, as cells are 
exposed to alterations in blood flow they will continuallly alter their size 
and shape. Under pathological conditions, the forces exerted would 
result in greater increases in mechanical perturbation of the cells. 
Therefore, to determine at the cellular and molecular level the signalling
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mechanisms involved when cells are mechanically deformed, an in vitro 
system was developed to mimic these conditions.
5.2 The development of an in vitro system
The major advantage of an in vitro study is that a particular situation can 
be studied in isolation, in the absence of other humoral influences. 
There have been several attempts to develop an in vitro cell stretching 
system for various biological applications. Many of these designs 
encountered serious problems (section 1.6). In particular, they failed to 
ensure uniform stretch throughout the experimental tissue. Therefore, 
this project concentrated on designing a system which could produce an 
even stretch. Two versions were constructed and tested in terms of 
effects on growth and proto-oncogene expression.
5.3 First proto-type
The first design was based on the Petriperm dish. A vacuum could be 
used to vertically displace the base of the dish and this could be easily 
achieved in the incubator in an environment optimal for vsmc and 
endothelial cell growth. Previous studies had shown that a range of cell 
types could be grown in Petriperm dishes and it seemed likely that vsmc 
and endothelial cells would tightly adhere to the base of the dish and 
remain attached when the base of the dish was stretched. This proved to 
be the case. This was a simple system which could be engineered 
relatively quickly and could be produced economically in bulk. Growth 
and function in the system were evaluated as follows.
5.3.1 Growth
The first study assessed the effect of cell adhesion-promoting agents on 
vsmc and endothelial cell growth. Figure 16 shows that coating the 
dishes with gelatin and fibronectin resulted in a 2- and 2.4- fold increase 
in growth, respectively. Fibronectin was chosen for subsequent 
experiments because it was more effective in potentiating vsmc growth 
and because, unlike gelatin, fibronectin forms a monolayer. If the cell 
adhesion-promoting agent forms multilayers, when the base of the dish
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is stretched, it is impossible to be sure that the cells attached to the cell 
adhesion agent are being stretched and not the cell adhesion-promoting 
agent alone. Fibronectin was also shown to produce a 1.5 fold increase 
in endothelial cell growth when compared to control cells (Figure 17). 
Both vsmc and endothelial cells grew well in Petriperm dishes coated 
with fibronectin.
As discussed earlier, the design of the system aimed to look at 
the effect of hemodynamic forces on cellular function, in the absence of 
other humoral influences. By introducing the use of fibronectin to the 
system these requirements remained satisfied because this extracellular 
adhesive glycoprotein is found in vivo, were it functions to mediate cell- 
matrix adhesion. This was also the function which it performed in this 
system. Therefore it was feasible to presume that fibronectin should not 
have any significant effects on the parameters which were to be 
examined in this study.
5.3.2 Proto-oncogene expression
The effect on c-fos mRNA expression caused by stretching vsmc by 
20% for various times was measured. Plate 6 shows that c-fos mRNA 
was undetectable in unstimulated cells. In response to stretch there was 
a rapid accumulation of c-fos mRNA which reached maximum levels by 
30 min, was still detectable at 180 min and returned to basal levels by 
360 min. Plate 14 shows the results obtained when quiescent vsmc were 
treated with the growth factor, ANG II (1 jiM). Expression of c-fos mRNA 
was undetectable in unstimulated cells. Maximum c-fos mRNA 
expression was achieved between 15 and 30 min and declined to basal 
levels after 60 min. These time courses of c-fos mRNA expression are 
in agreement with the observations made by Kawahara et al. 230 and 
Taubman et aL 231 for rat aortic vsmc. They observed maximum c-fos 
mRNA expression at 30 min in response to similar doses of ANG II. 
Thus, these results suggested that growth factors such as ANG II and 
mechanical stretch both induce c-fos mRNA expression via similar 
mechanisms. A stretching force does stimulate cell growth and therefore 
may contribute to the development of hypertrophy.
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5.3.3 Problems with first proto-type
The above study provided evidence that mechanical stretch stimulates 
proto-oncogene expression. However, a maximum value of only 0.3% 
could be achieved using this system which was too small to imitate 
physiological conditions.
The minimal internal circumference (Lq) achieved when a vessel 
contracts is 0.4 L0 and the maximum when fully relaxed is 1.8L0 
(Mulvany e i a l  237). Therefore, a 4.5 fold increase in internal 
circumference is achieved on relaxation of a contracted vessel. Such a 
dramatic change in the internal circumference of the vessel should cause 
the components of the vessel wall to experience large mechanical 
forces. Mulvany et a l 238 showed that in essential hypertensive patients 
the lumen diameter of vessels was reduced by 7% compared to 
normotensive patients. In combination, these facts suggest that although 
resistance vessels are extremely elastic in nature, changes in 
hemodynamic forces much smaller than maximal can initiate the process 
of vascular hypertophy, a factor which contributes to the development of 
hypertension. This conclusion is also suggested by the fact that a stretch 
of 0.3 % stimulated a growth response.
The major disadvantage of the Petriperm system was that the 
stretch achieved by the Petriperm dish was not uniform, being greatest in 
the central area of the base of the dish. To correct this and to increase 
the maximum stretch range an alternative system was devised.
5.4 Second prototype and final working model: performance criteria
The design of the new proto-type was based on the stretch frame which 
has been described in section 1.6 .2 . To develop an effective and reliable 
in vitro system was a time consuming and technically difficult task. 
However, with a knowledge of the essential features required of the 
system and the expertise of engineers, the new system was designed 
and constructed. Plate 8 shows the apparatus and its important features. 
Several types of silicone sheeting of varied thickness and elasticity from 
a range of manufacturers were tested, to find the most suitable. This 
system was based on the requirement that a thin piece of silicone 
sheeting exhibits elastic properties and is relatively easy to stretch
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without having to exert too great a force. By turning the handle of the 
stretching apparatus the length of silicone could be increased. Since 
cells grown on the silicone sheet adhere tightly to their substrate, as the 
length of the silicone sheet is increased, the cells also experience a 
similar increase in their length.
Replicate measurements of areas from 5 grid marked silicone 
sheets showed that the degree of stretch was linear and uniform 
throughout the sheets over a range from 5% to 20% stretch (3.3.2), thus 
improving on the Petriperm dish model. Although both vsmc and 
endothelial cells grew better under culture flask conditions than on 
silicone sheeting, fibronectin caused a 5-fold and 3-fold improvement, 
respectively. Moreover, coomassie blue staining showed that vsmc grew 
uniformly throughout the rectangular area of the fibronectin-coated 
silicone sheeting (3.3.3).
It was important to establish that vsmc were stretched to the same 
extent as the silicone sheet substrate. Measurement of single cells 
before and after 20% stretching gave an average increase of 22.7 ± 
1.63%. These performance criteria were judged to be good enough to 
proceed with the physiological study.
5.5 The effect of mechanical forces on proto-oncogene expression
The effect of stretch on proto-oncogene expression was studied in vsmc 
and endothelial cells. Preliminary experiments showed that an increase 
in c-fos mRNA expression was achieved with a stretching force of 0.3%. 
With the new apparatus a range of 0-20% was possible.
5.5.1 Proto-oncogene expression in vsmc in response to stretch
The expression of the proto-oncogenesc-fos, c-jun and c-myc, in 
response to stretch and to ANG II, were compared. These particular 
proto-oncogenes were chosen because as discussed in section 1.3.1:1 
they are known to be involved in the process of cell proliferation.
Expression of c-fos mRNA was undetectable in control cells. 
Maximum expression was achieved after 15 min of 20% stretch, 
remained detectable at 30 min and declined to basal levels after 60 min
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stimulation (Plate 13). The response of c-fos mRNA expression 
achieved is therefore dependent on the period of stretch. It was of 
interest to find out if the growth factor ANG II and stretch stimulate proto­
oncogene expression via similar mechanisms. Plate 14 shows the effect 
of 1fiM ANG II on proto-oncogene expression in vsmc. In unstimulated 
cells, c-fos mRNA expression was undetectable. Maximum c-fos mRNA 
expression was achieved at 15 and 30 min and the signal declined to 
basal levels after 60 min. The c-fos mRNA expression time course 
produced by 20% stretch was similar to that produced by 1jiM ANG II.
These were very exciting results because they identified the 
existance of a relationship in the mechanism by which a mechanical 
force and a growth factor can stimulate vsmc growth. It is known that 
when proto-oncogene production is stimulated specific RNAses are 
simultaneously produced which degrade the proto-oncogene mRNA. 
These RNAses were identified by the fact addition of a protein synthesis 
inhibitor to the medium e.g cycloheximide, intensified the proto­
oncogene mRNA response 34- 35« 37. Therefore, for both mechanical 
stretch and ANG II to have stimulated proto-oncogene production with 
similar time courses of expression, the mechanism by which this occurrs 
must be very similar in nature.
The advantage of the new system was that it was possible to look 
at the effect of different lengths of stretch on particular cell signalling 
events during the same experiment, whereas other systems were 
restricted in the magnitude of stretch which could be achieved (183> 184> 
215). The value of this is illustrated in the experiments described in 
section 2.7.3. Using 15 min periods as the optimum response time, 
maximum c-fos mRNA expression resulted from a stretch of between 15 
& 20%.
From the results obtained from the c-fos mRNA study, it was 
postulated that c-jun mRNA expression may also be induced. The 
protein products Fos and Jun interact with each other to form a 
heterodimeric transcription factor complex known as the AP-1 
transcription factor. The AP-1 transcription factor binds to a consensus 
DNA sequence containing AP-1 sites and switches on the expression of 
late response genes involved in cell proliferation and differentiation 
(1.3.1.1). To determine whether this was the mechanism through which 
stretch could stimulate proliferation in vsmc, the effect of 20% stretch on 
c-jun mRNA expression was investigated.
In contrast to c-fos, c-jun mRNA expression was apparent in
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unstretched cells but no further response was elicited by 20% stretch for 
up to 360 min. However, ANG II (1pm) did stimulate expression with a 
maximum expression achieved by 30 min, which persisted to 120 min 
(Plate 16). In this latter experiment c-jun mRNA expression was not 
detectable at time zero. Naftilan et al. 37 observed no c-jun mRNA 
expression in unstimulated vsmc. However, Schunkert et aL 234, 
Mollinedo et al. 235 and Viard et aL 236 have observed c-jun mRNA 
expression in unstimulated rat hearts, granulocytes and adrenocortical 
cells, respectively. This information suggests that c-jun mRNA may be 
expressed in some types of unstimulated cell, under some experimental 
conditions.
Another nuclear proto-oncogene of interest is that of c-myc, which 
is believed to play a role in the control of proliferation and differentiation 
46. To examine further the effect of a stretching force on cell growth the 
effect of 20% on c-myc mRNA expression was studied (2.7.1.1).
Although c-myc mRNA expression was observed under basal 
conditions over the 0-60 min time interval (Plate 17), no increase of 
expression occurred during stretching. A time interval of 0-60 min was 
chosen for this group of experiments because Naftilan et a[. 34 observed 
maximum c-myc mRNA within 30 min of stimulation, with ANG II. In my 
ANG II experiments, unstimulated vsmc showed c-myc mRNA 
expression which increased significantly by 15 min and reached 
maximum levels between 30 min and 60 min (Plate 18). These results 
agreed with those of Naftilan et a[. 34 Thus mechanical stretch was 
unable to stimulate c-myc mRNA expression in quiescent vsmc in 
contrast to the actions of ANG II.
5.5.2 Proto-oncogene expression in endothelial cells in response to 
stretch
An increased rate of endothelial cell growth is important in the 
development of hypertension through its contributory role to vascular 
hypertrophy. An increased rate of endothelial cell proliferation should 
result in the increased production of the vasoconstrictor, endothelin. 
Endothelin stimulates vasoconstriction of blood vessels and therefore 
increases TPR. Therefore, the effect of stretch on expression of the 
proto-oncogenes c-fos and c-jun, in endothelial cells, was also 
investigated. These particular proto-oncogenes were chosen because of 
their involvement in the activation of the AP-1 transcription factor, an
154
important cell signalling event. In combination, the vsmc and endothelial 
studies allowed comparison of the time courses of expression of different 
proto-oncogenes, in two different cell types.
Plate 19 (section 4.1.2.1) shows that c-fos mRNA was present 
in unstimulated cells, in contrast to observations made for vsmc. It is 
difficult to say whether this is a common observation made for 
endothelial cells because limited studies have examined this effect. As 
for vsmc, a maximum signal was obtained after a 20% stretch for 15 min. 
This declined to basal levels by 30 min and was undetectable by 60 min. 
Thus vsmc and endothelial cells control c-fos mRNA expression in a 
similar manner.
If stretch stimulates endothelial cell growth does this occur via 
activation of the AP-1 transcription factor? To examine this question the 
effect of 20% stretch on c-jun mRNA expression, in endothelial cells, 
was investigated. Expression of c-jun mRNA was observed in 
unstimulated endothelial cells, as shown in Plate 20 (section 4.1.2 .2 ). 
Maximum gene expression had occurred by 15 min and persisted at 60 
min. Expression fell by 180 min but still remained above basal levels at 
360 min. The time course of c-jun mRNA expression in endothelial cells 
was similar to that observed when ANG II was added to vsmc (Plate 16).
5.5.3 Summary of proto-oncogene studies
The proto-oncogene studies have shown that in vsmc, mechanical 
stretch stimulates c-fos mRNA expression in a similar time course to 
that of the growth factor ANG II. However, contrasting results were 
obtained for c-jun and c-myc mRNA expression. This suggests that 
mechanical stretch may not be involved in the development of vascular 
hypertrophy or that the expression of c-jun and c-myc mRNA are not 
pivotal in this process. If the latter is true this suggests that the formation 
of the AP-1 transcriptrion factor is not an important signalling event in the 
stimulation of vascular growth. From the available information it is not 
possible to say if this is the case.
The fact that mechanical stretch stimulates c-fos and c-jun 
mRNA expression in endothelial cells, in a time course similar to that 
observed for ANG II in vsmc, suggests that endothelial cells may play a 
vital role in vascular hypertrophy. Further studies are required to identify 
the precise role of endothelial cells in this process.
155
Thus, these results identify a precise difference in the role of vsmc 
and endothelial cells in the control of proto-oncogene expression and the 
subsequent stimulation of growth.
5.6 Phosphoinositide turnover in vsmc in response to stretch
Figure 5 of the introduction illustrates how a growth factor can stimulate 
the breakdown of PIP2 which results in the production of IP3 and DAG. A 
whole series of isomers of inositol phosphates are then produced via the 
action of various phosphatases. However, these phosphatases can be 
inhibited by lithium, which stabilises the isomers. This principle was 
exploited to measure the amount of inositol phosphates released in vsmc 
in response to 20% stretch. The inositol lipid pool was prelabelled with 
[3H]-myo-inositol before the stretch was applied and the release of 3H 
inositol phosphates measured.
From Figure 26, one can see that 20% stretch induced a 3.2 fold 
increase in inositol phosphate production, which was greater than the 2.3 
fold increase observed for the growth factor ANG II. 10% FCS which was 
included as a positive control produced a 7.7-fold increase. The 
response to ANG II was of the same order to the 1.8 fold increase 
previously observed by our group36. This study had shown that both a 
growth factor and mechanical stretch could stimulate phosphoinositide 
turnover, an important early signalling event in many cellular processes, 
and that this possibly occurred via similar mechanisms.
In vivo, both hemodynamic and non-hemodnamic factors will 
coexist. Therefore, it will be of great interest to study the effect of stretch 
in combination with that of ANG II to reproduce this situation. Future 
work will also investigate the effect of stretch on inositol phosphate 
production in endothelial cells as well as determine the effect of different 
amounts of stretch on phosphoinositide turnover in both vsmc and 
endothelial cells.
5.7 Summary of proto-oncogene and phosphoinositide turnover 
studies
From the vsmc studies, it appears that mechanical stretch can produce 
changes in c-fos mRNA expression and inositol phosphate release,
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typical of a growth factor, such as ANG II. However, this study found no 
evidence that mechanical stretch could stimulate c-jun and c-m yc  
mRNA expression in vsmc. In contrast, endothelial cells increased both 
c-fos and c-jun mRNA expression when stretched; c-myc was not 
studied.
Mechanical stretch and the growth factor ANG II can both 
stimulate the hydrolysis of PIP2, an important transmembrane signalling 
event known to be coupled to growth factor receptors 55. This hydrolysis 
results in the production of the second messenger IP3 responsible for the 
release of Ca2+ from intracellular stores. As shown in Figure 5, DAG is 
also a product of this hydrolysis which leads to the activation of the 
downstream regulatory enzyme PKC. PKC can then stimulate the 
expression of proto-oncogenes.
This study confirmed that both ANG II and mechanical stretch 
could stimulate c-fos mRNA expression in vsmc. ANG II also induced 
expression of c-jun and c-myc mRNA in vsmc, but mechanical stretch 
did not stimulate the expression of either of these proto-oncogenes. 
Therefore both early and later signalling events known to be involved in 
cell proliferation were shown to be stimulated via the growth factor action 
of ANG II or by mechanical stretch, in vsmc.
Although the ability of ANG II to stimulate proto-oncogene 
expression in endothelial cells was not investigated in this study, 
mechanical stretch was also shown to stimulate early signalling events in 
endothelial cells.
5.8 Vsmc growth
The process of vascular growth can arise as a result of hypertrophy, 
and/or hyperplasia or remodelling of the vasculature (section 1.2 ). 
Therefore, to further examine the role of mechanical stretch in this 
process, its effect on vsmc growth rate was investigated. The effect of 
stretching vsmc on growth rate was determined by the simple expedient 
of estimating vsmc numbers in control and stretched cells. Stretching by 
20% for 1, 2, or 3 days caused no significant increase in cell numbers 
compared with control. Of considerable practical value, no more cells 
were released into the supernatant medium in stretched than 
unstretched preparations. This indicates that the fibronectin-coated 
silicone sheeting provides a good substrate for cell growth and adhesion
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(Figure 28).
Although c-fos mRNA expression and phosphoinositide turnover 
were stimulated in vsmc in response to mechanical stretch, under the 
conditions used in this study, vsmc growth was increased but not 
statistically significant. It is possible to suggest that the inability of 
mechanical stretch to stimulate c-jun mRNA expression and thus 
activate the AP-1 transcription factor may be partially responsible for this 
effect.
A range of results have been observed when the rate of cell 
growth in response to mechanical stretch has been studied which largely 
depends on whether the cells are receiving a fixed stretch or a cyclic 
stretch, the cell type being studied, the system used to stretch the cells, 
the amount by which they are stretched and the time interval over which 
they are stretched. None of the following studies can be directly 
compared with my study because of the difference in experimental 
conditions.
Previous studies which looked at the effect of mechanical stretch 
on growth rate observed a variety of results. Brunette et a L 184 observed 
an increase in DNA synthesis in epithelial cells which received a fixed 
stretch of 4.2% and Sumpio et aL 186 observed a decrease in smc 
number and a decrease in DNA synthesis in response to a 24% cyclic 
strain over 7 days. However, Liu et al. 187 exposed fetal rat lung cells to 
48h of an intermittent stretch pattern of 5% elongation, 60 stretches/min, 
for 15 min of each hour and observed both an increase in DNA synthesis 
and a 10% increase in cell number.
5.9 The relevance of a fixed stretch
The cell stretching system which was designed produced a single fixed 
stretch. The fact that this stimulated second messenger system activity is 
very encouraging evidence that hemodynamic factors play an important 
role in the development of vascular hypertrophy. Under pathological 
conditions, mechanical forces will cause the cells of the vessel wall to 
experience multiple stretch regimens of varied frequency and duration. In 
such situations, an amplified effect on second messenger events might 
be expected. Perhaps a single stretch is not sufficient stimulus to induce 
any significant difference in expression of the proto-oncogenes c-jun 
and c-myc , or to significantly affect the rate of vsmc growth. However, it 
is reasonable to begin by studying a single stretching event because the
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mechanical forces experienced in vivo are in fact multiple single 
stretching events. Moreover, a single fixed stretch did stimulate c-fos 
mRNA expresion and phosphoinositide turnover in vsmc. Studying a 
single fixed stretch also allows decision as to whether the initial single 
stretching force experienced by the vessel triggers cell signalling 
mechanisms or whether continuous stretching is responsible for this 
effect.
5.10 Pulsatile system
To further investigate the effect of a mechanical load on signalling 
mechanisms involved in cell proliferation, a pulsatile system has been 
developed. The first proto-type of the pulsatile system is shown in Plate 
2 1 . The cell stretching apparatus is connected to a motor which 
displaces the handle of the stretching apparatus over a variable 
frequency of 0-60 cycles/min. Its performance is being assessed at 
present. Important factors which are to be checked is whether the 
silicone sheeting can withstand multiple stretches because this could 
introduce creasing of the silicone. The behaviour of the cells grown on 
the silicone, in response to a pulsatile force will also be studied.
5.11 Overall conclusions
The achievements of this project were the development an in vitro cell 
stretching system capable of mimicking the hemodynamic forces to 
which cells are exposed in the vessel wall and the preliminary 
investigation of the effect of mechanical forces on second messenger 
signalling events involved in cell proliferation. The final working model of 
the system satisfied the requirements of such a system and produced 
useful information on the biochemical and cell physiological effects of 
mechanical stretch. A single fixed stretch induced specific proto­
oncogene expression in both vsmc and endothelial cells and stimulated 
PIP2 hydrolysis in vsmc. The parallel experiments involved with the 
growth factor ANG II showed that mechanical stretch and ANG II had 
similar effects on these second messenger events. Differences observed 
between growth factor action and hemodynamic factors may be resolved
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motor
cell stretching apparatus
Plate 21. Pulsatile stretching system
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by looking at a cyclical stretch in preference to a fixed stretch and this is 
the direction in which this work should proceed.
161
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